FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU de Araujo, CAL
   Ray, JG
   Figueiroa, JN
   Alves, JG
AF de Araujo, Carla Adriane Leal
   Ray, Joel Geoffrey
   Figueiroa, Jose Natal
   Alves, Joao Guilherme
TI BRAzil magnesium (BRAMAG) trial: a double-masked randomized clinical
   trial of oral magnesium supplementation in pregnancy
SO BMC PREGNANCY AND CHILDBIRTH
LA English
DT Article
DE Pregnancy; Preterm birth; Newborn; Magnesium; Randomized clinical trial;
   Preeclampsia
ID ADULTS BORN PRETERM; SERUM MAGNESIUM; BLOOD-PRESSURE; LABOR;
   SUBSTITUTION; PREMATURITY; PREVENTION; BIRTH; WOMEN
AB Background There is conflicting evidence about the role of oral magnesium supplementation in the prevention of preterm birth and related adverse outcomes. The objective of this study was to compare magnesium citrate with placebo in the prevention of adverse perinatal and maternal outcomes among women at higher risk. Methods This multicenter, double-masked, placebo-controlled randomized superiority clinical trial compared oral magnesium citrate 300 mg to matched placebo, from 12 to 20 weeks' gestation until delivery. This trial was completed in three centers in northeastern Brazil. Eligible women were those with a singleton pregnancy and >= 1 risk factor, such as prior preterm birth or preeclampsia, or current chronic hypertension or pre-pregnancy diabetes mellitus, age > 35 years or elevated body mass index. The primary perinatal composite outcome comprised preterm birth < 37 weeks' gestation, stillbirth > 20 weeks, neonatal death or NICU admission < 28 days after birth, or small for gestational age birthweight < 3rd percentile. The co-primary maternal composite outcome comprised preeclampsia or eclampsia < 37 weeks, severe gestational hypertension < 37 weeks, placental abruption, or maternal stroke or death during pregnancy or <= 7 days after delivery. Results Analyses comprised 407 women who received magnesium citrate and 422 who received placebo. The perinatal composite outcome occurred among 75 (18.4%) in the magnesium arm and 76 (18.0%) in the placebo group - an adjusted odds ratio (aOR) of 1.10 (95% CI 0.72-1.68). The maternal composite outcome occurred among 49 (12.0%) women in the magnesium arm and 41 women (9.7%) in the placebo group - an aOR of 1.29 (95% CI 0.83-2.00). Conclusions Oral magnesium citrate supplementation did not appear to reduce adverse perinatal or maternal outcomes in high-risk singleton pregnancies.
C1 [de Araujo, Carla Adriane Leal; Alves, Joao Guilherme] Inst Med Integral Prof Fernando Figueira IMIP, Dept Pediat, Recife, PE, Brazil.
   [de Araujo, Carla Adriane Leal] FPS, Recife, PE, Brazil.
   [Ray, Joel Geoffrey] Univ Toronto, Dept Med, St Michaels Hosp, 30 Bond St, Toronto, ON M5B 1W8, Canada.
   [Ray, Joel Geoffrey] Univ Toronto, Dept Obstet & Gynaecol, St Michaels Hosp, 30 Bond St, Toronto, ON M5B 1W8, Canada.
   [Figueiroa, Jose Natal] Inst Med Integral Prof Fernando Figueira IMIP, Recife, PE, Brazil.
RP Ray, JG (corresponding author), Univ Toronto, Dept Obstet & Gynaecol, St Michaels Hosp, 30 Bond St, Toronto, ON M5B 1W8, Canada.
EM RayJ@smh.ca
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [401609/2013-8]; Bill & Melinda Gates FoundationBill & Melinda Gates
   Foundation [OPP1107597]
FX This work was supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq-process number 401609/2013-8), and Bill &
   Melinda Gates Foundation (Investment ID: OPP1107597). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Adegbesan-Omilabu MA, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/809536
   Alves JGB, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-222
   [Anonymous], EST VIT
   Araya BM, 2017, PUBLIC HEALTH, V147, P39, DOI 10.1016/j.puhe.2017.01.027
   Arikan GM, 1999, FETAL DIAGN THER, V14, P332, DOI 10.1159/000020952
   Black Libby, 2015, Manag Care, V24, P54
   Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2
   Bolton CE, 2015, THORAX, V70, P574, DOI 10.1136/thoraxjnl-2014-206590
   Bullarbo M, 2013, ARCH GYNECOL OBSTET, V288, P1269, DOI 10.1007/s00404-013-2900-2
   DAHLE LO, 1995, AM J OBSTET GYNECOL, V173, P175, DOI 10.1016/0002-9378(95)90186-8
   DALMEIDA A, 1992, WOMEN HEALTH, V19, P117, DOI 10.1300/J013v19n02_07
   de Baaij JHF, 2015, PHYSIOL REV, V95, P1, DOI 10.1152/physrev.00012.2014
   do Carmo Leal M, 2016, REPROD HLTH S3, V13, P164
   Enaruna NO, 2013, NIGER J CLIN PRACT, V16, P448, DOI 10.4103/1119-3077.116887
   França Elisabeth Barboza, 2017, Rev. bras. epidemiol., V20, P46, DOI 10.1590/1980-5497201700050005
   Grober U, 2015, NUTRIENTS, V7, P8199, DOI 10.3390/nu7095388
   Harrison V, 2007, BJOG-INT J OBSTET GY, V114, P994, DOI 10.1111/j.1471-0528.2007.01409.x
   Hovi P, 2016, HYPERTENSION, V68, P880, DOI 10.1161/HYPERTENSIONAHA.116.08167
   Idogun E S, 2007, Afr J Reprod Health, V11, P89, DOI 10.2307/25549719
   Indumati V, 2011, J CLIN DIAGN RES, V5, P66
   Jain S, 2010, BIOL TRACE ELEM RES, V133, P162, DOI 10.1007/s12011-009-8423-9
   Leal MD, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0230-0
   Makrides M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000937.pub2
   MARTIN RW, 1992, AM J OBSTET GYNECOL, V166, P144, DOI 10.1016/0002-9378(92)91849-6
   McCabe ERB, 2014, PEDIATRICS, V134, P1193, DOI 10.1542/peds.2014-2541
   Meier B, 2005, EUR J OBSTET GYN R B, V123, P157, DOI 10.1016/j.ejogrb.2005.04.002
   Newnham JP, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00066
   Nygaard IH, 2008, EUR J OBSTET GYN R B, V141, P23, DOI 10.1016/j.ejogrb.2008.07.005
   Pathak Priyali, 2004, Indian Journal of Pediatrics, V71, P1007
   Raju TNK, 2017, ACTA PAEDIATR, V106, P1409, DOI 10.1111/apa.13880
   Rocha VS, 2012, NUTR RES, V32, P542, DOI 10.1016/j.nutres.2012.05.010
   SIBAI BM, 1989, AM J OBSTET GYNECOL, V161, P115, DOI 10.1016/0002-9378(89)90246-9
   Soilly AL, 2014, PUBLIC HEALTH, V128, P43, DOI 10.1016/j.puhe.2013.09.014
   Souza AI, 2018, PUBLIC HEALTH REP, V133, P461, DOI 10.1177/0033354918777256
   SPATLING L, 1988, BRIT J OBSTET GYNAEC, V95, P120, DOI 10.1111/j.1471-0528.1988.tb06839.x
   Stritzke Amelie, 2017, Mol Cell Pediatr, V4, P2, DOI 10.1186/s40348-016-0068-0
   Tabrizi FM, 2014, INDIAN J CLIN BIOCHE, V29, P174, DOI 10.1007/s12291-013-0336-x
   Veronese N, 2020, EUR J NUTR, V59, P263, DOI 10.1007/s00394-019-01905-w
   Walker AF, 2003, MAGNESIUM RES, V16, P183
   World Health Organization, 2018, PRET BIRTH
   Zarean Elaheh, 2017, Adv Biomed Res, V6, P109, DOI 10.4103/2277-9175.213879
NR 41
TC 0
Z9 0
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2393
J9 BMC PREGNANCY CHILDB
JI BMC Pregnancy Childbirth
PD APR 21
PY 2020
VL 20
IS 1
AR 234
DI 10.1186/s12884-020-02935-7
PG 7
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA LI1PI
UT WOS:000529256300003
PM 32316938
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU de Araujo, CAL
   Oliveira, LD
   de Gusmao, IMB
   Guimaraes, A
   Ribeiro, M
   Alves, JGB
AF de Araujo, Carla Adriane Leal
   Oliveira, Larissa de Sousa
   de Gusmao, Isabela Melo Buarque
   Guimaraes, Angelica
   Ribeiro, Moranna
   Alves, Joao Guilherme Bezerra
TI Magnesium supplementation and preeclampsia in low-income pregnant women
   - a randomized double-blind clinical trial
SO BMC PREGNANCY AND CHILDBIRTH
LA English
DT Article
DE Pregnancy; Preeclampsia; Oral magnesium
ID HYPERTENSIVE DISORDERS; MATERNAL MORTALITY
AB Background: Preeclampsia is the major cause of maternal morbidity and mortality in developing countries. Magnesium sulfate is considered first-line therapy against eclampsia and magnesium deficiency in pregnancy has been associated with unfavourable perinatal outcomes. However there are doubts if magnesium supplementation during pregnancy can previne preeclampsia especially in population with high nutritional risk. This trial aims to verify the effect of oral magnesium supplmentation on preeclampsia incidence in low income pregnant women.
   Methods: This randomized, double-blind, placebo-controlled trial investigated the effect of oral magnesium citrate supplementation for preeclampsia in low-income Brazilian pregnant women, i.e. annual per capita income of US$ 1025 or less. Participants were admitted to the study with gestational age between 12 and 20 weeks. Magnesium serum level was measured pre-randomization and participants with hypermagnesemia were excluded. After randomizationg participants received magnesium citrate capsule (300 mg magnesium citrate) or a daily placebo capsule, until delivery. Intent-to-treat analysis was performed.
   Results: A total of 416 pregnant women were screened and 318 enrolled according to the inclusion criteria; 159 for each arm. Twenty-eight pregnant women were lost to follow-up. 55/290 (18.9%) of pregnant women developed preeclampsia; 26/143 (18.1%) in magnesium group and 29/147 (19.7%) in the control group; OR 0.90 (CI 95% 0.48-1.69), p = 0.747. No cases of eclampsia were registered.
   Conclusion: Oral magnesium supplementation did not reduce preeclampsia incidence in low-income and low-risk pregnant women.
C1 [de Araujo, Carla Adriane Leal; Ribeiro, Moranna; Alves, Joao Guilherme Bezerra] Inst Med Integral Prof Fernando Figueira IMIP, Dept Pediat, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
   [Oliveira, Larissa de Sousa; de Gusmao, Isabela Melo Buarque] FPS, Mother & Child Hlth, Ave Mal Mascarenhas de Morais 4861, BR-51150000 Recife, PE, Brazil.
   [Guimaraes, Angelica] Hosp Dom Malan, Dept Pediat, R Joaquim Nabuco S-N, BR-56304900 Petrolina, PE, Brazil.
RP Alves, JGB (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Dept Pediat, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
FU Conselho Nacional de Desenvovlimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Bill & Melinda Gates FoundationBill & Melinda Gates Foundation
   [4399862016-8, OPP1107597]
FX This work was supported by Conselho Nacional de Desenvovlimento
   Cientifico e Tecnologico (CNPq) and Bill & Melinda Gates Foundation
   [Grant numbers 4399862016-8, OPP1107597]. The study sponsors had no
   involvement in the research design, data collection, interpretation of
   the data, or publication.
CR Alves JGB, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-222
   [Anonymous], 1997, NAT AC COLL REP FUND, DOI NBK109825 [bookaccession]
   [Anonymous], 2016, COUNTR LEND GROUPS 2
   Bullarbo M, 2018, J PREGNANCY, V2018, DOI 10.1155/2018/4843159
   Conde-Agudelo A, 2011, AM J OBSTET GYNECOL, V503, pe1
   CONRADT A, 1984, Z GEBURTSH PERINATOL, V188, P49
   DALMEIDA A, 1992, WOMEN HEALTH, V19, P117, DOI 10.1300/J013v19n02_07
   Dalton LM, 2016, NUTR REV, V74, P549, DOI 10.1093/nutrit/nuw018
   De-Regil LM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008873.pub2
   Dorniak-Wall T, 2014, J HUM HYPERTENS, V28, P230, DOI 10.1038/jhh.2013.100
   DULEY L, 1992, BRIT J OBSTET GYNAEC, V99, P547, DOI 10.1111/j.1471-0528.1992.tb13818.x
   Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010
   Ghulmiyyah L, 2012, SEMIN PERINATOL, V36, P56, DOI 10.1053/j.semperi.2011.09.011
   Harrison V, 2007, BJOG-INT J OBSTET GY, V114, P994, DOI 10.1111/j.1471-0528.2007.01409.x
   Hofmeyr GJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001059.pub4
   Ismail Y, 2010, CLIN CHEM LAB MED, V48, P323, DOI 10.1515/CCLM.2010.077
   de Araujo CAL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227497
   Li S, 1997, Zhonghua Fu Chan Ke Za Zhi, V32, P613
   Makrides M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000937.pub2
   Mayrink J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46011-3
   Melo B, 2014, REV ASSOC MED BRAS, V60, P105, DOI 10.1590/1806-9282.60.02.006
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2535, 10.1371/journal.pmed.1000097]
   Schoenaker DAJM, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0157-7
   SIBAI BM, 1989, AM J OBSTET GYNECOL, V161, P115, DOI 10.1016/0002-9378(89)90246-9
   Williams PJ, 2011, BEST PRACT RES CL OB, V25, P405, DOI 10.1016/j.bpobgyn.2011.02.007
   WYNN A, 1988, Nutrition and Health (Bicester), V6, P69
NR 26
TC 0
Z9 0
U1 1
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2393
J9 BMC PREGNANCY CHILDB
JI BMC Pregnancy Childbirth
PD APR 9
PY 2020
VL 20
IS 1
AR 208
DI 10.1186/s12884-020-02877-0
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA LG3OM
UT WOS:000528014300006
PM 32272914
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU do Nascimento, GR
   Borges, MD
   Figueiroa, JN
   Alves, LV
   Alves, JG
AF do Nascimento, Graciliano Ramos
   Borges, Maria do Carmo
   Figueiroa, Jose Natal
   Alves, Lucas Victor
   Alves, Joao Guilherme
TI Physical activity pattern in early pregnancy and gestational diabetes
   mellitus risk among low-income women: A prospective cross-sectional
   study
SO SAGE OPEN MEDICINE
LA English
DT Article
DE Physical activity; gestational diabetes mellitus; low income;
   prospective study
ID EXERCISE; GLUCOSE; ASSOCIATIONS; METAANALYSIS; OVERWEIGHT; OUTCOMES;
   OBESITY; WEIGHT
AB Objective: Gestational diabetes mellitus is increasing worldwide, mainly in developing countries, and physical activity has not been studied in gestational diabetes mellitus prevention among low-income population. This prospective cross-sectional study assessed the gestational diabetes mellitus risk related to physical activity in early pregnancy among low-income women. Methods: A prospective cross-sectional study with 544 low-income pregnant women was conducted at the Instituto de Medicina Integral Prof. Fernando Figueira, Brazil. Gestational diabetes mellitus was diagnosed using the International Association of Diabetes and Pregnancy Study Groups criteria. Physical activity was assessed during early pregnancy using the Pregnancy Physical Activity Questionnaire and categorized as sedentary, light, moderate, or vigorous intensity. Results: Gestational diabetes mellitus occurred in 95 of 544 women (17.4%). Body mass index was higher in the gestational diabetes mellitus group. Nearly half of all pregnant women studied were physically inactive, and none of them were classified as vigorous physical active. Sedentary physical activity pattern was associated with a higher odds of gestational diabetes mellitus (odds ratio = 1.8, 95% confidence interval = 1.1-2.9), which did not change after adjusting for several covariates (odds ratio = 1.9, 95% confidence interval = 1.2-3.1). Conclusion: Physical inactivity in early pregnancy is associated with a higher risk of gestational diabetes mellitus among low-income women.
C1 [do Nascimento, Graciliano Ramos; Borges, Maria do Carmo] Univ Estadual Ciencias Saude Alagoas UNCISAL, Dept Biosci, Maceio, Brazil.
   [Figueiroa, Jose Natal] Inst Med Integral Prof Fernando Figueira IMIP, Dept Biostat, Recife, PE, Brazil.
   [Alves, Lucas Victor] Inst Med Integral Prof Fernando Figueira IMIP, Dept Neuropediat, Recife, PE, Brazil.
   [Alves, Joao Guilherme] Inst Med Integral Prof Fernando Figueira IMIP, Dept Pediat, Rua Coelhos,300 Boa Vista, BR-50070550 Recife, PE, Brazil.
RP Alves, JG (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Dept Pediat, Rua Coelhos,300 Boa Vista, BR-50070550 Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [401609/2013-8]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This study
   was supported by CNPq, 401609/2013-8.
CR Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009
   Anjana RM, 2016, DIABETES RES CLIN PR, V116, P253, DOI 10.1016/j.diabres.2016.04.041
   Aune D, 2016, EUR J EPIDEMIOL, V31, P967, DOI 10.1007/s10654-016-0176-0
   Badon SE, 2017, AM J EPIDEMIOL, V186, P326, DOI 10.1093/aje/kwx095
   Boriboonhirunsarn Dittakarn, 2006, J Med Assoc Thai, V89 Suppl 4, pS23
   Chasan-Taber L, 2004, MED SCI SPORT EXER, V36, P1750, DOI 10.1249/01.MSS.0000142303.49306.0D
   Chasan-Taber L, 2014, DIABETES METAB, V40, P67, DOI 10.1016/j.diabet.2013.09.005
   Comm Obstetric Practice, 2002, INT J GYNECOL OBSTET, V77, P79
   Cordero Y, 2015, MED SCI SPORT EXER, V47, P1328, DOI 10.1249/MSS.0000000000000547
   Cosson E, 2019, DIABETES METAB, V45, P465, DOI 10.1016/j.diabet.2018.11.006
   Cosson E, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007120
   Damm P, 2016, DIABETOLOGIA, V59, P1396, DOI 10.1007/s00125-016-3985-5
   Fatima SS, 2017, J PAK MED ASSOC, V67, P261
   Gittelsohn J, 2017, NUTR REV, V75, P62, DOI 10.1093/nutrit/nuw038
   International Diabetes Federation, 2013, IDF DIABETES ATLAS, P44
   Kim SY, 2010, AM J PUBLIC HEALTH, V100, P1047, DOI 10.2105/AJPH.2009.172890
   Lamminpaa R, 2018, EUR J NUTR, V57, P1721, DOI 10.1007/s00394-017-1567-z
   Leng JH, 2016, EUR J ENDOCRINOL, V174, P763, DOI 10.1530/EJE-15-1103
   Liu J, 2008, BIRTH-ISS PERINAT C, V35, P188, DOI 10.1111/j.1523-536X.2008.00239.x
   Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848
   Mijatovic-Vukas J, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060698
   Ming WK, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-2068-7
   Morkrid K, 2014, SCAND J MED SCI SPOR, V24, pE389, DOI 10.1111/sms.12183
   Morkrid K, 2012, EUR J ENDOCRINOL, V167, P579, DOI 10.1530/EJE-12-0452
   Nguyen CL, 2018, ACTA DIABETOL, V55, P955, DOI 10.1007/s00592-018-1174-3
   Nobles C, 2015, OBSTET GYNECOL, V125, P1195, DOI 10.1097/AOG.0000000000000738
   Coll CDN, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4036-y
   Oken E, 2006, OBSTET GYNECOL, V108, P1200, DOI 10.1097/01.AOG.0000241088.60745.70
   Oostdam N, 2012, BJOG-INT J OBSTET GY, V119, P1098, DOI 10.1111/j.1471-0528.2012.03366.x
   Parnell AS, 2017, MATERN CHILD HLTH J, V21, P1105, DOI 10.1007/s10995-016-2209-4
   Redden SL, 2011, MATERN CHILD HLTH J, V15, P514, DOI 10.1007/s10995-010-0586-7
   Russo LM, 2015, OBSTET GYNECOL, V125, P576, DOI 10.1097/AOG.0000000000000691
   Sauder KA, 2016, DIABETIC MED, V33, P663, DOI 10.1111/dme.13093
   Sibai BM, 2010, J MATERN-FETAL NEO M, V23, P229, DOI 10.3109/14767050903550899
   Silva FT, 2009, FIEP B, V79, P318
   Stafne SN, 2012, OBSTET GYNECOL, V119, P29, DOI 10.1097/AOG.0b013e3182393f86
   The World Bank, 2017, WORLD BANK COUNTR LE
   Tobias DK, 2011, DIABETES CARE, V34, P223, DOI 10.2337/dc10-1368
   Torloni MR, 2009, OBES REV, V10, P194, DOI 10.1111/j.1467-789X.2008.00541.x
   van der Ploeg HP, 2011, J SCI MED SPORT, V14, P149, DOI 10.1016/j.jsams.2010.09.002
   Wang Z, 2013, INT J GYNECOL OBSTET, V121, P14, DOI 10.1016/j.ijgo.2012.10.032
   Yan Y, 2017, J DIABETES INVEST, V8, P554, DOI 10.1111/jdi.12595
   Yin YN, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2013-092596
NR 43
TC 0
Z9 0
U1 1
U2 4
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 2050-3121
J9 SAGE OPEN MED
JI SAGE Open Med.
PD SEP
PY 2019
VL 7
AR UNSP 2050312119875922
DI 10.1177/2050312119875922
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA IW3NN
UT WOS:000484888700001
PM 31523429
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Souza, ASR
   Cavalcante, EVV
   Macedo, CA
   Freitas, SG
   Figueiredo, ATP
   Alves, SA
   Silva, TCAC
   Souza, GFD
   Alves, JG
AF Rolland Souza, Alex S.
   Cavalcante, Emanuela V. V.
   Macedo, Candice A.
   Freitas, Stenio G.
   Figueiredo, Amanda T. P.
   Alves, Susi A.
   Silva, Thaise C. A. C.
   de Albuquerque Souza, Gustavo F.
   Alves, Joao G.
TI The impact of maternal touch of the abdomen on cardiotocography fetal
   patterns
SO BRAIN AND BEHAVIOR
LA English
DT Article
DE abdomen touching; cardiotocography; fetal movements
ID STIMULATION; RESPONSES
AB Introduction Some studies suggest that maternal touch of the abdomen produces an increase in the number of movements of the fetus. However, the influence of maternal touch of the abdomen on fetal cardiotocography patterns has not been studied. Methods This nonrandomized, before-after clinical trial that assessed fetal cardiotocography patterns during maternal touch of the abdomen in 28 low-risk pregnant women. Results Baseline fetal heart rate, accelerations, decelerations, and variability did not change with maternal touch of the abdomen, but fetal movements increased (p = 0.044). Conclusion Fetal movements increases during maternal touch of the abdomen.
C1 [Rolland Souza, Alex S.; Macedo, Candice A.; Freitas, Stenio G.] Inst Med Integral Prof Fernando Figueira IMIP, Dept Fetal Med, Recife, PE, Brazil.
   [Cavalcante, Emanuela V. V.; Figueiredo, Amanda T. P.; Alves, Susi A.; Silva, Thaise C. A. C.] FPS, Recife, PE, Brazil.
   [de Albuquerque Souza, Gustavo F.] Univ Catolica Pernambuco UNICAP, Recife, PE, Brazil.
   [Alves, Joao G.] Inst Med Integral Prof Fernando Figueira IMIP, Dept Pediat, Rua Coelhos 300, Recife, PE, Brazil.
RP Alves, JG (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Dept Pediat, Rua Coelhos 300, Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Alves, Joao G/J-6483-2013; Souza, Alex Sandro Rolland/AAG-2471-2019
OI Alves, Joao G/0000-0002-9170-0808; Souza, Alex Sandro
   Rolland/0000-0001-7039-2052
CR Gonzalez JG, 2017, COMPLEMENT THER CLIN, V27, P61, DOI 10.1016/j.ctcp.2017.03.004
   Gebuza G, 2018, ADV CLIN EXP MED, V27, P615, DOI 10.17219/acem/68693
   HOOKER D, 1952, Anat Rec, V113, P503
   HUMPHREY T, 1959, J COMP NEUROL, V112, P75, DOI 10.1002/cne.901120110
   KISILEVSKY BS, 1992, CHILD DEV, V63, P1497
   Marx V, 2017, INFANT BEHAV DEV, V47, P83, DOI 10.1016/j.infbeh.2017.03.005
   Marx V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129118
   PIONTELLI A, 2015, DEV NORMAL FETAL MOV, DOI DOI 10.1161/01.STR.0000221308.94473.14
   Saadia Zaheera, 2018, Open Access Maced J Med Sci, V6, P1813, DOI 10.3889/oamjms.2018.405
   SILVEIRA C, 2010, REPROD HEALTH, V7, DOI DOI 10.1186/1742-4755-7-23
   2014, INTERPRETATION CARDI, P190
NR 11
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 2162-3279
J9 BRAIN BEHAV
JI Brain Behav.
PD AUG
PY 2019
VL 9
IS 8
AR e01345
DI 10.1002/brb3.1345
EA JUN 2019
PG 4
WC Behavioral Sciences; Neurosciences
SC Behavioral Sciences; Neurosciences & Neurology
GA IU4PR
UT WOS:000473891300001
PM 31254448
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Alves, JGB
   Alves, GV
AF Bezerra Alves, Joao Guilherme
   Alves, Guilherme Victor
TI Effects of physical activity on children's growth
SO JORNAL DE PEDIATRIA
LA English
DT Review
DE Physical activity; Physical exercise; Growth; Child; Adolescent
ID EXERCISE
AB Objective: To describe the current scientific knowledge on the effects of physical exercise on the growth of children and adolescents since intrauterine life.
   Source of data: A search was carried out in the Medline, Embase, Scielo, and Cochrane databases of studies published from 1990 to 2018. The authors included studies with different designs: clinical trials, cohort, cross-sectional and review studies.
   Synthesis of data: Studies that addressed the subject of physical exercise or physical activity, and weight-height growth or bone or muscle tissue growth were identified. These studies were analyzed, classified, and presented by age group: fetuses, preterm newborns, preschoolers, schoolchildren, and adolescents. It was observed that almost all studies indicated the safety of physical exercises, of mild to moderate intensity, for pregnant women, as well as children and adolescents, including both aerobic and anaerobic exercises. The retrieve studies did not demonstrate that the practice of physical exercises or certain sports, especially basketball and floor gymnastics, influenced the linear growth of children or adolescents. Some studies showed an increase in bone and muscle tissue growth in child and adolescent athletes.
   Conclusions: Despite the small number of studies with adequate methodology, especially randomized clinical trials, evidence appears to indicate that physical exercise is safe for both the pregnant woman and the child, from fetal life to adolescence. Physical exercise does not appear to impair the child's linear growth and contributes to the ideal shaping of bone and muscle tissues, ensuring possible beneficial effects throughout life. (C) 2018 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda.
C1 [Bezerra Alves, Joao Guilherme] Inst Med Integral Prof Fernando Figueira IMIP, Dept Pediat, Recife, PE, Brazil.
   [Alves, Guilherme Victor] HOB, Brasilia, DF, Brazil.
RP Alves, JGB (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Dept Pediat, Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
CR Atves C, 2008, REV PAUL PEDIATR, V26, P383
   Barakat R, 2015, BRIT J SPORT MED, V49, P1377, DOI 10.1136/bjsports-2015-094756
   Bielemann RM, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-77
   Chahar OS, 2014, AM J SPORTS SCI MED, V2, P17
   Comm Obstet Practice, 2015, OBSTET GYNECOL, V126, pe135, DOI 10.1097/AOG.0000000000001214
   da Silva CC, 2004, REV BRAS MED ESPORTE, V10, P525
   Frois RR, 2014, REV BRAS CIENC MOV, V22, P145
   Fuchs RK, 2001, J BONE MINER RES, V16, P148, DOI 10.1359/jbmr.2001.16.1.148
   Georgopoulos Neoklis A, 2004, Hormones (Athens), V3, P233
   GRIFFIN TGC, 2015, NELSON TXB PEDIAT, P1
   Jauregui A, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-109
   Kraemer WJ, 2005, SPORTS MED, V35, P339, DOI 10.2165/00007256-200535040-00004
   Krneta Zeljko, 2015, Coll Antropol, V39 Suppl 1, P35
   Litmanovitz I, 2016, CALCIFIED TISSUE INT, V99, P237, DOI 10.1007/s00223-016-0145-3
   Nilsson M, 2014, J BONE MINER RES, V29, P1795, DOI 10.1002/jbmr.2212
   Schulzke SM, 2014, COCHRANE DB SYST REV, V22
   TORUN B, 1994, EUR J CLIN NUTR, V48, pS186
   Twisk JWR, 2001, SPORTS MED, V31, P617, DOI 10.2165/00007256-200131080-00006
   Wold Health Organization, 2018, CHILD GROWTH STAND
   PEDIATRICS, V106, P1088
   2011, CLIN ENDOCRINOL OXF, V74, P495, DOI DOI 10.1111/J.1365-2265.2010.03964.X
   2016, PEDIAT EXERC SCI, V28, P178, DOI DOI 10.1123/PES.2015-0265
   2016, NEONATAL NETW, V35, P95, DOI DOI 10.1891/0730-0832.35.2.95
   2014, J CLIN DENSITOM, V17, P156, DOI DOI 10.1016/J.JOCD.2013.04.001
   2014, NUTR HOSP, V30, P719, DOI DOI 10.3305/NH.2014.30.4.7679
   J PEDIAT, V137, P510
   1985, PUBLIC HLTH REP, V100, P126
   MED SCI SPORTS EXERC, V32, P1698
   2017, J SCI MED SPORT, V20, P927, DOI DOI 10.1016/J.JSAMS.2017.03.021
   2003, CLIN OBSTET GYNECOL, V46, P423
   2018, INDIAN PEDIAT, V55, P115
   2017, CURR OPIN CARDIOL, V32, P541, DOI DOI 10.1097/HCO.0000000000000437
   2013, MED SCI SPORTS EXERC, V45, P2332, DOI DOI 10.1249/MSS.0B013E31829C32FE
   2015, OBSTET GYNECOL, V125, P1185, DOI DOI 10.1097/AOG.0000000000000801
   2014, MED SCI SPORTS EXERC, V46, P955, DOI DOI 10.1249/MSS.0000000000000181
   2007, SPORTS MED, V37, P533
   2012, CURR OPIN OBSTET GYN, V24, P387, DOI DOI 10.1097/GCO.0B013E328359F131
   2014, EARLY HUM DEV, V90, P137, DOI DOI 10.1016/J.EARLHUMDEV.2014.01.009
   2017, CLIN SPORTS MED, V36, P741, DOI DOI 10.1016/J.CSM.2017.05.005
   2017, ARCH GYNECOL OBSTET, V295, P273, DOI DOI 10.1007/S00404-016-4204-9
   1999, J BONE MINER RES, V14, P569
   2015, ACTA PAEDIATR, V104, P414, DOI DOI 10.1111/APA.12880
   J PEDIAT, V136, P149
NR 43
TC 0
Z9 0
U1 3
U2 7
PU SOC BRASIL PEDIATRIA
PI RIO DE JANEIRO, RJ
PA RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL
SN 0021-7557
EI 1678-4782
J9 J PEDIAT-BRAZIL
JI J. Pediatr.
PY 2019
VL 95
SU 1
BP S72
EP S78
DI 10.1016/j.jped.2018.11.003
PG 7
WC Pediatrics
SC Pediatrics
GA HU4QV
UT WOS:000465261900010
PM 30593790
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Alves, LV
   Paredes, CE
   Silva, GC
   Mello, JG
   Alves, JG
AF Alves, Lucas V.
   Paredes, Camila E.
   Silva, Germanna C.
   Mello, Julia G.
   Alves, Joao G.
TI Neurodevelopment of 24 children born in Brazil with congenital Zika
   syndrome in 2015: a case series study
SO BMJ OPEN
LA English
DT Article
DE paediatric neurology
AB Objective To describe the neurodevelopment of children with congenital Zika syndrome during the second year of life.
   Design Case series study.
   Setting Instituto de Medicina Integral Professor Fernando Figueira (IMIP), Pernambuco, Brazil.
   Participants 24 children with congenital Zika syndrome born with microcephaly during the Zika outbreak in Brazil in 2015 and followed up at the IMIP during their second year of life.
   Main outcome measure Denver Developmental Screening Test II, head circumference and clinical neurological examination.
   Results All children presented neurodevelopmental delay: for an average chronological age of 19.9 months, language was equivalent to that of age 2.1 months, gross motor 2.7 months, fine motor/adaptive 3.1 months and personal/social 3.4 months. Head circumference remained below the third percentile for age and gender, and growth rate up to the second year of life was 10.3cm (expected growth 13cm). Muscle tone was increased in 23 (95.5%) of 24 children, musculotendinous reflexes were increased in the whole sample and clonus was present in 18 (77.3%) of 24 children. All children except one had epilepsy.
   Conclusion Children born with microcephaly associated with congenital Zika virus have a significant neurodevelopmental delay.
C1 [Alves, Lucas V.] Inst Med Integral Prof Fernando Figueira, Dept Paediat Neurol, Recife, PE, Brazil.
   [Paredes, Camila E.; Silva, Germanna C.] Fac Pernambucana Saude, Teaching Dept, Recife, PE, Brazil.
   [Mello, Julia G.; Alves, Joao G.] Inst Med Integral Prof Fernando Figueira, Dept Paediat, Recife, PE, Brazil.
RP Alves, JG (corresponding author), Inst Med Integral Prof Fernando Figueira, Dept Paediat, Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
FU Bill & Melinda Gates FoundationBill & Melinda Gates Foundation;
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [439986/2016-8]
FX This research was supported by Bill & Melinda Gates Foundation and CNPq
   grant 439986/2016-8.
CR Abdel-Salam GMH, 2000, DEV MED CHILD NEUROL, V42, P760, DOI 10.1017/S0012162200001419
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   FRANKENBURG WK, 1992, PEDIATRICS, V89, P91
   Gordon-Lipkin E, 2017, J CHILD NEUROL, V32, P804, DOI 10.1177/0883073817707301
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Oliver SE, 2009, J CLIN VIROL, V46, pS22, DOI 10.1016/j.jcv.2009.08.012
   Passi D, 2017, INT J PREVENTIVE MED, V8, DOI 10.4103/2008-7802.199641
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Pinto Fernanda Chequer de Alcântara, 2015, Rev. CEFAC, V17, P1262, DOI 10.1590/1982-0216201517418214
   Saad T, 2018, CHILD NERV SYST, V34, P73, DOI 10.1007/s00381-017-3634-4
   Toizumi M, 2017, SCI REP-UK, V7, DOI 10.1038/srep46483
   Triunfol M, 2016, LANCET INFECT DIS, V16, P527, DOI 10.1016/S1473-3099(16)30015-9
NR 13
TC 20
Z9 20
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
J9 BMJ OPEN
JI BMJ Open
PD SEP
PY 2018
VL 8
IS 7
AR e021304
DI 10.1136/bmjopen-2017-021304
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA GV5YI
UT WOS:000446181900118
PM 30012787
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Alves, LV
   Mello, MJG
   Bezerra, PG
   Alves, JGB
AF Alves, Lucas V.
   Mello, Maria J. G.
   Bezerra, Patricia G.
   Bezerra Alves, Joao Guilherme
TI Congenital Zika Syndrome and Infantile Spasms: Case Series Study
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE Zika virus; congenital Zika syndrome; infantile spasms
ID VIRUS SYNDROME; INFECTION; BRAZIL
AB Recently described, the congenital Zika syndrome caused by the Zika virus has many features of other congenital infections. This case series study reports 22 infants with congenital Zika syndrome in Brazil who developed infantile spasms during their first year of life. The median age of infantile spasms onset was 4.3 (+/- 1.4) months and ranged from 1 to 7 months. Neurologic evaluation showed that all 22 children presented severe impairment of neuropsychomotor development. A total of 18 infants had an interictal hypsarrhythmia electroencephalogram (EEG) pattern. Vigabatrin was prescribed as first-line treatment; however, only 5 patients were controlled. Steroid regimes were started for children who did not respond to vigabatrin and they are being followed. In conclusion, congenital Zika syndrome may be considered as an etiological agent of infantile spasms.
C1 [Alves, Lucas V.; Mello, Maria J. G.; Bezerra, Patricia G.; Bezerra Alves, Joao Guilherme] Inst Med Integral Prof Fernando Figueira IMIP, Dept Paediat Neurol, Recife, PE, Brazil.
RP Alves, JGB (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Dept Pediat, Rua Coelhos 300 Boa Vista, BR-50070550 Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
CR [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x
   de Carvalho NS, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12616
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gordon-Lipkin E, 2017, J CHILD NEUROL, V32, P804, DOI 10.1177/0883073817707301
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   RIIKONEN R, 1993, NEUROPEDIATRICS, V24, P274, DOI 10.1055/s-2008-1071556
   Roze B, 2016, EUROSURVEILLANCE, P21, DOI DOI 10.28707/1560-7917.ES.2016.21.9.30154
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Suzuki Y, 2008, BRAIN DEV-JPN, V30, P420, DOI 10.1016/j.braindev.2007.12.004
   Widjaja E, 2015, EPILEPSY RES, V109, P155, DOI 10.1016/j.eplepsyres.2014.11.012
   Xixis KL, 2017, SPASM INFANTILE W SY
NR 12
TC 9
Z9 9
U1 0
U2 11
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD SEP
PY 2018
VL 33
IS 10
BP 664
EP 666
DI 10.1177/0883073818780105
PG 3
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA GQ3UU
UT WOS:000441593400006
PM 29897010
DA 2020-12-01
ER

PT J
AU Fuchs, FD
   Fuchs, SC
   Poli-de-Figueiredo, CE
   Neto, JAF
   Scala, LCN
   Vilela-Martin, JF
   Moreira, LB
   Chaves, H
   Gomes, MM
   de Sousa, MR
   Silva, RPE
   Castro, I
   Cesarino, EJ
   Sousa, ALL
   Alves, JG
   Steffens, AA
   Brandao, AA
   Bortolotto, LA
   Neto, AA
   Nobrega, AC
   Franco, RS
   Sobral, DC
   Nobre, F
   Schlatter, R
   Gus, M
   De David, CN
   Rafaelli, L
   Sesin, GP
   Berwanger, O
   Whelton, PK
AF Fuchs, Flavio D.
   Fuchs, Sandra C.
   Poli-de-Figueiredo, Carlos E.
   Figueiredo Neto, Jose A.
   Scala, Luiz Cesar N.
   Vilela-Martin, Jose F.
   Moreira, Leila B.
   Chaves, Hilton
   Gomes, Marco Mota
   de Sousa, Marcos R.
   Pereira e Silva, Ricardo
   Castro, Iran
   Cesarino, Evandro Jose
   Lima Sousa, Ana Luiza
   Alves, Joao Guilherme
   Steffens, Andre Avelino
   Brandao, Andrea Araujo
   Bortolotto, Luiz Aparecido
   Neto, Abrahao Afiune
   Nobrega, Antonio C.
   Franco, Roberto Silva
   Sobral Filho, Dario C.
   Nobre, Fernando
   Schlatter, Rosane
   Gus, Miguel
   De David, Caroline Nespolo
   Rafaelli, Leticia
   Sesin, Guilhermo Prates
   Berwanger, Otavio
   Whelton, Paul K.
TI Effectiveness of low-dose diuretics for blood pressure reduction to
   optimal values in prehypertension: a randomized clinical trial
SO JOURNAL OF HYPERTENSION
LA English
DT Article
DE chlorthalidone and amiloride; clinical trials; hypertension; optimal
   blood pressure; prehypertension
ID OUTCOME INCIDENCE; SODIUM REDUCTION; WEIGHT-LOSS; HYPERTENSION;
   PREVENTION; RISK; DISEASE; METAANALYSES; POPULATION; GUIDELINES
AB Background:To determine the effectiveness of low-dose diuretic therapy to achieve an optimal level of blood pressure (BP) in adults with prehypertension.Methods:The PREVER-prevention trial was a randomized, parallel, double-blinded, placebo-controlled trial, with 18 months of follow-up, conducted at 21 academic medical centers in Brazil. Of 1772 individuals evaluated for eligibility, 730 volunteers with prehypertension who were aged 30-70 years, and who did not reach optimal blood pressure after 3 months of lifestyle intervention, were randomized to a fixed association of chlorthalidone 12.5mg and amiloride 2.5mg or placebo once a day. The main outcomes were the percentage of participants who achieved an optimal level of BP.Results:A total of 372 participants were randomly allocated to diuretics and 358 to placebo. After 18 months of treatment, optimal BP was noted in 25.6% of the diuretic group and 19.3% in the placebo group (P<0.05). The mean net reduction in SBP and DBP for the diuretic group compared with placebo was 2.8mmHg (95% CI 1.1 to 4.5) and 1.1mmHg (95% CI -0.09 to 2.4), respectively. Most participants in the active treatment group (74.5%) and in the placebo group (80.7%) continued to have BP in the prehypertension range or progressed to hypertension.Conclusion:Low-dose diuretic therapy increased the probability of individuals with prehypertension to achieve optimal BP but most of those treated continued to have a BP in the prehypertension range or progressed to having overt hypertension.
C1 [Fuchs, Flavio D.; Fuchs, Sandra C.; Moreira, Leila B.; Schlatter, Rosane; Gus, Miguel; De David, Caroline Nespolo; Rafaelli, Leticia; Sesin, Guilhermo Prates] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Div Cardiol, Porto Alegre, RS, Brazil.
   [Poli-de-Figueiredo, Carlos E.] Pontificia Univ Catolica Rio Grande do Sul, Hosp Sao Lucas, Fac Med, Porto Alegre, RS, Brazil.
   [Figueiredo Neto, Jose A.] Univ Fed Maranhao, Univ Hosp, Sao Luis, Brazil.
   [Scala, Luiz Cesar N.] Univ Fed Mato Grosso, Hosp Univ Julio Muller, Cuiaba, Brazil.
   [Vilela-Martin, Jose F.] Fac Med Sao Jose do Rio Preto, Sao Jose Do Rio Preto, Brazil.
   [Vilela-Martin, Jose F.] Hosp Base, Sao Jose Do Rio Preto, Brazil.
   [Chaves, Hilton] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Gomes, Marco Mota] Hosp Coracao, Maceio, Brazil.
   [de Sousa, Marcos R.] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil.
   [Pereira e Silva, Ricardo] Univ Fed Ceara, Hosp Univ Walter Cantidio, Fortaleza, Ceara, Brazil.
   [Castro, Iran] Inst Cardiol, Porto Alegre, RS, Brazil.
   [Cesarino, Evandro Jose] USP Ribeirao Preto, Fac Ciencias Farmaceut, Ribeirao Preto, Brazil.
   [Lima Sousa, Ana Luiza] Univ Fed Goias, Hosp Clin, Goiania, Go, Brazil.
   [Alves, Joao Guilherme] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Steffens, Andre Avelino] Univ Fed Pelotas, Pelotas, Brazil.
   [Brandao, Andrea Araujo] Univ Estado Rio de Janeiro, Rio De Janeiro, Brazil.
   [Bortolotto, Luiz Aparecido] Univ Sao Paulo, Fac Med, Inst Coracao, Sao Paulo, Brazil.
   [Neto, Abrahao Afiune] Hosp Coracao Anis Rassi, Goiania, Go, Brazil.
   [Nobrega, Antonio C.] Univ Fed Fluminense, Hosp Univ Antonio Pedro, Niteroi, RJ, Brazil.
   [Franco, Roberto Silva] Fac Med Botucatu, Botucatu, SP, Brazil.
   [Sobral Filho, Dario C.] Hosp Univ PROCAPE, Recife, PE, Brazil.
   [Nobre, Fernando] USP Ribeirao Preto, Fac Med Ribeirao Preto, Ribeirao Preto, Brazil.
   [Berwanger, Otavio] HCor Hosp Coracao, Res Inst, Sao Paulo, Brazil.
   [Whelton, Paul K.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA.
RP Fuchs, FD (corresponding author), Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Serv Cardiol, Ramiro Barcelos 2350, BR-90035903 Porto Alegre, RS, Brazil.
EM ffuchs@hcpa.edu.br
RI Schlatter, Rosane/U-2709-2019; VILELA-MARTIN, JOSE/I-8305-2014; de
   Figueiredo, Carlos E Poli/A-2027-2013; Sousa, Ana Luiza/AAO-4239-2020;
   Sousa, Ana Luiza L/G-2936-2017; MOREIRA, LEILA LEILA B/AAC-2240-2019;
   Fuchs, Flavio D/L-5078-2016; Alves, Joao G/J-6483-2013; Cesarino,
   Evandro JosA© EJC/H-7018-2016; da Nobrega, Antonio Claudio
   Lucas/O-5107-2019; Fuchs, Sandra C/T-2670-2019; Filho, Dario
   Sobral/H-8624-2019
OI VILELA-MARTIN, JOSE/0000-0001-6960-2825; de Figueiredo, Carlos E
   Poli/0000-0002-7333-8884; Sousa, Ana Luiza L/0000-0002-7566-3541; Alves,
   Joao G/0000-0002-9170-0808; Cesarino, Evandro JosA©
   EJC/0000-0003-1672-4612; da Nobrega, Antonio Claudio
   Lucas/0000-0002-3830-2886; Filho, Dario Sobral/0000-0002-5301-7741;
   Nespolo de David, Caroline/0000-0002-6196-7501; da Silva Franco, Roberto
   Jorge/0000-0001-9787-4393
FU Ministry of Health, Division of Science and Technology (DECIT),
   Brazilian Innovation Agency (FINEP) [01080606/01]; Ministry of Science
   and Technology, Brazilian Innovation Agency (FINEP) [01080606/01];
   National Counsel of Technological and Scientific Development (CNPq),
   BrazilNational Council for Scientific and Technological Development
   (CNPq); National Institute of Health Technology Assessment (IATS), RS,
   Brazil; Hospital de Clinicas de Porto Alegre, RS, Brazil [FIPE-GPPG:
   08621]
FX The Ministry of Health, Division of Science and Technology (DECIT), and
   Ministry of Science and Technology, Brazilian Innovation Agency (FINEP)
   (number 01080606/01), National Counsel of Technological and Scientific
   Development (CNPq), Brazil, National Institute of Health Technology
   Assessment (IATS), and Hospital de Clinicas de Porto Alegre (FIPE-GPPG:
   08621), RS, Brazil sponsored the PREVER PREVENTION trial. The sponsors
   had no participation in the design and conduct of the study; collection,
   management, analysis, and interpretation of the data; and preparation,
   review, or approval of the manuscript.
CR Bundy JD, 2017, JAMA CARDIOL, V2, P775, DOI 10.1001/jamacardio.2017.1421
   COOK NR, 1995, ARCH INTERN MED, V155, P701, DOI 10.1001/archinte.155.7.701
   Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8
   Fuchs Flavio D, 2004, Expert Rev Cardiovasc Ther, V2, P771, DOI 10.1586/14779072.2.5.771
   Fuchs FD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-65
   Fuchs SC, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004248
   Gabb GM, 2016, MED J AUSTRALIA, V205, P85, DOI 10.5694/mja16.00526
   James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427
   Julius S, 2006, NEW ENGL J MED, V354, P1685, DOI 10.1056/NEJMoa060838
   Kang YY, 2016, PULSE, V4, P49, DOI 10.1159/000446922
   Kanno A, 2012, NEPHROL DIAL TRANSPL, V27, P3218, DOI 10.1093/ndt/gfs054
   Kurioka S, 2014, J HYPERTENS, V32, P236, DOI 10.1097/HJH.0000000000000031
   Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665
   Leung AA, 2016, CAN J CARDIOL, V32, P569, DOI 10.1016/j.cjca.2016.02.066
   Lewington S, 2002, LANCET, V360, P1903
   Luders S, 2008, J HYPERTENS, V26, P1487, DOI 10.1097/HJH.0b013e3282ff8864
   Mancia G, 2013, J HYPERTENS, V31, P1925, DOI 10.1097/HJH.0b013e328364ca4c
   Markus MRP, 2008, J HYPERTENS, V26, P2040, DOI 10.1097/HJH.0b013e328308da55
   Moreira LB, 2008, J HUM HYPERTENS, V22, P48, DOI 10.1038/sj.jhh.1002252
   Qaseem A, 2017, ANN INTERN MED, V166, P430, DOI 10.7326/M16-1785
   Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1
   Santos ABS, 2016, AM J HYPERTENS, V29, P568, DOI 10.1093/ajh/hpv156
   Sim JJ, 2014, J AM COLL CARDIOL, V64, P588, DOI 10.1016/j.jacc.2014.04.065
   Thomopoulos C, 2016, J HYPERTENS, V34, P613, DOI 10.1097/HJH.0000000000000881
   Thomopoulos C, 2014, J HYPERTENS, V32, P2285, DOI 10.1097/HJH.0000000000000378
   Thompson AM, 2011, JAMA-J AM MED ASSOC, V305, P913, DOI 10.1001/jama.2011.250
   Whelton PK, 1998, JAMA-J AM MED ASSOC, V279, P839, DOI 10.1001/jama.279.11.839
   Whelton PK, 1997, ARCH INTERN MED, V157, P657
   Whelton PK, 2002, JAMA-J AM MED ASSOC, V288, P1882, DOI 10.1001/jama.288.15.1882
   Williamson JD, 2016, JAMA-J AM MED ASSOC, V315, P2673, DOI 10.1001/jama.2016.7050
   Wright JT, 2015, NEW ENGL J MED, V373, P2103, DOI 10.1056/NEJMoa1511939
   Xie XF, 2016, LANCET, V387, P435, DOI 10.1016/S0140-6736(15)00805-3
NR 32
TC 3
Z9 4
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0263-6352
EI 1473-5598
J9 J HYPERTENS
JI J. Hypertens.
PD APR
PY 2018
VL 36
IS 4
BP 933
EP 938
DI 10.1097/HJH.0000000000001624
PG 6
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA GA0HQ
UT WOS:000427994500028
PM 29227377
DA 2020-12-01
ER

PT J
AU Alves, LV
   da Camara, FMP
   Granha, MB
   Neto, AM
   Alves, JGB
AF Alves, Lucas Victor
   Pinheiro da Camara, Filipe Marinho
   Granha, Mayara Batista
   Neto, Alfredo Meneses
   Alves, Bezerra J. G.
TI Chikungunya infection and horner syndrome
SO IDCASES
LA English
DT Article
DE Chikungunya virus; Horner syndrome
AB We describe an infant with Chikungunya virus (CHIKV) infection who developed Horner syndrome. The infant had diagnostic confirmation of CHIKV infection by IgM-ELISA positive in serum and cerebrospinal fluid, and clinical signs of Horner syndrome. Magnetic resonance angiography showed alterations in the cervical and intra cavernous portions of the internal carotid artery. To the best of our knowledge this is the first report of the association of CHIKV infection with Horner syndrome. (C) 2018 Published by Elsevier Ltd.
C1 [Alves, Lucas Victor; Granha, Mayara Batista] Inst Med Integral Prof Fernando IMIP, Neuropediat Dept, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
   [Pinheiro da Camara, Filipe Marinho; Neto, Alfredo Meneses; Alves, Bezerra J. G.] Inst Med Integral Prof Fernando IMIP, Pediat Dept, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
RP Alves, JGB (corresponding author), Inst Med Integral Prof Fernando IMIP, Pediat Dept, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
CR Acevedo Nathalie, 2017, Front Microbiol, V8, P42, DOI 10.3389/fmicb.2017.00042
   de Brito CAA, 2017, REV SOC BRAS MED TRO, V50, P585, DOI 10.1590/0037-8682-0479-2016
   Brizzi K, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0561-1
   Cerny T, 2017, NEUROCRIT CARE, V27, P447, DOI 10.1007/s12028-017-0413-8
   Dutta P, 2018, INT OPHTHALMOL, V38, P837, DOI 10.1007/s10792-017-0529-z
   Fernandez-Salas I, 2015, ANTIVIR RES, V124, P30, DOI 10.1016/j.antiviral.2015.10.015
   George NDL, 1998, BRIT J OPHTHALMOL, V82, P51, DOI 10.1136/bjo.82.1.51
   Magalhaes T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006055
   Peper SM, 2016, J GEN INTERN MED, V31, P576, DOI 10.1007/s11606-015-3459-3
   Rose N, 2011, INT J INFECT DIS, V15, pE147, DOI 10.1016/j.ijid.2010.10.004
   Singh A, 2017, INDIAN PEDIATR, V54, P249, DOI 10.1007/s13312-017-1040-3
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
NR 12
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-2509
J9 IDCases
JI IDCases
PY 2018
VL 14
AR e00473
DI 10.1016/j.idcr.2018.e00473
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA HM9WG
UT WOS:000459835100036
PM 30510900
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Agra, KF
   Pontes, IEA
   da Silva, JR
   Figueiroa, JN
   Clough, GF
   Alves, JGB
AF Agra, Karine Ferreira
   Albuquerque Pontes, Isabelle Eunice
   da Silva, Jose Roberto, Jr.
   Figueiroa, Jose Natal
   Clough, Geraldine F.
   Bezerra Alves, Joao Guilherme
TI Impaired neurovascular reactivity in the microvasculature of pregnant
   women with preeclampsia
SO MICROCIRCULATION
LA English
DT Article
DE laser doppler flowmetry; microcirculation; preeclampsia
ID PERIPHERAL-BLOOD FLOW; ENDOTHELIAL DYSFUNCTION; HYPERTENSIVE DISORDERS;
   VASCULAR DYSFUNCTION; RESISTANCE ARTERIES; THERMAL HYPEREMIA;
   MECHANISMS; MANAGEMENT; DISEASE; MARKERS
AB Introduction: PE is associated with maternal vascular dysfunction, leading to serious cardiovascular risk both during and following pregnancy.
   Objective: To assess microvascular reactivity in pregnant women with PE.
   Methods: A cross-sectional study was performed in 36 pregnant women with PE and 36 normotensive pregnant women (C) in the third trimester. Skin microvascular blood flow was measured using LDF at rest (RF), during the maximum hyperemic response to brief arterial occlusion (MF) and during the sympathetically mediated constrictor response to deep IBH.
   Results: In pregnant women with PE, RF was higher [C, 8.1 (4.6); PE, 12.0 (7.6), P<.001; PU perfusion units; median (IQR)] and MF/RF [C, 6.1 (3.7); PE, 3.9 (4.9) P<.001] and peak CVC lower (P=.009) compared to normotensive controls. The constrictor response to IBH [C, 62.4% (27.9); PE, 33.0% (50.6), P=.008] was reduced in women with PE. In univariate analysis, MF/RF was associated with PE status (r=-.417, P=.0001), systolic (r=-.385, P=.001), and diastolic (r=-.388, P=.001) blood pressure, but not BMI (r=.077, P=.536).
   Conclusions: Women with PE are more than three times more likely to exhibit a reduced microvascular reactivity in the third trimester of pregnancy than normotensive pregnant controls. These differences may be attributable in part to an altered sympathetic neural microvascular tone in PE.
C1 [Agra, Karine Ferreira; Albuquerque Pontes, Isabelle Eunice; da Silva, Jose Roberto, Jr.; Figueiroa, Jose Natal; Bezerra Alves, Joao Guilherme] Inst Med Integral Prof Fernando Figueira IMIP, Dept Mother & Child Hlth, Recife, PE, Brazil.
   [Clough, Geraldine F.] Univ Southampton, Fac Med, Southampton, Hants, England.
RP Clough, GF (corresponding author), Univ Southampton, Inst Dev Sci, Fac Med, Southampton Gen Hosp, MP 887, Southampton SO16 6YD, Hants, England.
EM g.f.clough@soton.ac.uk
RI de Albuquerque Pontes, Isabelle Eunice/AAG-6420-2019; Alves, Joao
   G/J-6483-2013
OI de Albuquerque Pontes, Isabelle Eunice/0000-0002-2194-8971; Alves, Joao
   G/0000-0002-9170-0808
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES -
   Brazil)CAPES; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq - Brazil)National Council for Scientific and
   Technological Development (CNPq)
FX Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES -
   Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq - Brazil)
CR Aggarwal PK, 2012, J HUM HYPERTENS, V26, P236, DOI 10.1038/jhh.2011.29
   Allen J, 2002, PHYSIOL MEAS, V23, P365, DOI 10.1088/0967-3334/23/2/312
   Anim-Nyame N, 2000, CLIN SCI, V99, P505, DOI 10.1042/CS20000091
   Anim-Nyame N, 2001, CARDIOVASC RES, V50, P603, DOI 10.1016/S0008-6363(01)00236-X
   Ashworth JR, 1997, BRIT J OBSTET GYNAEC, V104, P1152, DOI 10.1111/j.1471-0528.1997.tb10939.x
   Blaauw J, 2005, OBSTET GYNECOL, V105, P626, DOI 10.1097/01.AOG.0000153490.41973.e0
   Brennan LJ, 2014, MICROCIRCULATION, V21, P4, DOI 10.1111/micc.12079
   Brunt VE, 2012, J PHYSIOL-LONDON, V590, P3523, DOI 10.1113/jphysiol.2012.236398
   Brunt VE, 2011, J APPL PHYSIOL, V111, P5, DOI 10.1152/japplphysiol.00544.2011
   Chambers JC, 2001, JAMA-J AM MED ASSOC, V285, P1607, DOI 10.1001/jama.285.12.1607
   Chen CW, 2014, CARDIOVASC RES, V101, P579, DOI 10.1093/cvr/cvu018
   Cracowski JL, 2013, J APPL PHYSIOL, V114, P245, DOI 10.1152/japplphysiol.01085.2012
   D'Souza V, 2016, CLIN EXP HYPERTENS, V38, P225, DOI 10.3109/10641963.2015.1081226
   Davis KR, 2001, BRIT J OBSTET GYNAEC, V108, P610
   Duley L., 2011, BMJ CLIN EVID, V2011, P1402
   Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010
   Feger J, 2005, AUTON NEUROSCI-BASIC, V120, P88, DOI 10.1016/j.autneu.2005.04.004
   Fischer T, 2004, EUR J CLIN INVEST, V34, P443, DOI 10.1111/j.1365-2362.2004.01350.x
   Fischer T, 2000, AM J OBSTET GYNECOL, V183, P1489, DOI 10.1067/mob.2000.107323
   Frishman W H, 2006, Minerva Med, V97, P347
   Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928
   Grand'Maison S, 2016, HYPERTENSION, V68, P1447, DOI 10.1161/HYPERTENSIONAHA.116.07907
   Greenwood JP, 2001, CIRCULATION, V104, P2200, DOI 10.1161/hc4301.098253
   Hasan KM, 2002, J HYPERTENS, V20, P2439, DOI 10.1097/00004872-200212000-00024
   Houben AJHM, 2007, J HYPERTENS, V25, P1665, DOI 10.1097/HJH.0b013e3281900e0e
   Khan F, 2005, HYPERTENSION, V46, P1123, DOI 10.1161/01.HYP.0000186328.90667.95
   L'Esperance VS, 2013, EXP PHYSIOL, V98, P49, DOI 10.1113/expphysiol.2011.064055
   Luksha L, 2008, AM J PHYSIOL-REG I, V294, pR510, DOI 10.1152/ajpregu.00458.2007
   MCCARTHY AL, 1993, AM J OBSTET GYNECOL, V168, P1323, DOI 10.1016/0002-9378(93)90389-Z
   Minson CT, 2010, J APPL PHYSIOL, V109, P1239, DOI 10.1152/japplphysiol.00414.2010
   Murphy MSQ, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12217
   Noris M, 2005, NAT CLIN PRACT NEPHR, V1, P98, DOI 10.1038/ncpneph0035
   Podymow T, 2008, HYPERTENSION, V51, P960, DOI 10.1161/HYPERTENSIONAHA.106.075895
   Poston Lucilla, 2006, Pharmacol Rep, V58 Suppl, P69
   Quattrini C, 2007, DIABETES CARE, V30, P655, DOI 10.2337/dc06-2154
   Ramsay JE, 2003, BJOG-INT J OBSTET GY, V110, P1029, DOI 10.1111/j.1471-0528.2003.02069.x
   Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88
   ROSEN L, 1990, INT J MICROCIRC, V9, P257
   Roustit M, 2013, TRENDS PHARMACOL SCI, V34, P373, DOI 10.1016/j.tips.2013.05.007
   Savvidou MD, 2003, LANCET, V361, P1511, DOI 10.1016/S0140-6736(03)13177-7
   Schobel HP, 1996, NEW ENGL J MED, V335, P1480, DOI 10.1056/NEJM199611143352002
   Stark MJ, 2006, J SOC GYNECOL INVEST, V13, P573, DOI 10.1016/j.jsgi.2006.06.006
   Stewart FM, 2007, J CLIN ENDOCR METAB, V92, P969, DOI 10.1210/jc.2006-2083
   Takase B, 2003, J HUM HYPERTENS, V17, P697, DOI 10.1038/sj.jhh.1001599
   Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.02.001, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.04.017]
   Vollebregt KC, 2001, BRIT J OBSTET GYNAEC, V108, P1148
   WANG YP, 1991, AM J OBSTET GYNECOL, V165, P1695, DOI 10.1016/0002-9378(91)90017-L
   Wong BJ, 2003, J APPL PHYSIOL, V95, P504, DOI 10.1152/japplphysiol.00254.2003
   Yinon D, 2006, EUR RESPIR J, V27, P328, DOI 10.1183/09031936.06.00010905
   Yoshida A, 2000, HYPERTENSION, V36, P400, DOI 10.1161/01.HYP.36.3.400
   Young TM, 2006, J NEUROL, V253, P846, DOI 10.1007/s00415-006-0913-5
NR 51
TC 2
Z9 2
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1073-9688
EI 1549-8719
J9 MICROCIRCULATION
JI Microcirculation
PD OCT
PY 2017
VL 24
IS 7
AR e12383
DI 10.1111/micc.12383
PG 6
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA FJ2BT
UT WOS:000412526700002
PM 28544033
OA Green Accepted
DA 2020-12-01
ER

PT J
AU Lopes, KRM
   Souza, ASR
   Figueiroa, JN
   Alves, JGB
AF Lopes, Karina R. M.
   Souza, Alex Sandro R.
   Figueiroa, Jose N.
   Alves, Joao Guilherme B.
TI Correlation between pre-pregnancy body mass index and maternal visceral
   adiposity with fetal biometry during the second trimester
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Body mass index; Fetal body composition; Fetal growth; Fetal weight;
   Obesity; Pregnancy; Ultrasonography; Visceral adiposity
ID BIRTH-WEIGHT; OBESITY; RISK; PREGNANCY; GLUCOSE; GROWTH; WOMEN;
   ULTRASONOGRAPHY; METAANALYSIS; PROFILE
AB Objective: To determine the correlation between pre-pregnancy body mass index (BMI) and maternal visceral adiposity with fetal biometry during the second trimester.
   Methods: A cross-sectional observational study was conducted among pregnant women who received prenatal care at a center in Recife, Brazil, between October 3, 2011, and September 27, 2013. Pre-pregnancy BMI was determined at the first prenatal care visit. Maternal visceral adiposity and fetal biometry were measured at the same ultrasonography session. The associations between maternal and fetal variables were evaluated using the Pearson correlation coefficient (R). The Student t test was used to test the null hypothesis of adjusted correlation coefficients.
   Results: Overall, 740 women were included. No correlation was found between pre-pregnancy BMI and any of the fetal biometric variables assessed. By contrast, maternal visceral adiposity positively correlated with fetal abdominal circumference (R=0.529), estimated fetal weight (R=0.524), head circumference (R=0.521), femur length (R=0.521), and biparietal diameter (R=0.524; P<0.001 for all fetal variables). These findings remained statistically significant after controlling for pregnancy length.
   Conclusion: Maternal visceral adiposity, but not pre-pregnancy BMI, positively correlated with fetal biometry during the second trimester.
C1 [Lopes, Karina R. M.] Inst Med Integral Prof Fernando Figueira, Fetal Med Unit, Fetal Cardiol Dept, Recife, PE, Brazil.
   [Souza, Alex Sandro R.; Figueiroa, Jose N.] Inst Med Integral Prof Fernando Figueira, Integral Hlth Unit, Post Grad Dept, Recife, PE, Brazil.
   [Alves, Joao Guilherme B.] Inst Med Integral Prof Fernando Figueira, Pediat Unit, Pediat Dept, Recife, PE, Brazil.
RP Lopes, KRM (corresponding author), Inst Med Integral Prof Fernando Figueira, Fetal Med Unit, Fetal Cardiol Dept, Recife, PE, Brazil.
EM karinarml@gmail.com
RI Alves, Joao G/J-6483-2013; Souza, Alex Sandro Rolland/AAG-2471-2019
OI Alves, Joao G/0000-0002-9170-0808; Souza, Alex Sandro
   Rolland/0000-0001-7039-2052
CR BJORNTORP P, 1990, ARTERIOSCLEROSIS, V10, P493, DOI 10.1161/01.ATV.10.4.493
   Bray GA, 2008, AM J CLIN NUTR, V87, P1212
   Breij LM, 2015, HORM RES PAEDIAT, V84, P388, DOI 10.1159/000441298
   Canavan TP, 2014, J CLIN ULTRASOUND, V42, P456, DOI 10.1002/jcu.22158
   Castillo-Laura H, 2015, CAD SAUDE PUBLICA, V31, P2073, DOI 10.1590/0102-311X00159914
   Cisneiros RM, 2013, J OBSTET GYNAECOL CA, V35, P704, DOI 10.1016/S1701-2163(15)30860-4
   De Souza LR, 2016, DIABETES CARE, V39, P61, DOI 10.2337/dc15-2027
   Despres JP, 2001, BMJ-BRIT MED J, V322, P716, DOI 10.1136/bmj.322.7288.716
   Franca-Neto AH, 2014, OBSTET GYNECOL, V123, p51S
   Grivell RM, 2016, BJOG-INT J OBSTET GY, V123, P233, DOI 10.1111/1471-0528.13777
   Hamdy O, 2006, CURR DIABETES REV, V2, P367, DOI 10.2174/1573399810602040367
   Hull HR, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.796
   Laitinen J, 2001, AM J CLIN NUTR, V74, P287
   McCarthy EA, 2004, OBSTET GYNECOL SURV, V59, P731, DOI 10.1097/01.ogx.0000140039.10861.91
   McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003
   Pascot A, 2001, DIABETES CARE, V24, P902, DOI 10.2337/diacare.24.5.902
   Pilgaard K, 2011, J CLIN ENDOCR METAB, V96, P2835, DOI 10.1210/jc.2011-0577
   Pontual AC, 2016, MATERN CHILD HLTH J, V20, P1720, DOI 10.1007/s10995-016-1975-3
   Ribeiro FF, 2003, OBES RES, V11, P1488, DOI 10.1038/oby.2003.199
   Salomon LJ, 2011, ULTRASOUND OBST GYN, V37, P116, DOI 10.1002/uog.8831
   Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670
   Stolk RP, 2001, INT J OBESITY, V25, P1346, DOI 10.1038/sj.ijo.0801734
   Tanvig M, 2014, DAN MED J, V61
   Yoong SL, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-38
   Yu ZB, 2011, OBES REV, V12, P525, DOI 10.1111/j.1467-789X.2011.00867.x
NR 25
TC 4
Z9 4
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD AUG
PY 2017
VL 138
IS 2
BP 133
EP 137
DI 10.1002/ijgo.12202
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FA0AQ
UT WOS:000405093300001
PM 28485827
DA 2020-12-01
ER

PT J
AU Di Cavalcanti, D
   Alves, LV
   Furtado, GJ
   Santos, CC
   Feitosa, FG
   Ribeiro, MC
   Menge, P
   Lira, IM
   Alves, JG
AF Di Cavalcanti, Danielle
   Alves, Lucas V.
   Furtado, Geraldo J.
   Santos, Cleusa C.
   Feitosa, Fabiana G.
   Ribeiro, Maria C.
   Menge, Paulo
   Lira, Izabelle M.
   Alves, Joao G.
TI Echocardiographic findings in infants with presumed congenital Zika
   syndrome: Retrospective case series study
SO PLOS ONE
LA English
DT Article
ID ATRIAL SEPTAL-DEFECT; HEART-DISEASE; CHILDREN
AB Objective
   To report the echocardiographic evaluation of 103 infants with presumed congenital Zika syndrome.
   Methods
   An observational retrospective study was performed at Instituto de Medicina Integral Prof. Fernando Figueira (IMIP), Recife, Brazil. 103 infants with presumed congenital Zika syndrome. All infants had microcephaly and head computed tomography findings compatible with congenital Zika syndrome. Zika IgM antibody was detected in cerebrospinal fluid samples of 23 infants. In 80 infants, the test was not performed because it was not available at that time. All infants had negative serology for HIV, syphilis, rubella, cytomegalovirus and toxoplasmosis. A complete transthoracic two-dimensional, M-mode, continuous wave and pulsed wave Doppler and color Doppler echocardiographic (PHILIPS HD11XE or HD15) examination was performed on all infants.
   Results
   14/103 (13.5%) echocardiograms were compatible with congenital heart disease: 5 with an ostium secundum atrial septal defect, 8 had a hemodynamically insignificant small apical muscular ventricular septal defect and one infant with dyspnea had a large membranous ventricular septal defect. The echocardiograms considered normal included 45 infants with a persistent foramen ovale and 16 with a minimum patent ductus arteriosus.
   Conclusions
   Preliminarily this study suggests that congenital Zika syndrome may be associated with an increase prevalence of congenital heart disease. However the types of defects noted were septal defects, a proportion of which would not be hemodynamically significant.
C1 [Di Cavalcanti, Danielle; Alves, Lucas V.; Furtado, Geraldo J.] Inst Med Integral Prof Fernando Figueira IMIP, Dept Pediat, Recife, PE, Brazil.
   [Santos, Cleusa C.; Feitosa, Fabiana G.; Ribeiro, Maria C.; Menge, Paulo; Lira, Izabelle M.; Alves, Joao G.] Inst Med Integral Prof Fernando Figueira IMIP, Dept Pediat Cardiol, Recife, PE, Brazil.
RP Alves, JG (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Dept Pediat Cardiol, Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
CR Brassard M, 1999, AM J CARDIOL, V83, P1552, DOI 10.1016/S0002-9149(99)00146-0
   Brazilian Ministry of Health, 2015, MICR EP B
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Hanslik A, 2006, PEDIATRICS, V118, P1560, DOI 10.1542/peds.2005-3037
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ishikawa T, 2011, ACTA PAEDIATR, V100, pE55, DOI 10.1111/j.1651-2227.2011.02248.x
   Krittanawong C, 2016, INT J CARDIOL, V221, P859, DOI 10.1016/j.ijcard.2016.06.293
   Kushawaha Anurag, 2009, Cases J, V2, P7147, DOI 10.1186/1757-1626-2-7147
   Miranda CH, 2013, CLIN INFECT DIS, V57, P812, DOI 10.1093/cid/cit403
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   MITCHELL SC, 1957, J PEDIATR-US, V51, P12, DOI 10.1016/S0022-3476(57)80275-3
   MITCHELL SC, 1971, CIRCULATION, V43, P323, DOI 10.1161/01.CIR.43.3.323
   Ramussen AS, 2016, NEW ENGL J MED, V374, P1981
   Smith BG, 2012, J PAEDIATR CHILD H, V48, P1082, DOI 10.1111/j.1440-1754.2012.02467.x
   Zhang Jun, 2015, Proc (Bayl Univ Med Cent), V28, P516
NR 16
TC 5
Z9 5
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 20
PY 2017
VL 12
IS 4
AR e0175065
DI 10.1371/journal.pone.0175065
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ES9KM
UT WOS:000399875900017
PM 28426680
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Wells, JCK
   Figueiroa, JN
   Alves, JG
AF Wells, Jonathan C. K.
   Figueiroa, Jose N.
   Alves, Joao G.
TI Implications for growth plasticity in early life as adaptation
SO EVOLUTION MEDICINE AND PUBLIC HEALTH
LA English
DT Article
ID CORONARY-HEART-DISEASE; CATCH-UP GROWTH; LEAN BODY-MASS; BIRTH-WEIGHT;
   BLOOD-PRESSURE; THRIFTY PHENOTYPE; FETAL-GROWTH; IN-UTERO; PREGNANCY;
   ASSOCIATION
AB Patterns of fetal growth predict non-communicable disease risk in adult life, but fetal growth variability appears to have a relatively weak association with maternal nutritional dynamics during pregnancy. This challenges the interpretation of fetal growth variability as 'adaptation'. We hypothesized that associations of maternal size and nutritional status with neonatal size are mediated by the dimensions of the maternal pelvis. We analysed data on maternal height, body mass index (BMI) and pelvic dimensions (conjugate, inter-spinous and inter-cristal diameters) and neonatal gestational age, weight, length, thorax girth and head girth (n = 224). Multiple regression analysis was used to identify independent maternal predictors of neonatal size, and the mediating role of neonatal head girth in these associations. Pelvic dimensions displaced maternal BMI as a predictor of birth weight, explaining 11.6% of the variance. Maternal conjugate and inter-spinous diameters predicted neonatal length, thorax girth and head girth, whereas inter-cristal diameter only predicted neonatal length. Associations of pelvic dimensions with birth length, but not birth weight, were mediated by neonatal head girth. Pelvic dimensions predicted neonatal size better than maternal BMI, and these associations were mostly independent of maternal height. Sensitivity of fetal growth to pelvic dimensions reduces the risk of cephalo-pelvic disproportion, potentially a strong selective pressure during secular trends in height. Selection on fetal adaptation to relatively inflexible components of maternal phenotype, rather than directly to external ecological conditions, may help explain high levels of growth plasticity during late fetal life and early infancy.
C1 [Wells, Jonathan C. K.] UCL Great Ormond St Inst Child Hlth, Childhood Nutr Res Ctr, Populat Policy & Practice Programme, 30 Guilford St, London WC1N 1EH, England.
   [Figueiroa, Jose N.; Alves, Joao G.] Inst Med Integral Prof Fernando Figueira IMIP, Med Sch, FPS, Dept Pediat, Rua Coelhos 300, BR-52050080 Recife, PE, Brazil.
   [Figueiroa, Jose N.; Alves, Joao G.] Inst Med Integral Prof Fernando Figueira IMIP, Med Sch, FPS, Stat Unit, Rua Coelhos 300, BR-52050080 Recife, PE, Brazil.
RP Wells, JCK (corresponding author), UCL Great Ormond St Inst Child Hlth, Childhood Nutr Res Ctr, Populat Policy & Practice Programme, 30 Guilford St, London WC1N 1EH, England.
EM jonathan.wells@ucl.ac.uk
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
CR ADADEVOH SWK, 1989, INT J GYNECOL OBSTET, V28, P243, DOI 10.1016/0020-7292(89)90725-X
   Alves Joao G, 2013, Int J Adolesc Med Health, V25, P139, DOI 10.1515/ijamh-2013-0021
   [Anonymous], 1907, LANCET, V1, P150
   Barker D. J. P., 1992, FETAL INFANT ORIGINS
   Bentham J, 2016, ELIFE, V5, DOI [10.7554/eLife.13410.001, 10.7554/eLife.13410]
   Ceesay SM, 1997, BMJ-BRIT MED J, V315, P786, DOI 10.1136/bmj.315.7111.786
   Cohen M., 1984, PALAEOPATHOLOGY ORIG
   DAHRI S, 1991, DIABETES, V40, P115, DOI 10.2337/diab.40.2.S115
   Duggleby SL, 2001, CLIN SCI, V101, P65, DOI 10.1042/CS20000330
   Emanuel I, 2004, INT J EPIDEMIOL, V33, P1236, DOI 10.1093/ije/dyh269
   Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427
   Gielen M, 2008, BEHAV GENET, V38, P44, DOI 10.1007/s10519-007-9170-3
   Gluckman P., 2004, FETAL MATRIX EVOLUTI
   Gluckman Peter D, 2004, Semin Fetal Neonatal Med, V9, P419, DOI 10.1016/j.siny.2004.03.001
   HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248
   HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019
   Hayward AD, 2013, P NATL ACAD SCI USA, V110, P13886, DOI 10.1073/pnas.1301817110
   HOLLAND EL, 1982, ANN HUM BIOL, V9, P113, DOI 10.1080/03014468200005581
   JONES NB, 1978, ANN HUM BIOL, V5, P487, DOI 10.1080/03014467800003141
   Kramer MS, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000118
   Kulkarni B, 2006, EUR J CLIN NUTR, V60, P1341, DOI 10.1038/sj.ejcn.1602461
   Kumaran K, 2000, HEART, V83, P272, DOI 10.1136/heart.83.3.272
   Lane CA, 1903, LANCET, V162, P885
   LANGLEYEVANS SC, 1994, CLIN NUTR, V13, P319, DOI 10.1016/0261-5614(94)90056-6
   Leon DA, 1996, BRIT MED J, V312, P401, DOI 10.1136/bmj.312.7028.401
   Leventakou V, 2014, AM J CLIN NUTR, V99, P506, DOI 10.3945/ajcn.113.067421
   Li YP, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0409-1
   Li YP, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3672
   Lunde A, 2007, AM J EPIDEMIOL, V165, P734, DOI 10.1093/aje/kwk107
   Macones GA, 2013, AM J OBSTET GYNECOL, V209, pE1, DOI 10.1016/j.ajog.2013.06.032
   Mardones-Santander F, 1998, OBSTET GYNECOL, V91, P873, DOI 10.1016/S0029-7844(98)00109-4
   Martin RM, 2004, EPIDEMIOLOGY, V15, P308, DOI 10.1097/01.ede.0000120042.16363.e3
   Martyn CN, 1996, LANCET, V348, P1264, DOI 10.1016/S0140-6736(96)04257-2
   Mathews F, 2004, AM J CLIN NUTR, V79, P103
   Mathews F, 1999, BRIT MED J, V319, P339, DOI 10.1136/bmj.319.7206.339
   Mook-Kanamori DO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039901
   Moses RG, 2006, AM J CLIN NUTR, V84, P807
   Muleta M, 2010, ACTA OBSTET GYN SCAN, V89, P945, DOI 10.3109/00016341003801698
   Nystrom MJ, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.065
   Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967
   OUNSTED M, 1986, ANN HUM BIOL, V13, P143, DOI 10.1080/03014468600008281
   OUNSTED M, 1966, NATURE, V212, P995, DOI 10.1038/212995a0
   Painter RC, 2005, REPROD TOXICOL, V20, P345, DOI 10.1016/j.reprotox.2005.04.005
   Pan N, 1929, J ANAT, V63, P263
   RichEdwards JW, 1997, BRIT MED J, V315, P396, DOI 10.1136/bmj.315.7105.396
   Rozenberg P, 2007, GYNECOL OBSTET FERTI, V35, P6, DOI 10.1016/j.gyobfe.2006.09.028
   Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399
   Stanner S A, 2001, Twin Res, V4, P287, DOI 10.1375/1369052012498
   Thoms H, 1939, Yale J Biol Med, V11, P355
   Vasak B, 2015, ULTRASOUND OBST GYN, V45, P162, DOI 10.1002/uog.14644
   VIEGAS OAC, 1982, BMJ-BRIT MED J, V285, P592, DOI 10.1136/bmj.285.6342.592
   Wells JC, 2009, J LIFE SCI, V1, P115, DOI DOI 10.1080/09751270.2009.11885142
   Wells JC, 2016, METABOLIC GHETTO EVO, DOI DOI 10.1017/CBO9780511972959
   Wells JCK, 2016, EVOL MED PUBLIC HLTH, P133, DOI 10.1093/emph/eow011
   Wells JCK, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0067
   Wells JCK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061116
   Wells JCK, 2012, AM J PHYS ANTHROPOL, V149, P40, DOI 10.1002/ajpa.22160
   Wells JCK, 2012, INT J EPIDEMIOL, V41, P229, DOI 10.1093/ije/dyr239
   Wells JCK, 2011, AM J HUM BIOL, V23, P65, DOI 10.1002/ajhb.21100
   Wells JCK, 2010, AM J HUM BIOL, V22, P1, DOI 10.1002/ajhb.20994
   WIDDOWSON EM, 1963, PROC R SOC SER B-BIO, V158, P329, DOI 10.1098/rspb.1963.0051
   Yasmin S, 2001, B WORLD HEALTH ORGAN, V79, P608
NR 62
TC 5
Z9 5
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
EI 2050-6201
J9 EVOL MED PUBLIC HLTH
JI Evol. Med. Public Health
PY 2017
IS 1
BP 191
EP 200
DI 10.1093/emph/eox016
PG 10
WC Evolutionary Biology; Public, Environmental & Occupational Health
SC Evolutionary Biology; Public, Environmental & Occupational Health
GA GC3AA
UT WOS:000429654700008
PM 29423225
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Nascimento, GR
   Alves, LV
   Fonseca, CL
   Figueiroa, JN
   Alves, JG
AF Nascimento, Graciliano R.
   Alves, Lucas Victor
   Fonseca, Carla Leal
   Figueiroa, Jose Natal
   Alves, Joao Guilherme
TI Dietary patterns and gestational diabetes mellitus in a low income
   pregnant women population in Brazil - a cohort study
SO ARCHIVOS LATINOAMERICANOS DE NUTRICION
LA English
DT Article
DE Dietary patterns; factor analysis; gestational diabetes mellitus; low
   income population; pregnancy
ID FOOD FREQUENCY QUESTIONNAIRE; INTERNATIONAL ASSOCIATION; MEDITERRANEAN
   DIET; INSULIN-RESISTANCE; RISK; HYPERGLYCEMIA; DETERMINANTS; ADHERENCE;
   VALIDITY; ENERGY
AB Our aim is to verify the association between dietary patterns during early pregnancy and development of gestational diabetes mellitus (GDM) in a low income Brazilian population.
   A cohort study followed 841 healthy pregnant women from the 15-20th gestational week until delivery. This study was conducted at the Instituto de Medicina Integral Prof. Fernando Figueira, Brazil. 838 pregnant women during the first half of a healthy pregnancy with a monthly family income below US $ 500.00 were selected. 95 (11.3%) pregnant women developed gestational diabetes mellitus. Three dietary patterns from factor analysis were extracted. The traditional pattern was characterized by dairy products, fruits, vegetable and fish. The mixed pattern included fried food, pizza, juice, manioc flour, red meat and candies. The western pattern was characterized by eggs, white bread, cookies, pasta, pizza, fried food, chicken, candies, chocolate, salty snacks and soft drinks. There were no differences among GDM incidence according to these three dietary patterns. This finding remained after adjustment for maternal age, maternal education, body mass index pre-pregnancy and parity. We concluded that eating patterns studied during early pregnancy were not associated to the development of GDM in this sample of Brazilian pregnant women with low income.
C1 [Nascimento, Graciliano R.; Alves, Lucas Victor; Fonseca, Carla Leal; Figueiroa, Jose Natal; Alves, Joao Guilherme] Univ Estadual Ciencias Saude Alagoas UNCISAL, Dept Nutr, Dept Biostat, Mother & Child Hlth Care,Inst Med Integral Prof F, Recife, PE, Brazil.
RP Nascimento, GR (corresponding author), Univ Estadual Ciencias Saude Alagoas UNCISAL, Dept Nutr, Dept Biostat, Mother & Child Hlth Care,Inst Med Integral Prof F, Recife, PE, Brazil.
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
FU CnpqNational Council for Scientific and Technological Development (CNPq)
   [513751-2010-0]
FX This work was supported by the Cnpq (grant number 513751-2010-0).
CR Ambrosini GL, 2001, PUBLIC HEALTH NUTR, V4, P255, DOI 10.1079/PHN200062
   American Diabetes Association, 2004, DIABETES CARE S1, V27, ps88, DOI DOI 10.2337/DIACARE.27.2007.S88
   Bao W, 2014, AM J CLIN NUTR, V99, P1378, DOI 10.3945/ajcn.113.082966
   Buckley BS, 2012, DIABETIC MED, V29, P844, DOI 10.1111/j.1464-5491.2011.03541.x
   Crozier SR, 2009, J NUTR, V139, P1956, DOI 10.3945/jn.109.109579
   Cuco G, 2006, EUR J CLIN NUTR, V60, P364, DOI 10.1038/sj.ejcn.1602324
   Darmon N, 2008, AM J CLIN NUTR, V87, P1107
   De Caceres M, 2015, PUBLIC HEALTH NUTR, P1
   Freathy RM, 2010, DIABETES, V59, P2682, DOI 10.2337/db10-0177
   Gresham E, 2016, PUBLIC HEALTH NUTR, V30, P1
   He DH, 2015, BIOMED ENVIRON SCI, V28, P370, DOI 10.3967/bes2015.051
   Hu FB, 1999, AM J CLIN NUTR, V69, P243
   Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002
   Izadi V, 2016, NUTRITION, V19
   Karamanos B, 2014, EUR J CLIN NUTR, V68, P8, DOI 10.1038/ejcn.2013.177
   KRONDL M, 1986, PROG FOOD NUTR SCI, V10, P179
   Liese AD, 2009, DIABETES CARE, V32, P1434, DOI 10.2337/dc09-0228
   Lopes TS, 2013, J BIOSOC SCI, V45, P661, DOI 10.1017/S0021932012000685
   Mayen AL, 2014, AM J CLIN NUTR, V100, P1520, DOI 10.3945/ajcn.114.089029
   Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848
   Monteiro CA, 2000, REV SAUDE PUBL, V34, P251, DOI 10.1590/S0034-89102000000300007
   Monteiro CA, 2011, PUBLIC HEALTH NUTR, V14, P5, DOI 10.1017/S1368980010003241
   Radesky JS, 2008, PAEDIATR PERINAT EP, V22, P47, DOI 10.1111/j.1365-3016.2007.00899.x
   Salas-Salvado J, 2011, DIABETES CARE, V34, P14, DOI 10.2337/dc10-1288
   Schoenaker DAJM, 2016, DIABETES CARE, V39, P16, DOI 10.2337/dc15-0540
   Sichieri R, 1998, NUTR RES, V18, P1649, DOI 10.1016/S0271-5317(98)00151-1
   Tobias DK, 2012, AM J CLIN NUTR, V96, P289, DOI 10.3945/ajcn.111.028266
   Trujillo J, 2015, DIABETES RES CLIN PR, V108, P288, DOI 10.1016/j.diabres.2015.02.007
   Zhang C, 2006, DIABETOLOGIA, V49, P2604, DOI 10.1007/s00125-006-0422-1
   Zuo H, 2013, BRIT J NUTR, V109, P1662, DOI 10.1017/S0007114512003674
NR 30
TC 4
Z9 4
U1 0
U2 10
PU ARCHIVOS LATINOAMERICANOS NUTRICION
PI CARACAS
PA APARTADO 62778 CHACAO, AVENIDA FRANCISCO MIRANDA, CARACAS 1060,
   VENEZUELA
SN 0004-0622
EI 2309-5806
J9 ARCH LATINOAM NUTR
JI Arch. Latinoam. Nutr.
PD DEC
PY 2016
VL 66
IS 4
BP 301
EP 308
PG 8
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA EQ0LY
UT WOS:000397763900006
DA 2020-12-01
ER

PT J
AU Fuchs, SC
   Poli-de-Figueiredo, CE
   Neto, JAF
   Scala, LCN
   Whelton, PK
   Mosele, F
   de Mello, RB
   Vilela-Martin, JF
   Moreira, LB
   Chaves, H
   Gomes, MM
   de Sousa, MR
   Silva, RPE
   Castro, I
   Cesarino, EJ
   Jardim, PC
   Alves, JG
   Steffens, AA
   Brandao, AA
   Consolim-Colombo, FM
   de Alencastro, PR
   Neto, AA
   Nobrega, AC
   Franco, RS
   Sobral, DC
   Bordignon, A
   Nobre, F
   Schlatter, R
   Gus, M
   Fuchs, FC
   Berwanger, O
   Fuchs, FD
AF Fuchs, Sandra Costa
   Poli-de-Figueiredo, Carlos E.
   Figueiredo Neto, Jose A.
   Scala, Luiz Cesar N.
   Whelton, Paul K.
   Mosele, Francisca
   de Mello, Renato Bandeira
   Vilela-Martin, Jose F.
   Moreira, Leila B.
   Chaves, Hilton
   Gomes, Marco Mota
   de Sousa, Marcos R.
   Pereira e Silva, Ricardo
   Castro, Iran
   Cesarino, Evandro Jose
   Jardim, Paulo Cesar
   Alves, Joao Guilherme
   Steffens, Andre Avelino
   Brandao, Andrea Araujo
   Consolim-Colombo, Fernanda M.
   de Alencastro, Paulo Ricardo
   Neto, Abrahao Afiune
   Nobrega, Antonio C.
   Franco, Roberto Silva
   Sobral Filho, Dario C.
   Bordignon, Alexandro
   Nobre, Fernando
   Schlatter, Rosane
   Gus, Miguel
   Fuchs, Felipe C.
   Berwanger, Otavio
   Fuchs, Flavio D.
TI Effectiveness of Chlorthalidone Plus Amiloride for the Prevention of
   Hypertension: The PREVER-Prevention Randomized Clinical Trial
SO JOURNAL OF THE AMERICAN HEART ASSOCIATION
LA English
DT Article
DE amiloride; blood pressure; cardiovascular diseases; chlorthalidone;
   clinical trials; diuretics; hypertension; left ventricular mass;
   microalbuminuria; potassium-sparing antihypertensive agents;
   prehypertension; prevention
ID LEFT-VENTRICULAR HYPERTROPHY; JOINT NATIONAL COMMITTEE; HIGH
   BLOOD-PRESSURE; ANTIHYPERTENSIVE TREATMENT; MILD HYPERTENSION; 7TH
   REPORT; PREHYPERTENSION; METAANALYSIS; RELIABILITY; PROGRESSION
AB Background-Prehypertension is associated with higher cardiovascular risk, target organ damage, and incidence of hypertension. The Prevention of Hypertension in Patients with PreHypertension (PREVER-Prevention) trial aimed to evaluate the efficacy and safety of a low-dose diuretic for the prevention of hypertension and end-organ damage.
   Methods and Results-This randomized, parallel, double-blind, placebo-controlled trial was conducted in 21 Brazilian academic medical centers. Participants with prehypertension who were aged 30 to 70 years and who did not reach optimal blood pressure after 3 months of lifestyle intervention were randomized to a chlorthalidone/amiloride combination pill or placebo and were evaluated every 3 months during 18 months of treatment. The primary outcome was incidence of hypertension. Development or worsening of microalbuminuria, new-onset diabetes mellitus, and reduction of left ventricular mass were secondary outcomes. Participant characteristics were evenly distributed by trial arms. The incidence of hypertension was significantly lower in 372 study participants allocated to diuretics compared with 358 allocated to placebo (hazard ratio 0.56, 95% CI 0.38-0.82), resulting in a cumulative incidence of 11.7% in the diuretic arm versus 19.5% in the placebo arm(P=0.004). Adverse events; levels of blood glucose, glycosylated hemoglobin, creatinine, and microalbuminuria; and incidence of diabetes mellitus were no different between the 2 arms. Left ventricular mass assessed through Sokolow-Lyon voltage and voltage-duration product decreased to a greater extent in participants allocated to diuretic therapy compared with placebo (P=0.02).
   Conclusions-A combination of low-dose chlorthalidone and amiloride effectively reduces the risk of incident hypertension and beneficially affects left ventricular mass in patients with prehypertension.
C1 [Fuchs, Sandra Costa; Mosele, Francisca; de Mello, Renato Bandeira; Moreira, Leila B.; de Alencastro, Paulo Ricardo; Bordignon, Alexandro; Schlatter, Rosane; Gus, Miguel; Fuchs, Felipe C.; Fuchs, Flavio D.] Univ Fed Rio Grande do Sul, Div Cardiol, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.
   [Poli-de-Figueiredo, Carlos E.] Hosp Sao Lucas, Fac Med, Porto Alegre, RS, Brazil.
   [Figueiredo Neto, Jose A.] Univ Fed Maranhao, Univ Hosp, Sao Luis, Brazil.
   [Scala, Luiz Cesar N.] Univ Fed Mato Grosso, Hosp Univ Julio Muller, Cuiaba, Brazil.
   [Whelton, Paul K.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA.
   [Vilela-Martin, Jose F.] Sao Jose Rio Preto & Hosp Base, Fac Med, Sao Jose Do Rio Preto, Brazil.
   [Chaves, Hilton] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Gomes, Marco Mota] Hosp Coracao, Maceio, Brazil.
   [de Sousa, Marcos R.] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil.
   [Pereira e Silva, Ricardo] Univ Fed Ceara, Hosp Univ Walter Cantidio, Fortaleza, Ceara, Brazil.
   [Castro, Iran] Inst Cardiol, Porto Alegre, RS, Brazil.
   [Cesarino, Evandro Jose] USP Ribeirao Preto, Fac Ciencias Farmaceuticas, Ribeirao Preto, Brazil.
   [Nobre, Fernando] USP Ribeirao Preto, Fac Med Ribeirao Preto, Ribeirao Preto, Brazil.
   [Jardim, Paulo Cesar] Univ Fed Goias, Hosp Clin, Goiania, Go, Brazil.
   [Alves, Joao Guilherme] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Steffens, Andre Avelino] Univ Fed Pelotas, Pelotas, Brazil.
   [Brandao, Andrea Araujo] Univ Estado Rio de Janeiro, Rio De Janeiro, Brazil.
   [Consolim-Colombo, Fernanda M.] Univ Sao Paulo, Inst Coracao, Fac Med, Sao Paulo, Brazil.
   [Neto, Abrahao Afiune] Hosp Coracao Anis Rassi, Goiania, Go, Brazil.
   [Nobrega, Antonio C.] Univ Fed Fluminense, Hosp Univ Antonio Pedro, Niteroi, RJ, Brazil.
   [Franco, Roberto Silva] Fac Med Botucatu, Botucatu, SP, Brazil.
   [Sobral Filho, Dario C.] Hosp Univ PROCAPE, Recife, PE, Brazil.
   [Berwanger, Otavio] HCor Hosp Coracao, Res Inst, Sao Paulo, Brazil.
RP Fuchs, SC (corresponding author), Univ Fed Rio Grande do Sul, Clin Res Ctr, Hosp Clin Porto Alegre, 5th Floor,Ramiro Barcelos 2350, Porto Alegre, RS, Brazil.
EM sfuchs@hcpa.edu.br
RI da Nobrega, Antonio Claudio Lucas/O-5107-2019; Fuchs, Flavio
   D/L-5078-2016; Filho, Dario Sobral/H-8624-2019; MOREIRA, LEILA LEILA
   B/AAC-2240-2019; Cesarino, Evandro JosA© EJC/H-7018-2016; Fuchs, Felipe
   C./AAN-6828-2020; Alves, Joao G/J-6483-2013; Fuchs, Sandra
   C/T-2670-2019; Colombo, Fernanda MC/C-6911-2018; Schlatter,
   Rosane/L-5507-2017; VILELA-MARTIN, JOSE/I-8305-2014; Schlatter,
   Rosane/U-2709-2019; de Figueiredo, Carlos E Poli/A-2027-2013
OI da Nobrega, Antonio Claudio Lucas/0000-0002-3830-2886; Filho, Dario
   Sobral/0000-0002-5301-7741; Cesarino, Evandro JosA©
   EJC/0000-0003-1672-4612; Fuchs, Felipe C./0000-0001-5018-9989; Alves,
   Joao G/0000-0002-9170-0808; Colombo, Fernanda MC/0000-0003-3220-019X;
   VILELA-MARTIN, JOSE/0000-0001-6960-2825; de Figueiredo, Carlos E
   Poli/0000-0002-7333-8884; da Silva Franco, Roberto
   Jorge/0000-0001-9787-4393; de Figueiredo Neto, Jose
   Albuquerque/0000-0003-3739-7702; fuchs, flavio/0000-0002-1191-0523;
   Bandeira de Mello, Renato/0000-0003-4944-0085
FU Ministry of Health, Division of Science and Technology (DECIT); Ministry
   of Science and Technology, Brazilian Innovation Agency (FINEP)
   [01080606/01]; National Counsel of Technological and Scientific
   Development (CNPq), BrazilNational Council for Scientific and
   Technological Development (CNPq); National Institute of Health
   Technology Assessment (IATS); Hospital de Clinicas de Porto Alegre
   (FIPE-GPPG), RS, Brazil [08621]
FX The Ministry of Health, Division of Science and Technology (DECIT), and
   Ministry of Science and Technology, Brazilian Innovation Agency (FINEP)
   (number 01080606/01), National Counsel of Technological and Scientific
   Development (CNPq), Brazil, National Institute of Health Technology
   Assessment (IATS), and Hospital de Clinicas de Porto Alegre (FIPE-GPPG:
   08621), RS, Brazil sponsored the PREVER-Prevention trial. The sponsors
   had no participation in the design and conduct of the study; collection,
   management, analysis, and interpretation of the data; and preparation,
   review, or approval of the manuscript.
CR Bang CN, 2016, J HYPERTENS, V34, P842, DOI 10.1097/HJH.0000000000000905
   Barzilay JI, 2006, ARCH INTERN MED, V166, P2191, DOI 10.1001/archinte.166.20.2191
   Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560
   Cuspidi C, 2014, J HYPERTENS, V32, P921, DOI 10.1097/HJH.0000000000000085
   Fuchs FD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-65
   Fuchs FD, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-014-0505-1
   Fuchs Flavio Danni, 2009, Expert Rev Cardiovasc Ther, V7, P591, DOI 10.1586/erc.09.32
   Fuchs SC, 1996, INT J EPIDEMIOL, V25, P1005, DOI 10.1093/ije/25.5.1005
   Fuchs SC, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-1
   Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981
   Guerrero P, 2008, CLIN EXP HYPERTENS, V30, P553, DOI 10.1080/10641960802441906
   GUYTON AC, 1972, AM J MED, V52, P584, DOI 10.1016/0002-9343(72)90050-2
   Julius S, 2006, NEW ENGL J MED, V354, P1685, DOI 10.1056/NEJMoa060838
   Julius S, 2008, J AM SOC HYPERTENS, V2, P39, DOI 10.1016/j.jash.2007.07.005
   Kim SH, 2011, AM J HYPERTENS, V24, P218, DOI 10.1038/ajh.2010.213
   KLAG MJ, 1995, AM J EPIDEMIOL, V142, P295, DOI 10.1093/oxfordjournals.aje.a117635
   Kurioka S, 2014, J HYPERTENS, V32, P236, DOI 10.1097/HJH.0000000000000031
   Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665
   Lewington S, 2002, LANCET, V360, P1903
   LIEBSON PR, 1995, CIRCULATION, V91, P698, DOI 10.1161/01.CIR.91.3.698
   Luders S, 2008, J HYPERTENS, V26, P1487, DOI 10.1097/HJH.0b013e3282ff8864
   Mancia G, 2013, J HYPERTENS, V31, P1925, DOI 10.1097/HJH.0b013e328364ca4c
   Markus MRP, 2008, J HYPERTENS, V26, P2040, DOI 10.1097/HJH.0b013e328308da55
   Moreira LB, 2008, J HUM HYPERTENS, V22, P48, DOI 10.1038/sj.jhh.1002252
   NEATON JD, 1993, JAMA-J AM MED ASSOC, V270, P713, DOI 10.1001/jama.270.6.713
   OKIN PM, 1994, J AM COLL CARDIOL, V23, P133, DOI 10.1016/0735-1097(94)90511-8
   Powles J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003733
   PROBSTFIELD JL, 1991, JAMA-J AM MED ASSOC, V265, P3255
   SOKOLOW M, 1949, AM HEART J, V37, P161, DOI 10.1016/0002-8703(49)90562-1
   Thompson AM, 2011, JAMA-J AM MED ASSOC, V305, P913, DOI 10.1001/jama.2011.250
   Turner MJ, 2008, AM J HYPERTENS, V21, P85, DOI 10.1038/ajh.2007.25
   Whelton PK, 2015, ANNU REV PUBL HEALTH, V36, P109, DOI 10.1146/annurev-publhealth-031914-122949
   WHELTON PK, 1992, JAMA-J AM MED ASSOC, V267, P1213, DOI 10.1001/jama.1992.03480090061028
   Wright JT, 2015, NEW ENGL J MED, V373, P2103, DOI 10.1056/NEJMoa1511939
NR 34
TC 26
Z9 26
U1 0
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2047-9980
J9 J AM HEART ASSOC
JI J. Am. Heart Assoc.
PD DEC
PY 2016
VL 5
IS 12
AR e004248
DI 10.1161/JAHA.116.004248
PG 15
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EG1JF
UT WOS:000390787700027
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Pontual, AC
   Figueiroa, JN
   De Souza, LR
   Ray, JG
   Alves, JGB
AF Pontual, Andrea Cardoso
   Figueiroa, Jose Natal
   De Souza, Leanne R.
   Ray, Joel G.
   Bezerra Alves, Joao Guilherme
TI Visceral Adiposity in the First Half of Pregnancy in Association with
   Glucose, Lipid and Insulin Profiles in Later Pregnancy: A Cohort Study
SO MATERNAL AND CHILD HEALTH JOURNAL
LA English
DT Article
DE Obesity; Visceral adipose tissue; Insulin resistance; Dyslipidemia
ID GESTATIONAL DIABETES-MELLITUS; BODY-MASS INDEX; 1ST TRIMESTER; OBESITY;
   FAT; RISK; ULTRASONOGRAPHY; COUNTRIES; WEIGHT
AB Background Obesity is the most common risk factor in pregnancy but few studies have assessed the association of between visceral adiposity (VAT) depth in early to mild pregnancy and insulin resistance (IR), dysglycemia and dyslipidemia in later pregnancy. Objective To assess the association between VAT depth in early to mid pregnancy and IR [homeostatic model assessment of IR (HOMA-IR)], dysglycemia and dyslipidemia in later pregnancy. Methods We completed a prospective cohort study of 344 pregnant women at a single large hospital in Recife, Brazil. VAT depth was measured by ultrasound at 15-20 weeks gestation. Serum glucose, insulin and lipids were evaluated at 32-37 weeks gestation. Results In contrast to pre-pregnancy body mass index (BMI), VAT depth at 15-20 weeks was generally inferior in explaining the variation in the biochemical measures at 32-37 weeks gestation. This was the case for fasting HOMA-IR (adjusted r(2): 0.21 vs. 0.11, respectively), fasting insulin (adjusted r(2): 0.27 vs. 0.09, respectively), and lipids. Only for fasting glucose was the opposite true, but marginally (adjusted r(2) 0.03 vs. 0.06, respectively). Conclusion VAT depth measured in the first half of pregnancy is not better than pre-pregnancy BMI in predicting IR and related biochemical measures in later pregnancy.
C1 [Pontual, Andrea Cardoso; Bezerra Alves, Joao Guilherme] Inst Med Integral Prof Fernando Figueira IMIP, Dept Mother & Child Care, Rua Coelhos 300, Recife, PE, Brazil.
   [Figueiroa, Jose Natal] Inst Med Integral Prof Fernando Figueira IMIP, Dept Biostat, Rua Coelhos 300, Recife, PE, Brazil.
   [De Souza, Leanne R.; Ray, Joel G.] St Michaels Hosp, Dept Obstet & Gynecol, 30 Bond St, Toronto, ON, Canada.
RP Alves, JGB (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Dept Mother & Child Care, Rua Coelhos 300, Recife, PE, Brazil.
EM deapontual@bol.com.br; natal@imip.org.br; DeSouza@smh.ca; RayJ@smh.ca;
   joaoguilherme@imip.org.br
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
FU CnpqNational Council for Scientific and Technological Development (CNPq)
   [513751-2010-0]
FX This work was supported by the Cnpq (Grant Number 513751-2010-0).
CR ARMELLINI F, 1990, J CLIN ULTRASOUND, V18, P563, DOI 10.1002/jcu.1870180707
   Basraon S. K., 2015, AM J PERINATOLOGY
   Bjorntorp P, 2000, DIABETES METAB, V26, P10
   Brisson D, 2010, CAN MED ASSOC J, V182, pE722, DOI 10.1503/cmaj.100378
   Butte NF, 2000, AM J CLIN NUTR, V71, p1256S, DOI 10.1093/ajcn/71.5.1256s
   Cao S, 2014, J EPIDEMIOL COMMUN H, V68, P683, DOI 10.1136/jech-2013-203439
   Catalano KJ, 2005, OBES RES, V13, P11, DOI 10.1038/oby.2005.4
   Cisneiros RM, 2013, J OBSTET GYNAECOL CA, V35, P704, DOI 10.1016/S1701-2163(15)30860-4
   De Souza LR, 2014, J OBSTET GYNAECOL CA, V36, P969, DOI 10.1016/S1701-2163(15)30409-6
   DESOYE G, 1987, J CLIN ENDOCR METAB, V64, P704, DOI 10.1210/jcem-64-4-704
   Grewal E, 2012, METABOLISM, V61, P715, DOI 10.1016/j.metabol.2011.10.009
   Gur EB, 2014, ENDOCRINE, V47, P478, DOI 10.1007/s12020-013-0154-1
   Hamdy O, 2006, CURR DIABETES REV, V2, P367, DOI 10.2174/1573399810602040367
   Janssen I, 2004, AM J CLIN NUTR, V79, P379
   Martin AM, 2009, DIABETES CARE, V32, P1308, DOI 10.2337/dc09-0290
   Mission JF, 2013, OBSTET GYNECOL SURV, V68, P389, DOI 10.1097/OGX.0b013e31828738ce
   Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940
   Rahman MM, 2015, OBES REV, V16, P758, DOI 10.1111/obr.12293
   Ray JG, 2006, BJOG-INT J OBSTET GY, V113, P379, DOI 10.1111/j.1471-0528.2006.00889.x
   Ribeiro FF, 2003, OBES RES, V11, P1488, DOI 10.1038/oby.2003.199
   Ribeiro FF, 2001, HYPERTENSION, V38, P713, DOI 10.1161/01.HYP.38.3.713
   Roberts JM, 2011, PREGNANCY HYPERTENS, V1, P6, DOI 10.1016/j.preghy.2010.10.013
   ROSSNER S, 1990, INT J OBESITY, V14, P893
   Sirimi N, 2010, HORM-INT J ENDOCRINO, V9, P299, DOI 10.14310/horm.2002.1280
   Tsoi E, 2010, POSTGRAD MED J, V86, P617, DOI 10.1136/pgmj.2010.098186
   Virally M, 2010, DIABETES METAB, V36, P549, DOI 10.1016/j.diabet.2010.11.008
   Williams D, 2003, CURR OPIN OBSTET GYN, V15, P465, DOI 10.1097/00001703-200312000-00002
   Yachi Y, 2011, DIABETES RES CLIN PR, V92, P293, DOI 10.1016/j.diabres.2011.02.012
   Yokoyama H, 2003, DIABETES CARE, V26, P2426, DOI 10.2337/diacare.26.8.2426
NR 29
TC 6
Z9 6
U1 0
U2 4
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1092-7875
EI 1573-6628
J9 MATERN CHILD HLTH J
JI Matern. Child Health J.
PD AUG
PY 2016
VL 20
IS 8
BP 1720
EP 1725
DI 10.1007/s10995-016-1975-3
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DQ6WY
UT WOS:000379347900017
PM 26987856
DA 2020-12-01
ER

PT J
AU Chaves, MVB
   Ximenes, CV
   Borba, SKM
   Figueiroa, JN
   Alves, JGB
AF Braga Chaves, Mariana Vasconcelos
   Ximenes, Camila Viana
   Maciel Borba, Sandra Katia
   Figueiroa, Jose Natal
   Bezerra Alves, Joao Guilherme
TI Foot length in newborns small for gestational age
SO TROPICAL DOCTOR
LA English
DT Article
DE Foot length; small for gestational age; fetal growth restriction
ID BABIES BORN; FETAL; BIRTH
AB Small for gestational age (SGA) newborns have increased neonatal morbidity and mortality besides having a high risk of contracting chronic diseases during adult life. We compared foot length among 700 SGA and AGA newborns. Foot length was shorter in SGA newborns, both in term and preterm babies. Fetal growth restriction may impair foot growth and this finding may contribute to identify SGA newborns.
C1 [Braga Chaves, Mariana Vasconcelos; Ximenes, Camila Viana; Maciel Borba, Sandra Katia] FPS, Recife, PE, Brazil.
   [Figueiroa, Jose Natal; Bezerra Alves, Joao Guilherme] Inst Med Integral Prof Fernando Figueira IMIP, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
RP Alves, JGB (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
FU Programa Institucional de Bolsas de Iniciacao Cientifica (PIBIC), CNPq,
   Brazilian GovernmentNational Council for Scientific and Technological
   Development (CNPq)
FX Mariana Vasconcelos Braga Chaves was sponsored by Programa Institucional
   de Bolsas de Iniciacao Cientifica (PIBIC), CNPq, Brazilian Government.
CR Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X
   BALLARD JL, 1979, J PEDIATR-US, V95, P769, DOI 10.1016/S0022-3476(79)80734-9
   Boguszewski MCS, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-66
   Cosmi E, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/364381
   Cox P, 2009, BEST PRACT RES CL OB, V23, P751, DOI 10.1016/j.bpobgyn.2009.06.006
   HINRICHSEN KV, 1994, ANN ANAT, V176, P121
   Janchai Siriporn, 2005, J Med Assoc Thai, V88 Suppl 4, pS85
   Malamitsi-Puchner A, 2006, ANN NY ACAD SCI, V1092, P293, DOI 10.1196/annals.1365.026
   Marchant T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-859
   Nabiwemba E, 2013, CHILD CARE HLTH DEV, V39, P20, DOI 10.1111/j.1365-2214.2012.01383.x
   Salihagic-Kadic A, 2006, J MATERN-FETAL NEO M, V19, P387, DOI 10.1080/14767050600637861
   Sanz-Cortes M, 2013, FETAL DIAGN THER, V33, P122, DOI 10.1159/000346566
NR 12
TC 1
Z9 1
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0049-4755
EI 1758-1133
J9 TROP DOCT
JI Trop. Dr.
PD JUL
PY 2016
VL 46
IS 3
BP 156
EP 159
DI 10.1177/0049475515619511
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DS0LO
UT WOS:000380287300011
PM 26655687
DA 2020-12-01
ER

PT J
AU Barros, VO
   Amorim, MR
   Melo, AO
   Tavares, JS
   Silva, AC
   Alves, JG
AF Barros, Vivianne O.
   Amorim, Melania R.
   Melo, Adriana O.
   Tavares, Jousilene S.
   Silva, Andreza C.
   Alves, Joao G.
TI Abdominal Fat Distribution Among Breastfed and Formula-Fed Infants
SO BREASTFEEDING MEDICINE
LA English
DT Article
ID ANTHROPOMETRIC INDEXES; CHILDREN; COHORT; ACCUMULATION; METAANALYSIS;
   OVERWEIGHT; THICKNESS; GROWTH; RISK
AB Objectives: To compare abdominal subcutaneous and preperitoneal fat thickness among breastfed, mixed-fed, and formula-fed infants during the first 6 months of life.
   Study Design: A cohort study started with 94 healthy newborns and 76 were followed during the whole first semester of life. Breastfeeding status was assessed by a personal interview. Abdominal subcutaneous and preperitoneal fat thickness was measured by ultrasound at the first, third, and sixth month of life.
   Results: Subcutaneous and preperitoneal fat thickness showed no differences from the first to the sixth month of life among breastfed, mixed-fed,s and formula-fed infants, respectively; subcutaneous: 26.1 +/- 10.2 to 57.4 +/- 10.3 cm, 27.7 +/- 10.5 to 55.4 +/- 1.4, and 28.1 +/- 10.9 to 52.7 +/- 10.6; p = 0.344; preperitoneal: 10.6 +/- 2.0 to 15.2 +/- 1.7, 10.3 +/- 2.8 to 15.5 +/- 1.7, and 9.7 +/- 2.6 to 15.6 +/- 1.6; p = 0.623). No differences were observed among male and female infants.
   Conclusion: Abdominal fat distribution measured by ultrasound seems not to be different among breastfed and formula-fed infants during the first semester of life.
C1 [Barros, Vivianne O.; Amorim, Melania R.; Melo, Adriana O.; Tavares, Jousilene S.; Silva, Andreza C.] Inst Pesquisa Prof Joaquim Amorim Neto IPESQ, Dept Mother & Child Care, Campina Grande, Brazil.
   [Alves, Joao G.] Inst Med Integral Prof Fernando Figueira IMIP, Dept Mother & Child Care, Rua Coelhos 300 Boa Vista, BR-50070550 Recife, PE, Brazil.
RP Alves, JG (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Dept Mother & Child Care, Rua Coelhos 300 Boa Vista, BR-50070550 Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Melo, Adriana S O/H-5650-2016; Alves, Joao G/J-6483-2013; Amorim,
   Melania M/C-5807-2013
OI Alves, Joao G/0000-0002-9170-0808; Amorim, Melania M/0000-0003-1047-2514
FU CNPq, Brazilian governmentNational Council for Scientific and
   Technological Development (CNPq) [480761/20086]
FX This work was supported by CNPq (no 480761/20086), Brazilian government.
CR Alves JG, 2015, J PEDIATR ENDOCR MET, V28, P153, DOI 10.1515/jpem-2014-0191
   Arenz S, 2004, INT J OBESITY, V28, P1247, DOI 10.1038/sj.ijo.0802758
   Brei C, 2015, PEDIATR RES, V78, P342, DOI 10.1038/pr.2015.108
   DEBRUIN NC, 1995, AM J CLIN NUTR, V61, P1195
   Dewey KG, 1998, BIOL NEONATE, V74, P94, DOI 10.1159/000014016
   Ferreira APA, 2014, J PERINATOL, V34, P932, DOI 10.1038/jp.2014.110
   Gale C, 2012, AM J CLIN NUTR, V95, P656, DOI 10.3945/ajcn.111.027284
   Gale C, 2014, AM J CLIN NUTR, V99, P1034, DOI 10.3945/ajcn.113.080200
   Harder T, 2005, AM J EPIDEMIOL, V162, P397, DOI 10.1093/aje/kwi222
   Holzhauer S, 2009, EUR J EPIDEMIOL, V24, P521, DOI 10.1007/s10654-009-9368-1
   Liu KH, 2003, INT J OBESITY, V27, P1267, DOI 10.1038/sj.ijo.0802398
   Medina-Bravo P, 2011, ARCH MED RES, V42, P115, DOI 10.1016/j.arcmed.2011.03.002
   Mook-Kanamori DO, 2009, ULTRASOUND MED BIOL, V35, P1938, DOI 10.1016/j.ultrasmedbio.2009.07.002
   OAKLEY JR, 1977, ARCH DIS CHILD, V52, P79, DOI 10.1136/adc.52.1.79
   Polat TB, 2008, J PEDIATR ENDOCR MET, V21, P1031
   Stettler N, 2005, CIRCULATION, V111, P1897, DOI 10.1161/01.CIR.0000161797.67671.A7
   White UA, 2014, BBA-MOL BASIS DIS, V1842, P377, DOI 10.1016/j.bbadis.2013.05.006
NR 17
TC 4
Z9 4
U1 0
U2 2
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1556-8253
EI 1556-8342
J9 BREASTFEED MED
JI Breastfeed. Med.
PD JUN
PY 2016
VL 11
IS 5
BP 231
EP 234
DI 10.1089/bfm.2016.0033
PG 4
WC Obstetrics & Gynecology; Pediatrics
SC Obstetrics & Gynecology; Pediatrics
GA DO9GF
UT WOS:000378092300005
PM 27104359
DA 2020-12-01
ER

PT J
AU Vasconcelos, DD
   Amorim, MM
   de Macedo, LC
   Medeiros, MD
   da Silva, JR
   Alves, JGB
AF Vasconcelos, Danilo de Ameida
   Amorim, Melania M.
   de Macedo, Lorena Carneiro
   Medeiros, Marina de Sousa
   da Silva, Jose Roberto, Jr.
   Bezerra Alves, Joao Guilherme
TI Electromyographic Threshold and Microvascular Reactivity for Assessment
   of Muscle Fatigue in Elderly Women
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 14-17, 2016
CL Washington, DC
SP Amer Coll Obstetricians & Gynecologists
C1 [Vasconcelos, Danilo de Ameida; Amorim, Melania M.; de Macedo, Lorena Carneiro; Medeiros, Marina de Sousa; da Silva, Jose Roberto, Jr.; Bezerra Alves, Joao Guilherme] Inst Integrat Med Prof Fernando Figueira, Campina Grande, Brazil.
RI Amorim, Melania M/C-5807-2013; Alves, Joao G/J-6483-2013
OI Amorim, Melania M/0000-0003-1047-2514; Alves, Joao G/0000-0002-9170-0808
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2016
VL 127
SU 1
MA 1
BP 1S
EP 1S
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA ER6RO
UT WOS:000398934900002
DA 2020-12-01
ER

PT J
AU Vasconcelos, DD
   Amorim, MM
   de Macedo, LC
   Silva, EKR
   da Silva, JR
   Alves, JGB
AF Vasconcelos, Danilo de Ameida
   Amorim, Melania M.
   de Macedo, Lorena Carneiro
   Rodrigues Silva, Eujessika Katielly
   da Silva, Jose Roberto, Jr.
   Bezerra Alves, Joao Guilherme
TI Effects of Strength Training on Microcirculation, Muscle Performance and
   Functional Independence in Elderly Women
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 14-17, 2016
CL Washington, DC
SP Amer Coll Obstetricians & Gynecologists
C1 [Vasconcelos, Danilo de Ameida; Amorim, Melania M.; de Macedo, Lorena Carneiro; Rodrigues Silva, Eujessika Katielly; da Silva, Jose Roberto, Jr.; Bezerra Alves, Joao Guilherme] Inst Integrat Med Prof Fernando Figueira, Campina Grande, Brazil.
RI Alves, Joao G/J-6483-2013; Amorim, Melania M/C-5807-2013
OI Alves, Joao G/0000-0002-9170-0808; Amorim, Melania M/0000-0003-1047-2514
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2016
VL 127
SU 1
MA 3A
BP 12S
EP 12S
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA ER6RO
UT WOS:000398934900031
DA 2020-12-01
ER

PT J
AU Fuchs, FD
   Scala, LCN
   Vilela-Martin, JF
   de Mello, RB
   Mosele, F
   Whelton, PK
   Poli-de-Figueiredo, CE
   de Alencastro, PR
   Silva, RPE
   Gus, M
   Bortolotto, LA
   Schlatter, R
   Cesarino, EJ
   Castro, I
   Neto, JAF
   Chaves, H
   Steffens, AA
   Alves, JG
   Brandao, AA
   de Sousa, MR
   Jardim, PC
   Moreira, LB
   Franco, RS
   Gomes, MM
   Neto, AA
   Fuchs, FC
   Sobral, DC
   Nobrega, AC
   Nobre, F
   Berwanger, O
   Fuchs, SC
AF Fuchs, Flavio D.
   Scala, Luiz Cesar N.
   Vilela-Martin, Jose F.
   de Mello, Renato Bandeira
   Mosele, Francisca
   Whelton, Paul K.
   Poli-de-Figueiredo, Carlos E.
   de Alencastro, Paulo Ricardo
   Pereira e Silva, Ricardo
   Gus, Miguel
   Bortolotto, Luiz Aparecido
   Schlatter, Rosane
   Cesarino, Evandro Jose
   Castro, Iran
   Figueiredo Neto, Jose A.
   Chaves, Hilton
   Steffens, Andre Avelino
   Alves, Joao Guilherme
   Brandao, Andrea Araujo
   de Sousa, Marcos R.
   Jardim, Paulo Cesar
   Moreira, Leila B.
   Franco, Roberto Silva
   Gomes, Marco Mota
   Afiune Neto, Abrahao
   Fuchs, Felipe Costa
   Sobral Filho, Dario C.
   Nobrega, Antonio C.
   Nobre, Fernando
   Berwanger, Otavio
   Fuchs, Sandra C.
TI Effectiveness of chlorthalidone/amiloride versus losartan in patients
   with stage I hypertension: results fromthe PREVER-treatment randomized
   trial
SO JOURNAL OF HYPERTENSION
LA English
DT Article
DE amiloride; chlorthalidone; drug treatment; hypertension; losartan
ID CONVERTING ENZYME-INHIBITORS; ANGIOTENSIN RECEPTOR BLOCKERS;
   BLOOD-PRESSURE; CARDIOVASCULAR EVENTS; GLOBAL BURDEN; MORTALITY; RISK;
   INTERVENTION; METAANALYSIS; NEPHROPATHY
AB Objectives:To compare the blood pressure (BP)-lowering efficacy of a chlorthalidone/amiloride combination pill with losartan, during initial management of stage I hypertension.Methods:In a randomized, double-blind, controlled trial, 655 participants were followed for 18 months in 21 Brazilian academic centers. Trial participants were adult volunteers aged 30-70 years with stage I hypertension (BP 140-159 or 90-99mmHg) following 3 months of a lifestyle intervention. Participants were randomized to 12.5/2.5mg of chlorthalidone/amiloride (N=333) or 50mg of losartan (N=322). If BP remained uncontrolled after 3 months, study medication dose was doubled, and if uncontrolled after 6 months, amlodipine (5 and 10mg) and propranolol (40 and 80mg twice daily) were added as open-label drugs in a progressive fashion. At the end of follow-up, 609 (93%) participants were evaluated.Results:The difference in SBP during 18 months of follow-up was 2.3 (95% confidence interval: 1.2 to 3.3)mmHg favoring chlorthalidone/amiloride. Compared with those randomized to diuretic, more participants allocated to losartan had their initial dose doubled and more of them used add-on antihypertensive medication. Levels of blood glucose, glycosilated hemoglobin, and incidence of diabetes were no different between the two treatment groups. Serum potassium was lower and serum cholesterol was higher in the diuretic arm. Microalbuminuria tended to be higher in patients with diabetes allocated to losartan (28.540.4 versus 16.226.7mg, P=0.09).Conclusion:Treatment with a combination of chlorthalidone and amiloride compared with losartan yielded a greater reduction in BP.Clinical trials registration number:NCT00971165.
C1 [Fuchs, Flavio D.; de Mello, Renato Bandeira; Mosele, Francisca; de Alencastro, Paulo Ricardo; Gus, Miguel; Schlatter, Rosane; Moreira, Leila B.; Fuchs, Felipe Costa; Fuchs, Sandra C.] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, BR-90046900 Porto Alegre, RS, Brazil.
   [Scala, Luiz Cesar N.] Univ Fed Mato Grosso, Hosp Univ Julio Muller, Cuiaba, Mato Grosso, Brazil.
   [Vilela-Martin, Jose F.] Fac Med Sao Jose Rio Preto, Sao Paulo, Brazil.
   [Whelton, Paul K.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA.
   [Poli-de-Figueiredo, Carlos E.] PUCRS, Fac Med Hosp Sao Lucas, Sao Paulo, Brazil.
   [Pereira e Silva, Ricardo] Univ Fed Ceara, Hosp Univ Walter Cantidio, Sao Paulo, Brazil.
   [Bortolotto, Luiz Aparecido] Univ Sao Paulo, Fac Med, Inst Coracao, Sao Paulo, Brazil.
   [Cesarino, Evandro Jose] USP Ribeirao Preto, Fac Fac Ciencias Farmaceut, Sao Paulo, Brazil.
   [Castro, Iran] Inst Cardiol, Porto Alegre, RS, Brazil.
   [Figueiredo Neto, Jose A.] Univ Fed Maranhao, Univ Hosp, Sao Luis, Maranhao, Brazil.
   [Chaves, Hilton] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Steffens, Andre Avelino] Univ Univ Fed Pelotas, Pelotas, RS, Brazil.
   [Alves, Joao Guilherme] Inst Med Integral Prof Fernando Figueira, Pelotas, PE, Brazil.
   [Brandao, Andrea Araujo] Univ Estado Rio de Janeiro, BR-20550011 Rio De Janeiro, Brazil.
   [de Sousa, Marcos R.] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil.
   [Jardim, Paulo Cesar] Univ Fed Goias, Hosp Clin Goiania, Goiania, Go, Brazil.
   [Franco, Roberto Silva] Fac Med Botucatu, Sao Paulo, Brazil.
   [Gomes, Marco Mota] Hosp Coracao, Londrina, Alagoas, Brazil.
   [Afiune Neto, Abrahao] Anis Rassi Hosp, Oeste, Go, Brazil.
   [Sobral Filho, Dario C.] Hosp Univ Procape, Oeste, PE, Brazil.
   [Nobrega, Antonio C.] Hosp Univ Antonio Pedro, UFF, Rio De Janeiro, Brazil.
   [Nobre, Fernando] USP Ribeirao Preto, Fac Med Ribeirao Preto, Sao Paulo, Brazil.
   [Berwanger, Otavio] Hosp Coracao, Inst Pesquisa, Sao Paulo, Brazil.
RP Fuchs, FD (corresponding author), Hosp Clin Porto Alegre, Serv Cardiol, Ramiro Barcelos 2350, BR-90035903 Porto Alegre, RS, Brazil.
EM ffuchs@hcpa.edu.br
RI Fuchs, Felipe C./AAN-6828-2020; Cesarino, Evandro JosA© EJC/H-7018-2016;
   VILELA-MARTIN, JOSE/I-8305-2014; Schlatter, Rosane/U-2709-2019; Fuchs,
   Sandra C/T-2670-2019; Filho, Dario Sobral/H-8624-2019; Fuchs, Flavio
   D/L-5078-2016; Schlatter, Rosane/L-5507-2017; MOREIRA, LEILA LEILA
   B/AAC-2240-2019; de Figueiredo, Carlos E Poli/A-2027-2013; Bortolotto,
   Luiz A/S-1940-2017; Alves, Joao G/J-6483-2013
OI Fuchs, Felipe C./0000-0001-5018-9989; Cesarino, Evandro JosA©
   EJC/0000-0003-1672-4612; VILELA-MARTIN, JOSE/0000-0001-6960-2825; Filho,
   Dario Sobral/0000-0002-5301-7741; de Figueiredo, Carlos E
   Poli/0000-0002-7333-8884; Bortolotto, Luiz A/0000-0002-4865-6442; Alves,
   Joao G/0000-0002-9170-0808; Bandeira de Mello,
   Renato/0000-0003-4944-0085; da Silva Franco, Roberto
   Jorge/0000-0001-9787-4393; fuchs, flavio/0000-0002-1191-0523
FU Department of Science and Technology (DECIT), Health Ministry,
   BrazilDepartment of Science & Technology (India)Department of Science &
   Technology (DOST), Philippines; National Council of Research (CNPq),
   BrazilNational Council for Scientific and Technological Development
   (CNPq); Agency for Funding of Studies and Projects (FINEP), Science and
   Technology Ministry, Brazil; National Institute of Health Technology
   Assessment (IATS), Brazil; Funding of Incentive to Research (FIPE),
   Hospital de Clinicas de Porto Alegre, Brazil
FX this study was funded by grants from the Department of Science and
   Technology (DECIT), Health Ministry; National Council of Research (CNPq)
   and Agency for Funding of Studies and Projects (FINEP), Science and
   Technology Ministry; National Institute of Health Technology Assessment
   (IATS); and Funding of Incentive to Research (FIPE), Hospital de
   Clinicas de Porto Alegre, all in Brazil. The sponsors had no
   participation in the design and conduct of the study, preparation and
   approval of the manuscript.
CR [Anonymous], 2009, Lancet, V374, P1226, DOI 10.1016/S0140-6736(09)61768-2
   [Anonymous], 2013, EUR HEART J, V34, P1023, DOI 10.1093/ eurheartj/ ehp363
   Bangalore S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2234
   Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161
   Brown MJ, 2000, LANCET, V356, P366, DOI 10.1016/S0140-6736(00)02527-7
   Cheng J, 2014, JAMA INTERN MED, V174, P773, DOI 10.1001/jamainternmed.2014.348
   Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3
   Elgendy IY, 2015, AM J HYPERTENS, V28, P576, DOI 10.1093/ajh/hpu209
   Emdin CA, 2015, JAMA-J AM MED ASSOC, V313, P603, DOI 10.1001/jama.2014.18574
   Fuchs FD, 2002, LANCET, V359, P2203, DOI 10.1016/S0140-6736(02)09077-3
   Fuchs FD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-53
   Fuchs Flavio Danni, 2013, Evid Based Med, V18, P44, DOI 10.1136/eb-2012-100851
   Fuchs FD, 2012, VASC HEALTH RISK MAN, V8, P437, DOI 10.2147/VHRM.S32585
   Fuchs Flavio Danni, 2009, Expert Rev Cardiovasc Ther, V7, P591, DOI 10.1586/erc.09.32
   Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981
   Guerrero P, 2008, CLIN EXP HYPERTENS, V30, P553, DOI 10.1080/10641960802441906
   Haller H, 2011, NEW ENGL J MED, V364, P907, DOI 10.1056/NEJMoa1007994
   Imai E, 2011, DIABETOLOGIA, V54, P2978, DOI 10.1007/s00125-011-2325-z
   James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427
   Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9
   Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3
   Krause T, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4891
   Lancet Editors, 2013, Lancet, V382, P843, DOI 10.1016/S0140-6736(13)61847-4
   Law M, 2003, Health Technol Assess, V7, P1
   Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665
   Lewington S, 2002, LANCET, V360, P1903
   Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8
   Lithell H, 2003, J HYPERTENS, V21, P875, DOI 10.1097/00004872-200305000-00011
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc
   McMurray JJ, 2010, NEW ENGL J MED, V362, P1477, DOI 10.1056/NEJMoa1001121
   MEADE TW, 1992, BMJ-BRIT MED J, V304, P405
   OKIN PM, 1994, J AM COLL CARDIOL, V23, P133, DOI 10.1016/0735-1097(94)90511-8
   Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489
   Picon RV, 2013, AM J HYPERTENS, V26, P541, DOI 10.1093/ajh/hps076
   Picon RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048255
   PROBSTFIELD JL, 1991, JAMA-J AM MED ASSOC, V265, P3255
   SOKOLOW M, 1949, AM HEART J, V37, P161, DOI 10.1016/0002-8703(49)90562-1
   Thomopoulos C, 2015, J HYPERTENS, V33, P195, DOI 10.1097/HJH.0000000000000447
   Turnbull F, 2003, LANCET, V362, P1527
   van Vark LC, 2012, EUR HEART J, V33, P2088, DOI 10.1093/eurheartj/ehs075
   Weber MA, 2004, LANCET, V363, P2049, DOI 10.1016/S0140-6736(04)16456-8
   Yusuf S, 2008, LANCET, V372, P1174, DOI 10.1016/S0140-6736(08)61242-8
   Yusuf S, 2008, NEW ENGL J MED, V359, P1225, DOI 10.1056/NEJMoa0804593
   Yusuf S, 2011, NEW ENGL J MED, V364, P928, DOI 10.1056/NEJMoa1008816
NR 46
TC 10
Z9 10
U1 0
U2 15
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0263-6352
EI 1473-5598
J9 J HYPERTENS
JI J. Hypertens.
PD APR
PY 2016
VL 34
IS 4
BP 798
EP 806
DI 10.1097/HJH.0000000000000837
PG 9
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA DG1VZ
UT WOS:000371856900028
PM 26938814
DA 2020-12-01
ER

PT J
AU Lima, JHD
   Santos, AD
   Barros, SEB
   Morais, PSD
   Figueiroa, JN
   Alves, JGB
AF de Morais Lima, Jose Heriston
   Santos, Amilton da Cruz
   Benicio Barros, Sandra Emilia
   de Abreu Morais, Pollyana Soares
   Figueiroa, Jose Natal
   Alves, Joao Guilherme B.
TI Effect of short-term positive airway pressure on blood pressure in
   controlled hypertensive patients with obstructive sleep apnoea syndrome:
   a prospective cohort study
SO POSTGRADUATE MEDICAL JOURNAL
LA English
DT Article
ID CONTROLLED TRIAL
AB Background Obstructive sleep apnoea syndrome (OSAS) is associated with cardiovascular disease, especially in patients with high blood pressure. Continuous positive airway pressure (CPAP) seems to contribute to blood pressure control in patients with OSAS, mainly those with uncontrolled hypertension. However, the effect of CPAP on controlled hypertensive patients with OSAS is not known.
   Objective To evaluate the effects of CPAP on blood pressure of controlled hypertensive patients with OSAS.
   Design Prospective cohort study.
   Patients 36 recently diagnosed patients with OSAS and hypertension controlled with oral antihypertensive medication. Methods CPAP was performed for 5 days. Systolic and diastolic blood pressure were recorded at baseline and 5 days later using 24 h ambulatory blood pressure measurement.
   Results Mean (SD) 24 h systolic blood pressure was reduced from 128.9 (3.4) to 126.5 (3.5), p<0.001 and mean (SD) 24 h diastolic blood pressure was reduced from 86.9 (3.3) to 84.8 (3.3), p<0.001. A reduction in the proportion of 'non-dippers' in the participants was registered (from 40.6% at baseline to 18.2%).
   Conclusions A short course of CPAP may reduce systolic and diastolic blood pressure in patients with OSAS and controlled hypertension.
C1 [de Morais Lima, Jose Heriston; Santos, Amilton da Cruz] Univ Fed Paraiba UFPB, Joao Pessoa, Paraiba, Brazil.
   [de Morais Lima, Jose Heriston; Santos, Amilton da Cruz; Benicio Barros, Sandra Emilia; de Abreu Morais, Pollyana Soares; Figueiroa, Jose Natal] Clin Esperanca, Ave Esperanca 780, Joao Pessoa, Paraiba, Brazil.
   [Benicio Barros, Sandra Emilia; de Abreu Morais, Pollyana Soares] Ctr Univ Joao Pessoa UNIPE, Joao Pessoa, Paraiba, Brazil.
   [Figueiroa, Jose Natal; Alves, Joao Guilherme B.] Inst Med Integral Prof Fernando Figuei IMIP, Rua Antenor Navarro 301, BR-52050080 Recife, PE, Brazil.
RP Alves, JGB (corresponding author), Inst Med Integral Prof Fernando Figuei IMIP, Rua Antenor Navarro 301, BR-52050080 Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
CR Barbe F, 2001, ANN INTERN MED, V134, P1015, DOI 10.7326/0003-4819-134-11-200106050-00007
   Campos-Rodriguez F, 2006, CHEST, V129, P1459, DOI 10.1378/chest.129.6.1459
   Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560
   Donovan LM, 2015, J THORAC DIS, V7, P1323, DOI 10.3978/j.issn.2072-1439.2015.07.30
   Drager LF, 2011, HYPERTENSION, V57, P549, DOI 10.1161/HYPERTENSIONAHA.110.165969
   Fava C, 2011, SEMIN THROMB HEMOST, V37, P280, DOI 10.1055/s-0031-1273092
   McNicholas WT, 2007, EUR RESPIR J, V29, P156, DOI 10.1183/09031936.00027406
   Mohsenin V, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0482-4
   Parati G, 2012, J HYPERTENS, V30, P633, DOI 10.1097/HJH.0b013e328350e53b
   Quercioli A, 2010, SLEEP BREATH, V14, P261, DOI 10.1007/s11325-010-0338-3
   Yorgun H, 2014, ANGIOLOGY, V65, P98, DOI 10.1177/0003319713477908
NR 11
TC 0
Z9 0
U1 2
U2 5
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0032-5473
EI 1469-0756
J9 POSTGRAD MED J
JI Postgrad. Med. J.
PD MAR
PY 2016
VL 92
IS 1085
BP 134
EP 136
DI 10.1136/postgradmedj-2014-133158
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DE7PV
UT WOS:000370830100004
PM 26719450
DA 2020-12-01
ER

PT J
AU De Franca, E
   Silva, DSBS
   Silva, TFC
   Dornelles, CL
   Alves, JG
   Alho, CS
AF De Franca, E.
   Silva, D. S. B. S.
   Silva, T. F. C.
   Dornelles, C. L.
   Alves, J. G.
   Alho, C. S.
TI APOA5 polymorphisms associated with lipid metabolism in Brazilian
   children and adolescents
SO GENETICS AND MOLECULAR RESEARCH
LA English
DT Article
DE SNP; -1131T>C; Ser19Trp; APOA4/A5; Lipid metabolism
ID APOLIPOPROTEIN AV GENE; PLASMA TRIGLYCERIDES; CLUSTER; POPULATION; RISK;
   A5
AB Single nucleotide polymorphisms in the APOA5 gene have been studied for their association with metabolic syndrome. Thus, elucidating the effect of the mechanism involved in APOA5 gene polymorphisms on lipid metabolism is of great importance. In this study we aimed to determine the allelic and genotypic frequencies of -1131T>C, Ser19Trp, and intergenic APOA4/A5 and to evaluate the association between these variants with plasma lipid levels in children and adolescents from Brazil. This study included 524 healthy children and adolescents from Mother and Child Hospital in Recife, Pernambuco, Brazil. Data were obtained on medical history, drug intake, lifestyle variables, and demography. DNA from collected samples was extracted and genotyped for the three polymorphisms. In this studied population, triglycerides and very low-density protein levels were significantly high in subjects carrying the 19WW genotype (P < 0.001), demonstrating the presence of this genetic risk factor in children and adolescents.
C1 [De Franca, E.; Silva, D. S. B. S.; Silva, T. F. C.; Dornelles, C. L.; Alho, C. S.] Pontificia Univ Catolica Rio Grande do Sul, Lab Genet Humana & Mol, Porto Alegre, RS, Brazil.
   [Alves, J. G.] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
RP Alho, CS (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Lab Genet Humana & Mol, Porto Alegre, RS, Brazil.
EM csalho@pucrs.br
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808; SAMPAIO ALHO,
   CLARICE/0000-0002-4819-9587
FU  [MCT/CNPq/MS-SCTIE-DECIT/SAS-DAB51/2005]
FX The authors are grateful to Francis Jackson Paludo for statistical
   support and to Emilia da Silva Borges in the Haematology and
   Haemotherapy Centre of Pernambuco (HEMOPE) for assistance with blood
   collection. We would also like to thank Pietra Graebin. Research
   supported by MCT/CNPq/MS-SCTIE-DECIT/SAS-DAB51/2005.
CR Abe Y, 2009, J ATHEROSCLER THROMB, V16, P121, DOI 10.5551/jat.E356
   Ariza MJ, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-66
   Chen ES, 2006, CLIN CHEM LAB MED, V44, P32, DOI 10.1515/CCLM.2006.007
   De Andrade FM, 2011, NUTR METAB CARDIOVAS, V21, P584, DOI 10.1016/j.numecd.2009.12.013
   De Franca E, 2005, BRAZ J MED BIOL RES, V38, P535, DOI 10.1590/S0100-879X2005000400006
   Demirdogen BC, 2012, MOL BIOL REP, V39, P10459, DOI 10.1007/s11033-012-1926-z
   Horinek A, 2003, ATHEROSCLEROSIS, V167, P369, DOI 10.1016/S0021-9150(03)00022-4
   Klos KLE, 2005, J LIPID RES, V46, P564, DOI 10.1194/jlr.M400437-JLR200
   LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444
   Lai CQ, 2005, CURR OPIN LIPIDOL, V16, P153, DOI 10.1097/01.mol.0000162320.54795.68
   Mattei J, 2009, J NUTR, V139, P2301, DOI 10.3945/jn.109.109900
   Pennacchio LA, 2002, HUM MOL GENET, V11, P3031, DOI 10.1093/hmg/11.24.3031
   Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852
   Ribalta J, 2002, CLIN CHEM, V48, P1597
   Tai ES, 2008, CURR OPIN LIPIDOL, V19, P349, DOI 10.1097/MOL.0b013e328304b681
   Talmud PJ, 2002, HUM MOL GENET, V11, P3039, DOI 10.1093/hmg/11.24.3039
NR 16
TC 1
Z9 1
U1 0
U2 2
PU FUNPEC-EDITORA
PI RIBEIRAO PRETO
PA RUA FLORIANO PEIXOTO 2444, ALTO DA BOA VISTA, RIBEIRAO PRETO, SP 00000,
   BRAZIL
SN 1676-5680
J9 GENET MOL RES
JI Genet. Mol. Res.
PY 2016
VL 15
IS 1
AR 15017809
DI 10.4238/gmr.15017809
PG 4
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA DJ0GQ
UT WOS:000373880400082
PM 27051036
OA Bronze
DA 2020-12-01
ER

PT J
AU Pontes, IEA
   Afra, KF
   Silva, JR
   Borges, PSN
   Clough, GF
   Alves, JGB
AF Pontes, Isabelle E. A.
   Afra, Karine F.
   Silva, Jose R., Jr.
   Borges, Paulo S. N.
   Clough, Geraldine F.
   Alves, Joao G. B.
TI Microvascular reactivity in women with gestational diabetes mellitus
   studied during pregnancy
SO DIABETOLOGY & METABOLIC SYNDROME
LA English
DT Article
DE Microcirculation; Endothelium function; Pregnancy; Gestational diabetes
ID ENDOTHELIAL DYSFUNCTION; INSULIN-RESISTANCE; MICROCIRCULATION;
   VASODILATATION; OBESITY; DISEASE; RISK
AB Aim: To compare microvascular reactivity assessed in the skin using laser Doppler fluximetry (LDF) in women with gestational diabetes mellitus (GDM) and gestational age-matched control during pregnancy.
   Methods: 110 pregnant women at similar to 33 weeks gestation participated in the study. Skin microvascular reactivity was evaluated by LDF, at rest, during the response to brief arterial occlusion (post occlusive hyperaemic response) and during sympathetically mediated vasoconstrictor response to deep inspiratory breath hold.
   Results: No statistically significant differences were found in the microvascular variables studied (resting and maximum rate flux, post-ischaemic reactive hyperaemia and deep inspiratory breath holds) between +GDM and -GDM groups women. In women with GDM there was a negative correlation between resting flux and the response to the oral glucose tolerance test (OGTT), r = -0.282 (p = 0.037). There was also a negative correlation between the response to the OGTT and the sympathetically mediated constrictor response to inspiratory breath holds (r = -.298, p = .030) but not in women with GDM (r = .102, r = .468).
   Conclusion: Attenuated microvascular reactivity as an early marker of endothelial dysfunction is not present in women with GDM when assessed during pregnancy.
C1 [Pontes, Isabelle E. A.; Afra, Karine F.; Silva, Jose R., Jr.; Alves, Joao G. B.] Inst Med Integral Prof Fernando Figueira IMIP, Mother & Child Unit, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
   [Borges, Paulo S. N.; Clough, Geraldine F.] Univ Southampton, Fac Med, Southampton, Hants, England.
RP Alves, JGB (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Mother & Child Unit, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
EM joaoguilherme@imip.org
RI da silva Junior, Jose Roberto/K-2459-2015; Alves, Joao G/J-6483-2013; de
   Albuquerque Pontes, Isabelle Eunice/AAG-6420-2019
OI da silva Junior, Jose Roberto/0000-0003-3843-005X; Alves, Joao
   G/0000-0002-9170-0808; de Albuquerque Pontes, Isabelle
   Eunice/0000-0002-2194-8971
FU CNPq (Brazilian Government-National Council for Scientific and
   Technological Development) [563751/2010-0]
FX This research was funded by CNPq (Brazilian Government-National Council
   for Scientific and Technological Development), Process number
   563751/2010-0.
CR Anastasiou E, 1998, DIABETES CARE, V21, P2111, DOI 10.2337/diacare.21.12.2111
   Atalah E, 1997, REV MED CHILE, V125, P1429
   Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5
   Black MH, 2013, DIABETES CARE, V36, P56, DOI 10.2337/dc12-0741
   Brewster S, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/382670
   Calles-Escandon J, 2001, ENDOCR REV, V22, P36, DOI 10.1210/er.22.1.36
   Ce GV, 2011, J CLIN ENDOCR METAB, V96, P1493, DOI 10.1210/jc.2010-2363
   Clapp JF, 1997, AM J CARDIOL, V80, P1469, DOI 10.1016/S0002-9149(97)00738-8
   Clough GF, 2011, MICROCIRCULATION, V18, P74, DOI 10.1111/j.1549-8719.2010.00070.x
   Dabelea D, 2005, DIABETES CARE, V28, P579, DOI 10.2337/diacare.28.3.579
   Davenport MH, 2012, AM J PHYSIOL-REG I, V302, pR768, DOI 10.1152/ajpregu.00115.2011
   Hannemann MM, 2002, J VASC RES, V39, P311, DOI 10.1159/000065543
   Hernandez-Rivas E, 2013, DIABETES RES CLIN PR, V100, P215, DOI 10.1016/j.diabres.2013.01.030
   Hu J, 1998, BRIT J OBSTET GYNAEC, V105, P1279, DOI 10.1111/j.1471-0528.1998.tb10006.x
   Jaffer U, 2008, EUR J VASC ENDOVASC, V35, P603, DOI 10.1016/j.ejvs.2007.12.006
   JEANLUC MR, 2013, TRENDS PHARMACOL SCI, V34, P373, DOI DOI 10.1016/J.TIPS.2013.05.007
   Knock GA, 1997, BRIT J OBSTET GYNAEC, V104, P229, DOI 10.1111/j.1471-0528.1997.tb11051.x
   L'Esperance VS, 2013, EXP PHYSIOL, V98, P49, DOI 10.1113/expphysiol.2011.064055
   Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848
   Mrizak I, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-93
   Nazzaro P, 2008, AM J HYPERTENS, V21, P432, DOI 10.1038/ajh.2008.7
   Rask-Madsen C, 2007, NAT CLIN PRACT ENDOC, V3, P46, DOI 10.1038/ncpendmet0366
   Rasool AHG, 2010, MALAYS J MED SCI, V17, P14
   Retnakaran R, 2010, J CLIN ENDOCR METAB, V95, P670, DOI 10.1210/jc.2009-1990
   Shah BR, 2008, DIABETES CARE, V31, P1668, DOI 10.2337/dc08-0706
   Sobrevia L, 2011, PLACENTA, V32, pS159, DOI 10.1016/j.placenta.2010.12.011
   Struijker-Boudier HAJ, 2011, HYPERTENSION, V58, P768, DOI 10.1161/HYPERTENSIONAHA.111.181107
   Wiernsperger N, 2007, AN ACAD BRAS CIENC, V79, P617, DOI 10.1590/S0001-37652007000400005
   Wroblewska-Seniuk K, 2009, PEDIATR DIABETES, V10, P432, DOI 10.1111/j.1399-5448.2009.00507.x
   Yvonne-Tee Get Bee, 2005, Journal of Pharmacological and Toxicological Methods, V52, P286, DOI 10.1016/j.vascn.2004.11.003
NR 30
TC 6
Z9 7
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1758-5996
J9 DIABETOL METAB SYNDR
JI Diabetol. Metab. Syndr.
PD MAR 28
PY 2015
VL 7
AR 27
DI 10.1186/s13098-015-0017-4
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA VA9VW
UT WOS:000411357300001
PM 26056535
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-01
ER

PT J
AU Sa, AZ
   Silva, JR
   Alves, JG
AF Sa, Andrea Zacche
   Silva Junior, Jose Roberto
   Alves, Joao G.
TI Facial responses to basic tastes in the newborns of women with
   gestational diabetes mellitus
SO JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
LA English
DT Article
DE Diabetes; facial expression; gestational; taste perception
ID PREGNANT-WOMEN; ACCEPTANCE; PERCEPTION; INGESTION; GLUCOSE; ODORS
AB Objective: To compare facial responses to basic tastes among newborns of women with and without gestational diabetes mellitus (GDM).
   Methods: Two-hundred and one healthy newborns, 100 from GDM women were studied at the Instituto de Medicina Integral Prof. Fernando Figueira (IMIP), Brazil. Basic tastes were evaluated through administration of glucose (25%), sodium chloride (1.4%), citric acid (25%) and quinine hydrochloride (25%); 0.2 ml of solution on the dorsal surface of the tongue. All newborns had their face videotaped and facial responses were coded according to the Baby Facial Action Coding System. The frequency of the facial action units was compared among newborns from mothers with and without GDM.
   Results: Facial responses to salt was more liking among newborns from GDM mothers as compared to controls; 33 (33%) versus 21 (21%), p = 0.039). Facial responses to sweet, sour and bitter showed no differences among newborns from mothers with and without GDM. Facial expressions to basic tastes showed no differences among newborns from controlled and non-controlled GDM mothers.
   Conclusion: Newborns from GDM mothers seem to have a little more preference taste to salt. Further studies are needed to confirm this finding and to verify if these newborns responses to basic tastes remain life-long.
C1 [Sa, Andrea Zacche; Silva Junior, Jose Roberto; Alves, Joao G.] Inst Med Integral Prof Fernando Figueira IMIP, Dept Pediat, Recife, PE, Brazil.
RP Alves, JG (corresponding author), Inst Med Integral Prof Fernando Figueira, Dept Pediat, Rua Dsos Coelhos 300, BR-50070550 Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
CR Beauchamp GK, 2011, DIGESTION, V83, P1, DOI 10.1159/000323397
   Cooke L, 2011, APPETITE, V57, P808, DOI 10.1016/j.appet.2011.05.317
   Dashe JS, 2000, AM J OBSTET GYNECOL, V182, P901, DOI 10.1016/S0002-9378(00)70343-7
   Harris G, 2008, CURR OPIN CLIN NUTR, V11, P315, DOI 10.1097/MCO.0b013e3282f9e228
   HAUSER GJ, 1985, EUR J PEDIATR, V144, P403, DOI 10.1007/BF00441788
   Kainer F, 1997, EARLY HUM DEV, V49, P97, DOI 10.1016/S0378-3782(97)00027-3
   MENNELLA JA, 1995, CHEM SENSES, V20, P207, DOI 10.1093/chemse/20.2.207
   Mennella JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.6.e88
   Mennella JA, 2014, AM J CLIN NUTR, V99, p704S, DOI 10.3945/ajcn.113.067694
   Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848
   Rinala SG, 2009, AM J OBSTET GYNECOL, V200, pE43, DOI 10.1016/j.ajog.2008.10.046
   Robinson S, 2013, BRIT J NUTR, V109, P1114, DOI 10.1017/S000711451200267X
   ROSENSTEIN D, 1988, CHILD DEV, V59, P1555, DOI 10.2307/1130670
   Schaal B, 2000, CHEM SENSES, V25, P729, DOI 10.1093/chemse/25.6.729
   Schwartz C, 2009, BRIT J NUTR, V102, P1375, DOI 10.1017/S0007114509990286
   Small DM, 2005, EXP BRAIN RES, V166, P345, DOI 10.1007/s00221-005-2376-9
   Willett WC, 2013, ANNU REV PUBL HEALTH, V34, P77, DOI 10.1146/annurev-publhealth-031811-124646
   Zhang L, 2007, WORLD J PEDIATR, V3, P203
NR 18
TC 2
Z9 2
U1 0
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-7058
EI 1476-4954
J9 J MATERN-FETAL NEO M
JI J. Matern.-Fetal Neonatal Med.
PY 2015
VL 28
IS 14
BP 1687
EP 1690
DI 10.3109/14767058.2014.964680
PG 4
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA CQ2OA
UT WOS:000360439400012
PM 25212980
DA 2020-12-01
ER

PT J
AU Alves, JG
   Vasconcelos, SA
   de Almeida, TS
   Lages, R
   Just, E
AF Alves, Joao Guilherme
   Vasconcelos, Sarita Amorim
   de Almeida, Tais Sa
   Lages, Raquel
   Just, Eduardo
TI Influence of catch-up growth on abdominal fat distribution in very low
   birth weight children - cohort study
SO JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
LA English
DT Article
DE abdominal adiposity; catch-up growth; subcutaneous fat; very low birth
   weight
ID CHILDHOOD GROWTH; ADULT LIFE; OBESITY; UNDERNUTRITION; ADIPOSITY;
   INFANTS; HEALTH; AGE
AB Background/aims: A rapid catch-up growth in very low birth weight has been associated both with a higher height growth and a higher risk to metabolic disturbances, including insulin resistance and its consequences. Abdominal fat distribution in early postnatal life may play a role in these outcomes and can help in addressing this neonatal dilemma. This study aimed to compare abdominal fat distribution among very low birth weight (VLBW) children with and without rapid catch-up growth.
   Materials and methods: A cohort study followed 86 VLBW (< 1500) children born in Brazil, during the first 3 years of life. Rapid catch-up growth was considered as an increased in length > 2 Z score during the first year of life. Abdominal subcutaneous and preperitoneal fat thickness was determined by ultrasound. chi(2)-Test and Student's t-test were used to compare the groups.
   Results: A total of 79 VLBW children completed the study, of whom 22 (27.8%) showed rapid catch-up growth. Abdominal subcutaneous and preperitoneal fat thickness showed no differences among children with or without rapid catch-up growth at 3.3 mm vs. 3.8 mm, respectively (p=0.79) and 4.0 mm vs. 4.0 mm (p=0.55), respectively. VLBW children with rapid catch-up growth were also taller.
   Conclusions: Rapid catch-up growth during the first year of life in VLBW children does not seem to change abdominal fat distribution until the third year of life.
C1 [Alves, Joao Guilherme; Just, Eduardo] Inst Med Integral Prof Fernando Figueira IMIP, BR-50070550 Recife, PE, Brazil.
   [Vasconcelos, Sarita Amorim; de Almeida, Tais Sa; Lages, Raquel] FPS, Pernambuco, Brazil.
RP Alves, JG (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Rua Coelhos,300 Boa Vista, BR-50070550 Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
FU Programa Institucional de Bolsas de Iniciacao Cientifica (PIBIC), FACEPE
FX Sarita Amorim Vasconcelos was sponsored by Programa Institucional de
   Bolsas de Iniciacao Cientifica (PIBIC), FACEPE.
CR Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8
   Alves JG, 2010, INDIAN J PEDIATR, V77, P1266, DOI 10.1007/s12098-010-0179-x
   [Anonymous], 2006, ACTA PAEDIAT S, V450, P76
   Argente J, 2010, PEDIATR NEPHROL, V25, P679, DOI 10.1007/s00467-009-1432-2
   Bellinger L, 2006, INT J OBESITY, V30, P729, DOI 10.1038/sj.ijo.0803205
   Beltrand J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005343
   Bibby E, 2004, NEUROENDOCRINOL LETT, V25, P43
   Eriksson J, 2001, INT J OBESITY, V25, P735, DOI 10.1038/sj.ijo.0801602
   Eriksson JG, 2003, DIABETES CARE, V26, P3006, DOI 10.2337/diacare.26.11.3006
   Forsen TJ, 2004, ANN MED, V36, P389, DOI 10.1080/07853890410028438
   Holzhauer S, 2009, EUR J EPIDEMIOL, V24, P521, DOI 10.1007/s10654-009-9368-1
   Iacovidou N, 2010, ANN NY ACAD SCI, V1205, P130, DOI 10.1111/j.1749-6632.2010.05657.x
   Ibanez L, 2008, J CLIN ENDOCR METAB, V93, P2079, DOI 10.1210/jc.2007-2850
   Jain V, 2012, REV ENDOCR METAB DIS, V13, P141, DOI 10.1007/s11154-012-9216-6
   Knops Noel B B, 2005, BMC Pediatr, V5, P26, DOI 10.1186/1471-2431-5-26
   Labayen I, 2006, J NUTR, V136, P147
   LAW CM, 1992, J EPIDEMIOL COMMUN H, V46, P184, DOI 10.1136/jech.46.3.184
   Mackay CA, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-50
   Niklasson A, 2003, PEDIATR RES, V54, P899, DOI 10.1203/01.PDR.0000091287.38691.EF
   Okosun IS, 2000, INT J OBESITY, V24, P479, DOI 10.1038/sj.ijo.0801182
   Sichieri R, 2010, BRIT J NUTR, V103, P1534, DOI 10.1017/S0007114509993448
   SUZUKI R, 1993, AM J MED, V95, P309, DOI 10.1016/0002-9343(93)90284-V
   Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011
   Thureen PJ, 2007, J PEDIATR GASTR NUTR, V45, pS152, DOI 10.1097/01.mpg.0000302962.08794.62
   Wit JM, 2002, J PEDIATR ENDOCR MET, V15, P1229
NR 25
TC 6
Z9 9
U1 0
U2 13
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0334-018X
EI 2191-0251
J9 J PEDIATR ENDOCR MET
JI J. Pediatr. Endocrinol. Metab.
PD JAN
PY 2015
VL 28
IS 1-2
BP 153
EP 156
DI 10.1515/jpem-2014-0191
PG 4
WC Endocrinology & Metabolism; Pediatrics
SC Endocrinology & Metabolism; Pediatrics
GA AX2HQ
UT WOS:000346764500024
PM 25153564
DA 2020-12-01
ER

PT J
AU Ferreira, APA
   da Silva, JR
   Figueiroa, JN
   Alves, JGB
AF Ferreira, A. P. A.
   da Silva Junior, J. R.
   Figueiroa, J. N.
   Alves, J. G. B.
TI Abdominal subcutaneous and visceral fat thickness in newborns:
   correlation with anthropometric and metabolic profile
SO JOURNAL OF PERINATOLOGY
LA English
DT Article
ID CORD-BLOOD; ADIPOSE-TISSUE; BIRTH-WEIGHT; PREDICTION; ORIGINS; GROWTH
AB OBJECTIVE: To correlate abdominal subcutaneous and visceral fat thickness with anthropometric data and metabolic profile in newborns.
   STUDY DESIGN: A cross-sectional study with 99 newborns was performed at Instituto de Medicina Integral Professor Fernando Figueira, Brazil. Abdominal subcutaneous and visceral thickness were measured by ultrasound. Glucose, insulin, homeostatic model assessment-insulin resistance (HOMA-IR), total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, very-low-density lipoprotein cholesterol and triglycerides were determined. Pearson correlation coefficients were calculated.
   RESULT: Abdominal subcutaneous fat thickness was positively correlated with birth weight (r=0.31; P<0.001), height (r=0.27; P<0.001) and abdominal circumference (r=0.26; P<0.001), but not with metabolic profile. Abdominal visceral fat thickness was correlated with abdominal circumference (r=0.23; P=0.01), insulin (r=0.21; P=0.04) and HOMA (r=0.24; P=0.02). The results remained the same among males and females.
   CONCLUSION: Abdominal fat distribution in newborns has a different correlation with anthropometric and metabolic profile. Abdominal subcutaneous fat thickness is positively correlated with anthropometric data whereas abdominal visceral fat thickness is correlated with insulin and HOMA-IR.
C1 [Ferreira, A. P. A.; da Silva Junior, J. R.; Figueiroa, J. N.; Alves, J. G. B.] Inst Med Integral Prof Fernando Figueira IMIP, BR-50070550 Recife, PE, Brazil.
RP Alves, JGB (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI da silva Junior, Jose Roberto/K-2459-2015; Alves, Joao G/J-6483-2013
OI da silva Junior, Jose Roberto/0000-0003-3843-005X; Alves, Joao
   G/0000-0002-9170-0808
FU CNPq (Brazilian Government-National Council for Scientific and
   Technological Development)National Council for Scientific and
   Technological Development (CNPq) [563751/2010-0]
FX This research was funded by CNPq (Brazilian Government-National Council
   for Scientific and Technological Development), Process number
   563751/2010-0. The funder had no role in study design, data collection,
   analysis or preparation of the manuscript.
CR Alves JG, 2010, INDIAN J PEDIATR, V77, P1266, DOI 10.1007/s12098-010-0179-x
   Bansal N, 2005, CURR OPIN LIPIDOL, V16, P400, DOI 10.1097/01.mol.0000174154.61307.16
   Bastida S, 1997, J PERINAT MED, V25, P184, DOI 10.1515/jpme.1997.25.2.184
   de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548
   Despres JP, 2006, ANN MED, V38, P52, DOI 10.1080/07853890500383895
   Dessi A, 2011, J MATERN-FETAL NEO M, V24, P36, DOI 10.3109/14767058.2011.605868
   Duvnjak L, 2009, J PHYSIOL PHARMACOL, V60, P19
   GLUECK CJ, 1973, J LAB CLIN MED, V82, P467
   Holzhauer S, 2009, EUR J EPIDEMIOL, V24, P521, DOI 10.1007/s10654-009-9368-1
   Joss-Moore LA, 2010, EARLY HUM DEV, V86, P179, DOI 10.1016/j.earlhumdev.2010.02.006
   Kazemi SAN, 2013, INT J PREVENTIVE MED, V4, P755
   Larciprete G, 2007, J OBSTET GYNAECOL RE, V33, P635, DOI 10.1111/j.1447-0756.2007.00624.x
   McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003
   Morrison JL, 2010, PEDIATR NEPHROL, V25, P669, DOI 10.1007/s00467-009-1407-3
   Rodriguez G, 2011, J PERINAT MED, V39, P355, DOI [10.1515/JPM.2011.023, 10.1515/jpm.2011.023]
   Rogers I, 2003, INT J OBESITY, V27, P755, DOI 10.1038/sj.ijo.0802316
   Rolfe ED, 2013, J OBES, V2013, DOI 10.1155/2013/951954
   ROSSNER S, 1990, INT J OBESITY, V14, P893
   Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9
   SUZUKI R, 1993, AM J MED, V95, P309, DOI 10.1016/0002-9343(93)90284-V
   Teixeira PJ, 2001, OBES RES, V9, P432, DOI 10.1038/oby.2001.57
   Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697
   West J, 2013, J EPIDEMIOL COMMUN H, V67, P544, DOI 10.1136/jech-2012-201891
   World Health Organization, 2010, GLOB STAT REP NONC D
NR 24
TC 6
Z9 7
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0743-8346
EI 1476-5543
J9 J PERINATOL
JI J. Perinatol.
PD DEC
PY 2014
VL 34
IS 12
BP 932
EP 935
DI 10.1038/jp.2014.110
PG 4
WC Obstetrics & Gynecology; Pediatrics
SC Obstetrics & Gynecology; Pediatrics
GA AU3AS
UT WOS:000345486000012
PM 24901453
DA 2020-12-01
ER

PT J
AU Gonzaga, NC
   Medeiros, CCM
   de Carvalho, DF
   Alves, JGB
AF Gonzaga, Nathalia C.
   Medeiros, Carla C. M.
   de Carvalho, Danielle F.
   Alves, Joao G. B.
TI Leptin and cardiometabolic risk factors in obese children and
   adolescents
SO JOURNAL OF PAEDIATRICS AND CHILD HEALTH
LA English
DT Article
DE cardiovascular disease; leptin; metabolic syndrome; obesity
ID INSULIN-RESISTANCE SYNDROME; BODY-MASS INDEX; METABOLIC SYNDROME; PLASMA
   LEPTIN; CARDIOVASCULAR-DISEASE; SYNDROME COMPONENTS; PHYSICAL-ACTIVITY;
   AGE; INFLAMMATION
AB Aim: To verify the relationship between leptin and cardiometabolic risk factors in obese children and adolescents.
   Methods: A cross-sectional study evaluated 200 children and adolescents treated in Campina Grande, Brazil, from April 2009 to March 2010. Leptin, fasting glucose, insulin, homeostasis model assessment of insulin resistance (HOMA-IR), total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and triglycerides were determined. The t-test was used to compare leptin means of two groups and analysis of variance to compare means of three groups. Multiple comparisons of pairs of group means were performed with Tukey's test. In all tests, a significance level of 0.05 was adopted.
   Results: The leptin sample mean was 22.7 +/- 10.0 mu g/L (95% confidence interval: 21.3 mu g/L to 24.1 mu g/L). Leptin was significantly higher in the following groups: female, teenager, increased waist circumference, high systolic blood pressure, elevated triglycerides hyperinsulinemia, insulin resistance and metabolic syndrome. Most cardiometabolic risk factors had higher means in the last quartile of leptin, except total-cholesterol, LDL-C and triglycerides levels. HDL-C was reduced in the last quartile of leptin. Simple linear regression analysis showed a significant negative correlation between leptin and HDL-C and a positive correlation between leptin and triglycerides, insulin, HOMA-IR, body mass index, waist circumference, and systolic and diastolic blood pressure. Multiple linear regression models showed an independent association between leptin and HDL-C, triglycerides, insulin, HOMA-IR, body mass index, waist circumference, systolic and diastolic blood pressure, after age and gender control.
   Conclusion: Leptin may be a useful marker of metabolic syndrome and insulin resistance in obese adolescents.
C1 [Gonzaga, Nathalia C.; Medeiros, Carla C. M.; de Carvalho, Danielle F.] State Univ Paraiba, Masters Program Publ Hlth, BR-58429500 Campina Grande, PB, Brazil.
   [Alves, Joao G. B.] Inst Integrat Med Prof Fernando Figueira IMIP, Dept Pediat, Recife, PE, Brazil.
RP Gonzaga, NC (corresponding author), State Univ Paraiba, Ctr Childhood Obes, Nucleo Estudos & Pesquisas Epidemiol Cent Integra, 3 Andar Sala 330,Rua Baraunas S-N, BR-58429500 Campina Grande, PB, Brazil.
EM nathaliacgonzaga@gmail.com
RI Alves, Joao G/J-6483-2013; de Carvalho, Danielle F/E-6181-2017
OI Alves, Joao G/0000-0002-9170-0808; 
FU Universidade Estadual da Paraiba through Programa de Incentivo a
   Pos-Graduacao e Pesquisa (PROPESQ) [01/2008, 98/2008]
FX This study received financial support from the Universidade Estadual da
   Paraiba through Programa de Incentivo a Pos-Graduacao e Pesquisa
   (PROPESQ) Edict 01/2008 (PRPGP/UEPB Term Concession N0 98/2008).
CR [Anonymous], 2005, Arq. Bras. Cardiol., V85, P3, DOI 10.1590/S0066-782X2005002500001
   *CDCP, 2002, TABL CALC BOD MASS I
   Chu NF, 2000, INT J OBESITY, V24, P1265, DOI 10.1038/sj.ijo.0801404
   de Almeida CAN, 2007, J PEDIAT-BRAZIL, V83, P181, DOI [10.1590/S0021-75572007000200014, 10.2223/JPED.1604]
   Dubey S, 2007, INDIAN PEDIATR, V44, P257
   GarciaMayor RV, 1997, J CLIN ENDOCR METAB, V82, P2849, DOI 10.1210/jc.82.9.2849
   Gomes F, 2010, ARQ BRAS CARDIOL, V94, P273, DOI 10.1590/S0066-782X2010000200021
   Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143
   Hermsdorff Helen Hermana Miranda, 2006, Rev. Nutr., V19, P369, DOI 10.1590/S1415-52732006000300008
   Huang KC, 2004, INT J OBESITY, V28, P470, DOI 10.1038/sj.ijo.0802531
   International Diabetes Federation (IDF), 2007, IDF CONS DEF MET SYN
   Kshatriya S, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/270624
   Lassek WD, 2007, AM J PHYS ANTHROPOL, V133, P1147, DOI 10.1002/ajpa.20644
   Madeira IR, 2009, J PEDIAT-BRAZIL, V85, P261, DOI [10.2223/JPED.1873, 10.1590/S0021-75572009000300013]
   Madeira IR, 2008, ARQ BRAS ENDOCRINOL, V52, P1466, DOI 10.1590/S0004-27302008000900010
   Martinez-Gomez D, 2012, J PEDIATR-US, V160, P104, DOI 10.1016/j.jpeds.2011.06.037
   Misra A, 2001, DIABETES NUTR METAB, V14, P18
   Nobre F., 2010, REV BRAS HIPERTENS, V17, P4
   Platat C, 2006, DIABETOLOGIA, V49, P2078, DOI 10.1007/s00125-006-0320-6
   Poveda E, 2007, BIOMEDICA, V27, P505
   Retnakaran R, 2006, J PEDIATR-US, V148, P176, DOI 10.1016/j.jpeds.2005.08.025
   Sociedade Brasileira de Cardiologia (SBC), 2007, ARQ BRAS CARDIOL, V89, P24
   Serrano HMS, 2010, ARQ BRAS CARDIOL, V95, P464, DOI 10.1590/S0066-782X2010005000109
   Steinberger J, 2003, OBES RES, V11, P1124, DOI 10.1038/oby.2003.153
   Steinberger J, 2009, CIRCULATION, V119, P628, DOI 10.1161/CIRCULATIONAHA.108.191394
   Sudi K, 2000, J PEDIATR ENDOCR MET, V13, P923
   Tamer L, 2002, Indian Heart J, V54, P692
   Valle M, 2003, INT J OBESITY, V27, P13, DOI 10.1038/sj.ijo.0802154
   Venner AA, 2006, CLIN BIOCHEM, V39, P1047, DOI 10.1016/j.clinbiochem.2006.07.010
   Wallace AM, 2001, CIRCULATION, V104, P3052, DOI 10.1161/hc5001.101061
   Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102
   *WHO, 1995, 854 WHO
   Zimmet PZ, 1998, INT J OBESITY, V22, P171, DOI 10.1038/sj.ijo.0800559
NR 33
TC 19
Z9 19
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1034-4810
EI 1440-1754
J9 J PAEDIATR CHILD H
JI J. Paediatr. Child Health
PD SEP
PY 2014
VL 50
IS 9
BP 707
EP 712
DI 10.1111/jpc.12610
PG 6
WC Pediatrics
SC Pediatrics
GA AO2HV
UT WOS:000341141200009
PM 24923191
DA 2020-12-01
ER

PT J
AU Dutra, LP
   Cisneiros, RM
   Souza, AS
   Diniz, CP
   Moura, LA
   Figueiroa, JN
   Alves, JGB
AF Dutra, Luciana P.
   Cisneiros, Rosangela M.
   Souza, Alex S.
   Diniz, Carolina P.
   Moura, Lais A.
   Figueiroa, Jose N.
   Alves, Joao G. B.
TI Longitudinal variance of visceral fat thickness in pregnant adolescents
SO AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY
LA English
DT Article
DE adolescent; pregnancy; visceral fat
ID ADIPOSE-TISSUE; SUBCUTANEOUS FAT; ULTRASONOGRAPHY; MASS; DEPOSITION;
   OBESITY; WEIGHT
AB This study aims to investigate the longitudinal change in visceral fat thickness (VFT) during normal pregnancy. A prospective cohort study with 75 primiparous adolescents was carried out in Petrolina, Brazil. VFT was evaluated by ultrasound between 12-20 weeks gestation and immediately after delivery. We noted a statistically significant increase in VFT; 1.3cm +/- 1.0. No correlation was found between VFT and maternal anthropometric variables. VFT increases about 30% from the first to the second half of pregnancy in primiparous adolescents.
C1 [Dutra, Luciana P.; Moura, Lais A.] Univ Fed Vale Sao Francisco UNIVASF, Dept Nursery Educ, Petrolina, Brazil.
   [Cisneiros, Rosangela M.] Univ Fed Vale Sao Francisco UNIVASF, Endocrinol & Diabet Unit, Petrolina, Brazil.
   [Souza, Alex S.] Inst Med Integral Prof Fernando Figueira IMIP, Dept Fetal Med, BR-50070550 Recife, PE, Brazil.
   [Diniz, Carolina P.] Hosp Dom Malan, Petrolina, Brazil.
   [Figueiroa, Jose N.] Inst Med Integral Prof Fernando Figueira IMIP, Dept Biostat, BR-50070550 Recife, PE, Brazil.
   [Alves, Joao G. B.] Inst Med Integral Prof Fernando Figueira IMIP, Dept Pediat, BR-50070550 Recife, PE, Brazil.
RP Alves, JGB (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Souza, Alex Sandro Rolland/AAG-2471-2019; Alves, Joao G/J-6483-2013
OI Souza, Alex Sandro Rolland/0000-0001-7039-2052; Alves, Joao
   G/0000-0002-9170-0808
FU FACEPE [APQ - 0145-4.01/10]
FX This study was funded by FACEPE (APQ - 0145-4.01/10).
CR ARMELLINI F, 1990, J CLIN ULTRASOUND, V18, P563, DOI 10.1002/jcu.1870180707
   Bartha JL, 2007, OBESITY, V15, P2233, DOI 10.1038/oby.2007.265
   Batra A, 2012, DIGEST DIS, V30, P70, DOI 10.1159/000335722
   Bazzocchi A, 2011, ACAD RADIOL, V18, P1133, DOI 10.1016/j.acra.2011.04.014
   Blaudeau TE, 2006, INT J OBESITY, V30, P1119, DOI 10.1038/sj.ijo.0803252
   Bosello O, 2000, Obes Rev, V1, P47, DOI 10.1046/j.1467-789x.2000.00008.x
   Kemp MW, 2012, J PAEDIATR CHILD H, V48, P86, DOI 10.1111/j.1440-1754.2010.01940.x
   Kim SK, 2004, AM J CLIN NUTR, V79, P593
   Kinoshita T, 2006, GYNECOL OBSTET INVES, V61, P115, DOI 10.1159/000089456
   Martin AM, 2009, DIABETES CARE, V32, P1308, DOI 10.2337/dc09-0290
   Oteng-Ntim E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053749
   Perrini Sebastio, 2008, Archives of Physiology and Biochemistry, V114, P277, DOI [10.1080/13813450802334752, 10.1080/13813450802334752 ]
   PIPE NGJ, 1979, BRIT J OBSTET GYNAEC, V86, P929, DOI 10.1111/j.1471-0528.1979.tb11240.x
   Samano R, 2011, REV INVEST CLIN, V63, P500
   Stevens-Simon C, 2002, J AM DIET ASSOC, V102, P563, DOI 10.1016/S0002-8223(02)90131-8
   Straughen JK, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.25
   Suresh A, 2012, AUST NZ J OBSTET GYN, V52, P420, DOI 10.1111/j.1479-828X.2012.01471.x
   Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011
NR 18
TC 1
Z9 1
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0004-8666
EI 1479-828X
J9 AUST NZ J OBSTET GYN
JI Aust. N. Z. J. Obstet. Gynaecol.
PD FEB
PY 2014
VL 54
IS 1
BP 91
EP 93
DI 10.1111/ajo.12167
PG 3
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 298IS
UT WOS:000330318000018
PM 24471851
DA 2020-12-01
ER

PT J
AU da Silva, JR
   Borges, PS
   Agra, KF
   Pontes, IA
   Alves, JGB
AF da Silva, Jose Roberto, Jr.
   Borges, Paulo Sergio
   Agra, Karine F.
   Pontes, Isabelle Albuquerque
   Bezerra Alves, Joao Guilherme
TI Effects of an aquatic physical exercise program on glycemic control and
   perinatal outcomes of gestational diabetes: study protocol for a
   randomized controlled trial
SO TRIALS
LA English
DT Article
DE Aquatic physical exercise; Gestational diabetes mellitus
ID PREGNANCY
AB Background: Gestational diabetes mellitus (GDM) is increasing worldwide and has been associated with adverse perinatal outcomes and high risk for chronic disease both for the mother and for the child. Physical exercise is feasible for diabetic pregnant women and contributes to better glycemic control and to a decrease in adverse perinatal outcomes. However, there are no randomized controlled trials (RCT) assessing the effects of aquatic physical exercise on GDM control and adverse maternal and fetal outcomes.
   Methods/Design: An RCT will be conducted at Instituto de Medicina Integral Prof Fernando Figueira (IMIP), Brazil. A total of 72 pregnant women will be studied; 36 gestational diabetics will undergo an aquatic physical exercise program in a thermal pool, 3 times per week over 2 months. The primary endpoint will be glucose level control and use of insulin; secondary endpoints will be the following maternal and fetal outcomes: weight gain during pregnancy, blood pressure, pre-eclampsia diagnosis, intrauterus growth restriction, preterm birth, Cesarean section, macrosomia and maternal or neonatal intensive care admission. Endpoints between intervention and control group will analyzed by t test for unpaired data and chi(2) test, and the level of significance will set at <0.05.
   Discussion: The physical proprieties of water make aquatic exercises ideal for pregnant women. An aquatic physical exercise program developed for GDM women will be trialed in a thermal pool and under the supervision of physiotherapist to ensure compliance. It is expected that this study will provide evidence as to the effect of aquatic physical exercise on GDM control.
C1 [da Silva, Jose Roberto, Jr.; Borges, Paulo Sergio; Agra, Karine F.; Pontes, Isabelle Albuquerque; Bezerra Alves, Joao Guilherme] Inst Med Integral Prof Fernando Figueira IMIP, Mother & Child Dept, Recife, PE, Brazil.
RP Alves, JGB (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Mother & Child Dept, Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Alves, Joao G/J-6483-2013; de Albuquerque Pontes, Isabelle
   Eunice/AAG-6420-2019; da silva Junior, Jose Roberto/K-2459-2015
OI Alves, Joao G/0000-0002-9170-0808; de Albuquerque Pontes, Isabelle
   Eunice/0000-0002-2194-8971; da silva Junior, Jose
   Roberto/0000-0003-3843-005X
FU CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)
   (National Council for Scientific and Technological Development),
   Brazilian Federal GovernmentNational Council for Scientific and
   Technological Development (CNPq) [563751/2010-0]; FACEPE (Fundacao de
   Amparo a Ciencia e Tecnologia do Estado de Pernambuco) (Science and
   Technology Foundation of the State of Pernambuco), State Government of
   Pernambuco
FX This study is supported by grants from the CNPq (Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico) (National Council for
   Scientific and Technological Development), Brazilian Federal Government,
   no. 563751/2010-0). Jose Roberto Junior and Paulo Borges are sponsored
   by FACEPE (Fundacao de Amparo a Ciencia e Tecnologia do Estado de
   Pernambuco) (Science and Technology Foundation of the State of
   Pernambuco), State Government of Pernambuco. The study sponsors played
   no role in the design, analysis or in the decision to publish. We are
   grateful to the comments and suggestions of Professor Joel G Ray.
CR American Diabetes Association, 2003, Diabetes Care, V26 Suppl 1, pS103
   [Anonymous], 2002, OBSTET GYNECOL, V99, P171
   Barakat R, 2012, BRIT J SPORT MED, V46, P656, DOI 10.1136/bjsports-2011-090009
   Ceysens G, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004225.pub2
   Hartmann S, 1999, J PERINAT MED, V27, P204, DOI 10.1515/JPM.1999.029
   Kamioka H, 2011, INT J GEN MED, V4, P239, DOI 10.2147/IJGM.S17384
   Matsudo S, 2001, RBAFS, V6, P5
   Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848
   Negrato CA, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-41
   Paglia MJ, 2011, CURR OPIN OBSTET GYN, V23, P72, DOI 10.1097/GCO.0b013e328342d21e
   Parker Kara Mallory, 2003, J Perinat Educ, V12, P6
   Sato Y, 2007, DIABETES RES CLIN PR, V77, pS87, DOI 10.1016/j.diabres.2007.01.039
   Smith SA, 2006, JOGNN-J OBST GYN NEO, V35, P315, DOI 10.1111/J.1552-6909.2006.00045.x
   Thomas DR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002968.pub2
   Vallim AL, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-14
   Veeraswamy S, 2012, DIABETES RES CLIN PR, V97, P350, DOI 10.1016/j.diabres.2012.04.024
   Ward EJ, 2005, HYPERTENS PREGNANCY, V24, P93, DOI 10.1081/PRG-200059828
   Yessoufou A, 2011, EXP DIABETES RES, DOI 10.1155/2011/218598
NR 18
TC 6
Z9 9
U1 0
U2 22
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1745-6215
J9 TRIALS
JI Trials
PD NOV 19
PY 2013
VL 14
AR 390
DI 10.1186/1745-6215-14-390
PG 5
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 276MA
UT WOS:000328753200001
PM 24245914
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Meneses, J
   Bhandari, V
   Alves, JG
AF Meneses, Jucille
   Bhandari, Vineet
   Alves, Joao Guilherme
TI Questions Concerning Nasal Intermittent Positive-Pressure Ventilation vs
   Nasal Continuous Positive Airway Pressure Reply
SO JAMA PEDIATRICS
LA English
DT Letter
ID RESPIRATORY-DISTRESS-SYNDROME
C1 [Meneses, Jucille; Alves, Joao Guilherme] Inst Med Integral Prof Fernando Figueira, Dept Pediat, Recife, PE, Brazil.
   [Bhandari, Vineet] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA.
RP Meneses, J (corresponding author), Ave Boa Viagem 2080, BR-51111 Recife, PE, Brazil.
EM jucille.meneses@gmail.com
RI Alves, Joao G/J-6483-2013; Bhandari, Vineet/AAS-3365-2020
OI Alves, Joao G/0000-0002-9170-0808; 
CR Bader D, 2007, J PEDIAT, V150, pe1
   Kishore MSS, 2009, ACTA PAEDIATR, V98, P1412, DOI 10.1111/j.1651-2227.2009.01348.x
   Kugelman A, 2007, J PEDIATR-US, V150, P521, DOI 10.1016/j.jpeds.2007.01.032
   Meneses J, 2012, ARCH PEDIAT ADOL MED, V166, P372, DOI 10.1001/archpediatrics.2011.1142
   Meneses J, 2011, PEDIATRICS, V127, P300, DOI 10.1542/peds.2010-0922
NR 5
TC 1
Z9 1
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6203
EI 2168-6211
J9 JAMA PEDIATR
JI JAMA Pediatr.
PD SEP
PY 2013
VL 167
IS 9
BP 873
EP 873
DI 10.1001/jamapediatrics.2013.2212
PG 1
WC Pediatrics
SC Pediatrics
GA 232GD
UT WOS:000325479200020
PM 24026787
DA 2020-12-01
ER

PT J
AU Alves, JGB
   Russo, PC
   Alves, GV
AF Bezerra Alves, Joao Guilherme
   Russo, Pedro Cerqueira
   Alves, Guilherme Victor
TI Facial Responses to Basic Tastes in Breastfeeding and Formula-Feeding
   Infants
SO BREASTFEEDING MEDICINE
LA English
DT Letter
ID ACCEPTANCE
C1 [Bezerra Alves, Joao Guilherme] Inst Med Integral Prof Fernando Figueira IMIP, Dept Pediat, Recife, PE, Brazil.
   [Russo, Pedro Cerqueira; Alves, Guilherme Victor] FPS, Recife, PE, Brazil.
RP Alves, JGB (corresponding author), Inst Med Integral Prof Fernando Figueira, Dept Pediat, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
CR Cooke L, 2011, APPETITE, V57, P808, DOI 10.1016/j.appet.2011.05.317
   Harris G, 2008, CURR OPIN CLIN NUTR, V11, P315, DOI 10.1097/MCO.0b013e3282f9e228
   Hausner H, 2010, CLIN NUTR, V29, P141, DOI 10.1016/j.clnu.2009.11.007
   Mennella JA, 2009, AM J CLIN NUTR, V90, p780S, DOI 10.3945/ajcn.2009.27462O
   ROSENSTEIN D, 1988, CHILD DEV, V59, P1555, DOI 10.2307/1130670
NR 5
TC 3
Z9 3
U1 0
U2 5
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1556-8253
EI 1556-8342
J9 BREASTFEED MED
JI Breastfeed. Med.
PD APR
PY 2013
VL 8
IS 2
BP 235
EP 236
DI 10.1089/bfm.2012.0092
PG 2
WC Obstetrics & Gynecology; Pediatrics
SC Obstetrics & Gynecology; Pediatrics
GA 124NY
UT WOS:000317472700021
PM 23390990
DA 2020-12-01
ER

PT J
AU de Albuquerque, LL
   Gaete, MIL
   Figueiroa, JN
   Alves, JGB
AF de Albuquerque, Luciano Lira
   Lynch Gaete, Maria Isabel
   Figueiroa, Jose Natal
   Bezerra Alves, Joao Guilherme
TI The correlation between body mass index and intraocular pressure in
   children
SO ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
LA English
DT Article
DE Intraocular pressure; Tonometry; Body mass index; Obesity; Overweight;
   Child
ID OBESITY
AB Purpose: There is evidence from some studies that support an association between obesity in adults and higher intraocular pressure (IOP). However, this association has not been completely studied in children. Our aim is to evaluate the association between child body mass index (BMI) and IOP.
   Methods: Ninety-six children attending the Instituto de Medicina Integral Prof. Fernando Figueira (IMIP) in Brazil were studied. Thirty-three were overweight/obese with a mean BMI of 29.7 +/- 5.2 and 63 with a mean BMI of 20.8 +/- 3.3. IOP was measured using the Goldmann applanation tonometer and was corrected for corneal thickness. The coefficient of correlation between BMI and IOP was calculated.
   Results: There was no significant difference in the IOP of children with or without overweight/obesity. The mean IOP was 13.5 and 13.0 mmHg for the right eye and 13.1 and 12.9 mmHg for left eye, respectively (p=0.38 and p=0.71). The results remained the same after correction by pachymetry; 13.0 and 13.1 mmHg for the right eye and 12.4 and 12.9 mmHg for the left eye, respectively (p=0.88 and p=0.41). The coefficient of correlation between BMI and IOP was 0.070 (p=0.496).
   Conclusion: These results do not show a correlation between body mass index and IOP in children. Further studies are warranted to clarify the association between BMI and IOP in children.
C1 [de Albuquerque, Luciano Lira; Lynch Gaete, Maria Isabel; Figueiroa, Jose Natal; Bezerra Alves, Joao Guilherme] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
RP Alves, JGB (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
CR Akinci A, 2007, J GLAUCOMA, V16, P627, DOI 10.1097/IJG.0b013e318057528a
   Cheung N, 2007, SURV OPHTHALMOL, V52, P180, DOI 10.1016/j.survophthal.2006.12.003
   Coleman Anne L, 2009, Open Ophthalmol J, V3, P38, DOI 10.2174/1874364100903020038
   dos Santos MG, 1998, OPHTHALMOLOGY, V105, P2260, DOI 10.1016/S0161-6420(98)91226-X
   Gasser P, 1999, J GLAUCOMA, V8, P8
   Harris Alon, 2005, Ophthalmol Clin North Am, V18, P345, DOI 10.1016/j.ohc.2005.04.001
   Lee Jong Soo, 2002, Korean J Ophthalmol, V16, P13
   Mackenzie P, 2008, SURV OPHTHALMOL, V53, pS39, DOI 10.1016/j.survophthal.2008.08.008
   Mori K, 2000, INT J EPIDEMIOL, V29, P661, DOI 10.1093/ije/29.4.661
   Park Sang-shin, 2010, J Prev Med Public Health, V43, P125, DOI 10.3961/jpmph.2010.43.2.125
NR 10
TC 9
Z9 9
U1 0
U2 1
PU CONSEL BRASIL OFTALMOLOGIA
PI SAO PAULO
PA ALAMEDA SANTOS 1343, 11 ANDAR CJ 1110, CERQUEIRA CESAR, SAO PAULO, SP
   00000, BRAZIL
SN 0004-2749
J9 ARQ BRAS OFTALMOL
JI Arq. Bras. Oftalmol.
PD JAN-FEB
PY 2013
VL 76
IS 1
BP 10
EP 12
DI 10.1590/S0004-27492013000100004
PG 3
WC Ophthalmology
SC Ophthalmology
GA 177TE
UT WOS:000321397500004
PM 23812519
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Figueiroa, JN
   Alves, JGB
   de Lira, PIC
   Batista, M
AF Figueiroa, Jose Natal
   Bezerra Alves, Joao Guilherme
   Cabral de Lira, Pedro Israel
   Batista Filho, Malaquias
TI Intergenerational evolution of stature in Pernambuco State, Brazil
   (1945-2006). 2-analytical aspects
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Anthropometry; Growth and Development; Stature by Age
ID CHILDREN; HEIGHT
AB This study used multivariate regression models to identify factors associated with the height trend in residents of Pernambuco State, Brazil, in 2006, born from 1945 onward. The data were from two population-based statewide surveys. In the final model for each age bracket, year of birth, gender, schooling, and residence in urban areas were positively associated with stature in adults, as well as in children and adolescents 5 to 19 years of age. In children under five years, in addition to these variables, birth weight and prenatal care were also positively associated, while diarrhea in the two weeks prior to the interview showed a negative association. The findings show that stature was favored by settings with better socioeconomic and environmental conditions.
C1 [Figueiroa, Jose Natal; Bezerra Alves, Joao Guilherme; Batista Filho, Malaquias] Inst Med Integral Prof Fernando Figueira, BR-50070550 Recife, PE, Brazil.
   [Cabral de Lira, Pedro Israel] Univ Fed Pernambuco, Recife, PE, Brazil.
RP Figueiroa, JN (corresponding author), Inst Med Integral Prof Fernando Figueira, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
EM natal@imip.org.br
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
CR Abramovay R, 2010, CIENC CULT, V62, P38
   [Anonymous], 2007, SIT MUND INF
   Batista Filho M, 2010, VIABILIZACAO SEMIARI
   Batista FM, 2010, CIENC CULT, V62, P26
   Bezerra JG, 1998, DOENCAS ADULTO RAIZE
   CASTRO J, 1992, GEOGRAFIA FOME DILEM
   Onis M, 2006, ACTA PAEDIATR, V95, P7, DOI 10.1080/08035320500495407
   de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27
   Figueiroa JN, 2012, CAD SAUDE PUBLICA, V28, P1285, DOI 10.1590/S0102-311X2012000700007
   Fishler C, 2008, MANGER FRANCAIS EURO
   Fundo das Nacoes Unidas para a Infancia, 2011, SIT MUND INF
   Godoy RA, 2007, ECON HUM BIOL, V5, P82, DOI 10.1016/j.ehb.2006.10.001
   GrummerStrawn LM, 1996, B WORLD HEALTH ORGAN, V74, P369
   Haghdoost AA, 2008, IRAN J PUBLIC HEALTH, V37, P1
   Hox J.J., 2010, MULTILEVEL ANAL TECH
   Jelliffe DB, 1968, ORG MUNDIAL SALUD SE, P53
   Kues AB, 2010, ECON HUM BIOL, V8, P67, DOI 10.1016/j.ehb.2009.09.002
   Lima JPR, 2007, REV EC NORDESTE, V38, P525
   Menezes Risia Cristina Egito de, 2011, Rev. Saúde Pública, V45, P1079, DOI 10.1590/s0034-89102011000600010
   MORLEY D, 1974, LANCET, V1, P712
   POPKIN BM, 1993, POPUL DEV REV, V19, P138, DOI 10.2307/2938388
   Poulain J.-P., 2009, SOCIOLOGIE OBESITE
   Ranasinghe P, 2011, ECON HUM BIOL, V9, P23, DOI 10.1016/j.ehb.2010.09.005
   Rissin A, 2011, CIENC SAUDE COLETIVA, V16, P4067, DOI 10.1590/S1413-81232011001100012
   SACHS I., 2008, CAMINHOS DESENVOLVIM
   SEN A., 2001, DESENVOLVIMENTO COMO
   TANNER JM, 1990, FOETUS MAN
   Van de Poel E, 2007, SOC SCI MED, V65, P1986, DOI 10.1016/j.socscimed.2007.06.032
   WATERLOW JC, 1973, LANCET, V2, P87
NR 29
TC 7
Z9 9
U1 0
U2 3
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD AUG
PY 2012
VL 28
IS 8
BP 1468
EP 1478
DI 10.1590/S0102-311X2012000800006
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 991TQ
UT WOS:000307725200006
PM 22892967
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Figueiroa, JN
   Alves, JGB
   de Lira, PIC
   Batista, M
AF Figueiroa, Jose Natal
   Bezerra Alves, Joao Guilherme
   Cabral de Lira, Pedro Israel
   Batista Filho, Malaquias
TI Intergenerational evolution of stature in Pernambuco State, Brazil
   (1945-2006). 1-descriptive aspects
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Anthropometry; Growth and Development; Stature by Age
AB Linear regression models with random intercepts were used to describe the evolution in stature among residents in Pernambuco State, Brazil, in 2006, born from 1945 onward. From 1947 to 1987, yearly height gain was 0.23cm in adult men and 0.15cm in women. In relation to World Health Organization standard values (2006), children and adolescents showed a declining annual height deficit of -0.019 z-scores (H/A) for girls and -0.013 for boys (1987-2006). Men and women who completed 19 years of age in 1987 showed a height deficit of 5.0cm. Projecting the trends observed in 2006, adult men and women in Pernambuco would wait 22 and 33 years, respectively, to reach the international standard. Within 6 to 7 years, children under five would show a height deficit of 2.3%, which is the occurrence verified in the WHO standard, thus correcting the historical growth retardation in this population group in Pernambuco.
C1 [Figueiroa, Jose Natal; Bezerra Alves, Joao Guilherme; Batista Filho, Malaquias] Inst Med Integral Prof Fernando Figueira, BR-50070550 Recife, PE, Brazil.
   [Cabral de Lira, Pedro Israel] Univ Fed Pernambuco, Recife, PE, Brazil.
RP Figueiroa, JN (corresponding author), Inst Med Integral Prof Fernando Figueira, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
EM natal@imip.org.br
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
CR Abramovay R, 2010, CIENC CULT, V62, P38
   Batista Filho Malaquias, 2003, Cad. Saúde Pública, V19, pS181, DOI 10.1590/S0102-311X2003000700019
   BATISTA M, 2007, EPIDEMIOLOGIA NUTR, P445
   Conway G., 2003, PRODUCAO ALIMENTOS S
   Onis M, 2006, ACTA PAEDIATR, V95, P7, DOI 10.1080/08035320500495407
   Departamento de Atencao Basica Secretaria de Politicas de Saude Ministerio da Saude, 2002, SER CAD AT BAS A
   Fishler C, 2008, FRANCAIS EUROPEENS A
   Fogel RW, 2004, ECON DEV CULT CHANGE, V52, P643, DOI 10.1086/383450
   FREDERIKSEN H, 1969, SCIENCE, V166, P837, DOI 10.1126/science.166.3907.837
   Fundo das Nacoes Unidas para a Infancia, 2011, SIT MUND INF
   Grummer-Strawn LM, 1966, B WORLD HEALTH ORGAN, V74, P369
   Hamill PV, 1977, VITAL HLTH STAT 11, V11, p[i, 1]
   Instituto de Pesquisa Econamica Aplicada, 2010, COM PRES
   KAC G, 2003, CAD SAUDE PUBLICA, V19, P4
   Keele LJ, 2008, SEMIPARAMETRIC REGRE
   Komlos J, EUROPEAN HEIGHTS EAR
   Monasterio L., 2008, EC SELECTA, V9, P111
   MONTEIRO CA, 1994, ANN HUM BIOL, V21, P381, DOI 10.1080/03014469400003372
   Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940
   Monteiro CA, 2009, REV SAUDE PUBL, V43, P35, DOI [10.1590/S0034-89102009000100005, 10.1590/s0034-89102009000100005]
   Musgrove P, 2004, HLTH EC DEV
   Niewenweg R, 2003, ANN HUM BIOL, V30, P563, DOI 10.1080/0301446032000112661
   OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375
   POPKIN BM, 1993, POPUL DEV REV, V19, P138, DOI 10.2307/2938388
   Poulain J.-P., 2009, SOCIOLOGIE OBESITE
   SACHS I., 2008, CAMINHOS DESENVOLVIM
   SEN A., 2001, DESENVOLVIMENTO COMO
   Steckel RH, 1995, J ECON LIT, V33, P1903
   TANNER JM, 1990, FOETUS MAN
   TOURAINE Alain, 2006, NOVO PARADIGMA COMPR
   World Health Organization, 1995, WHO TECHN REP SER, V854
NR 31
TC 2
Z9 3
U1 0
U2 2
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD JUL
PY 2012
VL 28
IS 7
BP 1285
EP 1296
DI 10.1590/S0102-311X2012000700007
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 962XF
UT WOS:000305582000007
PM 22729259
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Meneses, J
   Bhandari, V
   Alves, JG
AF Meneses, Jucille
   Bhandari, Vineet
   Alves, Joao G.
TI Nasal Intermittent Positive-Pressure Ventilation vs Nasal Continuous
   Positive Airway Pressure for Preterm Infants With Respiratory Distress
   Syndrome A Systematic Review and Meta-analysis
SO ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE
LA English
DT Review
ID NONINVASIVE VENTILATION; MANDATORY VENTILATION; LUNG INJURY; CPAP;
   BIRTH; INFLAMMATION; SURFACTANT
AB Objective: To determine among preterm infants with respiratory distress syndrome whether the use of early nasal intermittent positive-pressure ventilation (NIPPV) vs nasal continuous positive airway pressure (NCPAP) decreases the need for invasive ventilation within the first 72 hours of life.
   Data Sources: MEDLINE, EMBASE, CINAHL, Cochrane Central Register of Controlled Trials, and clinicaltrials.gov were searched, as well as abstracts from meetings of the Pediatric Academic Societies.
   Study Selection: Randomized controlled trials involving infants with respiratory distress syndrome who received NIPPV vs NCPAP.
   Data Extraction: Data were extracted on the use of NIPPV vs NCPAP. Also extracted were data on the need for invasive ventilation within the first 72 hours of life and the incidences of bronchopulmonary dysplasia, pneumothorax, necrotizing enterocolitis, and intraventricular hemorrhage, as well as the time to full feeds and the duration of hospital stay.
   Data Synthesis: Three trials were included (n=360). A significant decrease in the need for invasive ventilation was found in the NIPPV group (risk ratio, 0.60; 95% CI, 0.43-0.83). No difference between groups was found in the incidence of bronchopulmonary dysplasia (risk ratio, 0.56; 95% CI, 0.09-3.49). No differences in the other outcomes were observed between the 2 groups.
   Conclusions: Among preterm infants with respiratory distress syndrome, NIPPV decreases the need for invasive ventilation within the first 72 hours of life compared with NCPAP. Trials are needed to assess whether NIPPV minimizes the occurrence of bronchopulmonary dysplasia and other comorbidities.
C1 [Meneses, Jucille] Inst Med Integral Prof Fernando Figueira, Div Neonatol, BR-51111000 Recife, PE, Brazil.
   [Alves, Joao G.] Inst Med Integral Prof Fernando Figueira, Dept Pediat, BR-51111000 Recife, PE, Brazil.
   [Bhandari, Vineet] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA.
RP Meneses, J (corresponding author), Inst Med Integral Prof Fernando Figueira, Div Neonatol, Ave Boa Viagem 2080,Apt 2801, BR-51111000 Recife, PE, Brazil.
EM jucille.meneses@gmail.com.br
RI Bhandari, Vineet/AAS-3365-2020; Mahdian Jouybari, Reza/Q-4798-2016;
   Alves, Joao G/J-6483-2013
OI Mahdian Jouybari, Reza/0000-0001-5016-938X; Alves, Joao
   G/0000-0002-9170-0808
CR Aghai ZH, 2006, PEDIATR PULM, V41, P875, DOI 10.1002/ppul.20461
   Ammari A, 2005, J PEDIATR-US, V147, P341, DOI 10.1016/j.jpeds.2005.04.062
   Bancalari E, 2008, EARLY HUM DEV, V84, P815, DOI 10.1016/j.earlhumdev.2008.09.010
   Bhandari V, 2010, J PERINATOL, V30, P505, DOI 10.1038/jp.2009.165
   Bhandari V, 2009, PEDIATRICS, V124, P517, DOI 10.1542/peds.2008-1302
   Chang HY, 2011, PEDIATR RES, V69, P84, DOI 10.1203/PDR.0b013e3181ff6770
   Cochrane Collaboration, 2010, REV MAN VERS 5 0
   Davis PG, 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858, DOI 10.1002/14651858.CD003212]
   Dumpa V, 2011, AM J PERINAT, V28, P321, DOI 10.1055/s-0030-1268708
   Finer NN, 2010, NEW ENGL J MED, V362, P1970, DOI 10.1056/NEJMoa0911783
   Fuchs H, 2011, ARCH DIS CHILD-FETAL, V96, pF343, DOI 10.1136/adc.2010.205898
   GARLAND JS, 1985, PEDIATRICS, V76, P406
   Glasziou PP, 2002, STAT MED, V21, P1503, DOI 10.1002/sim.1183
   Jobe AH, 2002, PEDIATR RES, V52, P387, DOI 10.1203/01.PDR.0000025341.25481.42
   Jobe AH, 2011, CURR OPIN PEDIATR, V23, P167, DOI 10.1097/MOP.0b013e3283423e6b
   Kiciman NM, 1998, PEDIATR PULM, V25, P175, DOI 10.1002/(SICI)1099-0496(199803)25:3<175::AID-PPUL7>3.0.CO;2-L
   Kieran EA, 2011, ARCH DIS CHILD-FETAL, V96, pF156, DOI 10.1136/adc.2010.203190
   Kishore MSS, 2009, ACTA PAEDIATR, V98, P1412, DOI 10.1111/j.1651-2227.2009.01348.x
   Kugelman A, 2007, J PEDIATR-US, V150, P521, DOI 10.1016/j.jpeds.2007.01.032
   Lampland AL, 2008, CRIT CARE MED, V36, P183, DOI 10.1097/01.CCM.0000295311.61378.7D
   Laughon M, 2009, PEDIATRICS, V123, P1124, DOI 10.1542/peds.2008-0862
   Lemyre B., 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002272
   Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3
   Meneses J, 2011, PEDIATRICS, V127, P300, DOI 10.1542/peds.2010-0922
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2535, 10.1371/journal.pmed.1000097]
   Moretti C, 1999, EARLY HUM DEV, V56, P167, DOI 10.1016/S0378-3782(99)00046-8
   Morley CJ, 2008, NEW ENGL J MED, V358, P700, DOI 10.1056/NEJMoa072788
   Owen L S, 2008, Arch Dis Child Fetal Neonatal Ed, V93, pF148
   Polglase GR, 2009, PEDIATR RES, V65, P67, DOI 10.1203/PDR.0b013e318189487e
   Ramanathan R, 2010, J PERINATOL, V30, pS67, DOI 10.1038/jp.2010.99
   Van Marter LJ, 2000, PEDIATRICS, V105, P1194, DOI 10.1542/peds.105.6.1194
   Verder H, 2009, ACTA PAEDIATR, V98, P1400, DOI 10.1111/j.1651-2227.2009.01413.x
NR 32
TC 48
Z9 59
U1 1
U2 9
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 1072-4710
EI 1538-3628
J9 ARCH PEDIAT ADOL MED
JI Arch. Pediatr. Adolesc. Med.
PD APR
PY 2012
VL 166
IS 4
BP 372
EP 376
PG 5
WC Pediatrics
SC Pediatrics
GA 918UU
UT WOS:000302277500011
PM 22474063
OA Bronze
DA 2020-12-01
ER

PT J
AU Alves, JGB
   Figueiroa, JN
   Meneses, J
   Alves, GV
AF Bezerra Alves, Joao Guilherme
   Figueiroa, Jose Natal
   Meneses, Jucille
   Alves, Guilherme Victor
TI Breastfeeding Protects Against Type 1 Diabetes Mellitus: A Case-Sibling
   Study
SO BREASTFEEDING MEDICINE
LA English
DT Article
ID BETA-CELL AUTOIMMUNITY; EARLY INFANT DIET; COWS MILK; RISK; IDDM;
   ASSOCIATION; CHILDREN; BRAZIL
AB Background: Some epidemiological studies have shown a protective effect of breastfeeding against type 1 diabetes mellitus (T1DM), whereas others have found opposite results. The role of early exposure to cow's milk protein and shorter duration of breastfeeding are still controversial. This study aimed to compare the frequency and duration of breastfeeding among siblings with and without T1DM.
   Methods: A case-control study was conducted at the Prof. Fernando Figueira Institute of Integral Medicine, Recife, PE, Brazil, between June 2009 and August 2010. The case patients were children with T1DM, and the controls were their unaffected sibling. The World Health Organization criteria for T1DM were used. All T1DM cases had the diagnostic criteria confirmed by checking their medical records. Data on infant feeding during the first year of life, prenatal care, gestational age, delivery, birth weight, and immunization status were collected through information provided by the mothers.
   Results: In total, 123 children with diabetes mellitus type 1 and their respective siblings were studied. There was no difference in breastfeeding rates among the two groups, but patients with diabetes had a shorter duration of breastfeeding (3.3 vs. 4.6 months, p < 0.001). The diabetic group was exposed earlier to cow's milk. After controlling for other associated variables it was shown that a longer duration of breastfeeding was associated with a protective effect against diabetes.
   Conclusions: Our data support the proposal that a shorter breastfeeding interval may contribute to T1DM in Brazilian children.
C1 [Bezerra Alves, Joao Guilherme; Figueiroa, Jose Natal; Meneses, Jucille; Alves, Guilherme Victor] Inst Med Integral Prof Fernando Figueira, BR-50070550 Recife, PE, Brazil.
RP Alves, JGB (corresponding author), Inst Med Integral Prof Fernando Figueira, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Pesquisa,
   Brazil
FX G.V.A. was sponsored by the Programa Institucional de Bolsas de
   Iniciacao Cientifica, Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico Pesquisa, Brazil.
CR [Anonymous], 1985, WHO TECH REP SER, V727, P1
   Caminha MDC, 2010, REV SAUDE PUBL, V44, P240, DOI 10.1590/s0034-89102010000200003
   Forchielli ML, 2005, BRIT J NUTR, V93, pS41, DOI 10.1079/BJN20041356
   Gauderman WJ, 2002, BIOSTATISTICAL GENET, P267
   Gil A, 2002, NUTR RES REV, V15, P263, DOI 10.1079/NRR200248
   Gimeno SGA, 1997, DIABETES CARE, V20, P1256, DOI 10.2337/diacare.20.8.1256
   Hummel M, 2000, DIABETES CARE, V23, P969, DOI 10.2337/diacare.23.7.969
   Karrison MGE, 2001, DIABETOLOGIA, V44, P1140
   Knip M, 2010, NEW ENGL J MED, V363, P1900, DOI 10.1056/NEJMoa1004809
   Knip M, 2010, AM J CLIN NUTR, V91, p1506S, DOI 10.3945/ajcn.2010.28701C
   KOSTRABA JN, 1992, DIABETES CARE, V15, P626, DOI 10.2337/diacare.15.5.626
   Maahs DM, 2010, ENDOCRIN METAB CLIN, V39, P481, DOI 10.1016/j.ecl.2010.05.011
   Meloni T, 1997, DIABETES CARE, V20, P340, DOI 10.2337/diacare.20.3.340
   Norris JM, 1996, JAMA-J AM MED ASSOC, V276, P609, DOI 10.1001/jama.276.8.609
   Pitkaniemi J, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-5
   Rosenbauer J, 2008, DIABETES-METAB RES, V24, P211, DOI 10.1002/dmrr.791
   Sartorelli Daniela Saes, 2003, Cad. Saúde Pública, V19, pS29, DOI 10.1590/S0102-311X2003000700004
   SIEMIATYCKI J, 1989, DIABETES CARE, V12, P209, DOI 10.2337/diacare.12.3.209
   Sipetic S, 2005, NUTRITION, V21, P474, DOI 10.1016/j.nut.2004.07.014
   Thorsdottir I, 2011, NESTLE NUTR WORKS SE, V67, P29, DOI 10.1159/000325573
   Turck D, 2007, NESTLE NUTR WORKS SE, V60, P31, DOI 10.1159/000106358
   Vaarala O, 2002, ANN NY ACAD SCI, V958, P38
   Virtanen SM, 2003, AM J CLIN NUTR, V78, P1053
   Wadsworth EJK, 1997, DIABETIC MED, V14, P390, DOI 10.1002/(SICI)1096-9136(199705)14:5<390::AID-DIA364>3.0.CO;2-E
NR 24
TC 15
Z9 16
U1 0
U2 13
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1556-8253
J9 BREASTFEED MED
JI Breastfeed. Med.
PD FEB
PY 2012
VL 7
IS 1
BP 25
EP 28
DI 10.1089/bfm.2011.0009
PG 4
WC Obstetrics & Gynecology; Pediatrics
SC Obstetrics & Gynecology; Pediatrics
GA 893XT
UT WOS:000300391800005
PM 21819204
DA 2020-12-01
ER

PT J
AU Alves, JGB
   de Brito, RDCM
   Cavalcanti, TS
AF Bezerra Alves, Joao Guilherme
   Coelho Moraes de Brito, Rita de Cassia
   Cavalcanti, Telma Samila
TI Effectiveness of Mentha piperita in the Treatment of Infantile Colic: A
   Crossover Study
SO EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
LA English
DT Article
ID IRRITABLE-BOWEL-SYNDROME; PEPPERMINT OIL; PHARMACOLOGY; SIMETHICONE;
   TRIAL
AB Background. Infantile colic is a distressing and common condition for which there is no proven standard treatment. Objective. To compare the efficacy of Mentha piperita with simethicone in treatment for infantile colic. Methods. A double-blind crossover study was performed with 30 infants attending IMIP, Recife, Brazil. They were randomized to use Mentha piperita or simethicone in the treatment of infantile colic during 7 days with each drug. Primary outcomes were mother_s opinion about responses to the treatment, number of daily episodes of colic, and time spent crying, measured by a chronometer. Mann-Whitney and chi-square tests were used to compare the results. This study was previously approved by the Ethical Committee in Research at IMIP. Results. At baseline daily episodes of infantile colic was 3.9 (+/- 1.1) and the mean crying time per day was 192 minutes (+/- 51.6). At the end of the study daily episodes of colic fell to 1.6 (+/- 0.6) and the crying duration decreased to 111 (+/- 28) minutes. All mothers reported decrease of frequency and duration of the episodes of infantile colic and there were no differences between responses to Mentha piperita and simethicone. Conclusions. These findings suggest that Mentha piperitamay be used to help control infantile colic. However, these results must be repeated by others studies.
C1 [Bezerra Alves, Joao Guilherme; Coelho Moraes de Brito, Rita de Cassia; Cavalcanti, Telma Samila] Inst Med Integral Prof Fernando Figueira IMIP, BR-52050080 Recife, PE, Brazil.
RP Alves, JGB (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Rua Coelhos,301 Boa Vista, BR-52050080 Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
FU INFAN, Brazil
FX This study was sponsored by INFAN, Brazil. The funding sponsor has no
   involvement in the design, analysis, or writing process.
CR [Anonymous], 2007, SIMETHICONE DRUG INF
   Cappello G, 2007, DIGEST LIVER DIS, V39, P530, DOI 10.1016/j.dld.2007.02.006
   Cosmetic Ingredient Review Expert, 2001, INT J TOXICOL, V20, P61
   DANIELSSON B, 1985, ACTA PAEDIATR SCAND, V74, P446, DOI 10.1111/j.1651-2227.1985.tb11001.x
   Garrison MM, 2000, PEDIATRICS, V106, P184
   Grigoleit HG, 2005, PHYTOMEDICINE, V12, P607, DOI 10.1016/j.phymed.2004.10.006
   Grigoleit HG, 2005, PHYTOMEDICINE, V12, P612, DOI 10.1016/j.phymed.2004.10.007
   Grigoleit HG, 2005, PHYTOMEDICINE, V12, P601, DOI 10.1016/j.phymed.2004.10.005
   Hall B, 2012, J PAEDIATR CHILD H, V48, P128, DOI 10.1111/j.1440-1754.2011.02061.x
   Keifer David, 2007, Journal of Herbal Pharmacotherapy, V7, P91, DOI 10.1300/J157v07n02_07
   Kline RM, 2001, J PEDIATR-US, V138, P125, DOI 10.1067/mpd.2001.109606
   Leung AKC, 2004, J R SOC PROMO HEALTH, V124, P162, DOI 10.1177/146642400412400407
   Lobo Marie L, 2004, J Pediatr Health Care, V18, P115, DOI 10.1016/j.pedhc.2003.10.001
   Lucassen PLBJ, 2001, ARCH DIS CHILD, V84, P398, DOI 10.1136/adc.84.5.398
   Merat S, 2010, DIGEST DIS SCI, V55, P1385, DOI 10.1007/s10620-009-0854-9
   Savino F, 2005, PHYTOTHER RES, V19, P335, DOI 10.1002/ptr.1668
   Savino F, 2007, ACTA PAEDIATR, V96, P1259, DOI 10.1111/j.1651-2227.2007.00428.x
   Savino F, 2007, PEDIATRICS, V119, pE124, DOI 10.1542/peds.2006-1222
   Savino F, 2010, CURR OPIN PEDIATR, V22, P791, DOI 10.1097/MOP.0b013e32833fac24
   Tate S, 1997, J ADV NURS, V26, P543, DOI 10.1046/j.1365-2648.1997.t01-15-00999.x
   Taylor B. A., 1983, GUT A, V24, P992
   Vidal F, 2007, EXP PARASITOL, V115, P25, DOI 10.1016/j.exppara.2006.05.001
   Waddell Lisa, 2011, J Fam Health Care, V21, P12
   WESSEL MA, 1954, PEDIATRICS, V14, P421
   WOODGATE P, 2005, COCHRANE DB SYST REV
NR 25
TC 12
Z9 13
U1 0
U2 0
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1741-427X
EI 1741-4288
J9 EVID-BASED COMPL ALT
JI Evid.-based Complement Altern. Med.
PY 2012
VL 2012
AR 981352
DI 10.1155/2012/981352
PG 4
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA 989QT
UT WOS:000307576000001
PM 22844342
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Alves, JG
   Sarinho, F
   Barros, V
   Amorim, MM
AF Alves, Joao G.
   Sarinho, Felipe
   Barros, Vivianne
   Amorim, Melania M.
TI A Measurement Model of Infants Physical Activity Using Pedometer
SO JOURNAL OF DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE
LA English
DT Meeting Abstract
C1 [Alves, Joao G.; Sarinho, Felipe; Amorim, Melania M.] Inst Med Integral Prof Fernando Figueira IMIP, Pernambuco, Brazil.
   [Barros, Vivianne] Univ Fed Paraiba, Joao Pessoa, Paraiba, Brazil.
RI Amorim, Melania M/C-5807-2013; Alves, Joao G/J-6483-2013
OI Amorim, Melania M/0000-0003-1047-2514; Alves, Joao G/0000-0002-9170-0808
NR 0
TC 0
Z9 0
U1 0
U2 0
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 2040-1744
J9 J DEV ORIG HLTH DIS
JI J. Dev. Orig. Health Dis.
PD SEP
PY 2011
VL 2
SU 1
BP S64
EP S64
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 837CK
UT WOS:000296168500213
DA 2020-12-01
ER

PT J
AU Alves, JG
   Russo, P
   Alves, GV
AF Alves, Joao G.
   Russo, Pedro
   Alves, Guilherme V.
TI Facial Responses to Primary Taste in Breast and Formula Feeding Infants
SO JOURNAL OF DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE
LA English
DT Meeting Abstract
C1 [Alves, Joao G.; Russo, Pedro; Alves, Guilherme V.] Inst Med Integral Prof Fernando Figueira IMIP, Recife, PE, Brazil.
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
NR 0
TC 0
Z9 0
U1 0
U2 0
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 2040-1744
J9 J DEV ORIG HLTH DIS
JI J. Dev. Orig. Health Dis.
PD SEP
PY 2011
VL 2
SU 1
BP S43
EP S44
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 837CK
UT WOS:000296168500141
DA 2020-12-01
ER

PT J
AU Alves, JG
   Falcao, RW
   Pinto, RA
   Correia, JB
AF Alves, Joao G.
   Falcao, Romero W.
   Pinto, Renato A.
   Correia, Jailson B.
TI Obesity Patterns among Women in a Slum Area in Brazil
SO JOURNAL OF HEALTH POPULATION AND NUTRITION
LA English
DT Article
DE Caloric intake; Cross-sectional studies; Obesity; Physical activity;
   Slum; Brazil
ID SHORT STATURE; PREVALENCE; UNDERNUTRITION; POPULATION; TRANSITION;
   NORTHEAST; NUTRITION; DISEASES; ALAGOAS; ORIGINS
AB High-energy diet and sedentary lifestyle fail to completely explain the epidemic of obesity in developing countries. In this cross-sectional survey, the prevalence and patterns of overweight/obesity were assessed among women in a slum in Brazil. Using anthropometric measurements, shorter form of the International Physical Activity Questionnaire (IPAQ), and a 24-hour diet recall questionnaire, data were collected from 632 women aged 20-60 years. The prevalence of overweight and obesity was 29% and 17% respectively. Physical inactivity was found in 17% of the women; 12% of them had short stature, and 44% had energy intake below the recommended dietary allowance. Results of multiple logistic regression showed that overweight/obesity differed significantly (p<0.05) in the following aspects: abdominal circumference, energy intake, and short stature. A high prevalence of overweight/obesity was found in a very poor community associated with high-energy intake and short stature.
C1 [Alves, Joao G.; Correia, Jailson B.] Inst Med Integral Prof Fernando Figueira, Dept Epidemiol, BR-50070550 Recife, PE, Brazil.
   [Falcao, Romero W.; Pinto, Renato A.] Escola Pernambucana Saude, Recife, PE, Brazil.
RP Alves, JG (corresponding author), Inst Med Integral Prof Fernando Figueira, Dept Epidemiol, Rua Coelhos,300 Boa Vista, BR-50070550 Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Correia, Jailson B./J-4331-2015; Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
FU Brazil's National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Ciencia e Tecnologia do Estado de
   Pernambuco
FX The study was supported by Brazil's National Council for Scientific and
   Technological Development (CNPq) and Fundacao de Amparo a Ciencia e
   Tecnologia do Estado de Pernambuco.
CR Barker DJP, 2007, OBES REV, V8, P45, DOI 10.1111/j.1467-789X.2007.00317.x
   Benyshek DC, 2007, COLLEGIUM ANTROPOL, V31, P11
   BLANCO C, 2008, SLUMS BRAZIL, P1
   BUNNAG SC, 1990, DIABETES RES CLIN PR, V10, pS81, DOI 10.1016/0168-8227(90)90145-J
   Choi BCK, 2005, J EPIDEMIOL COMMUN H, V59, P1030, DOI 10.1136/jech.2005.032805
   Ferreira HS, 2009, BRIT J NUTR, V101, P1239, DOI 10.1017/S0007114508059357
   Florencio TT, 2007, EUR J CARDIOV PREV R, V14, P346, DOI 10.1097/HJR.0b013e328010f24d
   Florencio TT, 2003, EUR J CLIN NUTR, V57, P1437, DOI 10.1038/sj.ejcn.1601708
   Haeffner LSB, 2002, ANN HUM BIOL, V29, P627, DOI 10.1080/03014460210145847
   Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5
   Hallal PC, 2003, MED SCI SPORT EXER, V35, P1894, DOI 10.1249/01.MSS.0000093615.33774.0E
   Instituto Brasileiro de Geografia e Estatistica, 2008, SINT IND SOC AN COND, P1
   James WPT, 2008, J INTERN MED, V263, P336, DOI 10.1111/j.1365-2796.2008.01922.x
   *NUCL EST PESQ ALI, 2004, TAB BRAS COMP AL BRA, P1
   Popkin BM, 2001, ASIA PAC J CLIN NUTR, V10, pS13, DOI 10.1046/j.1440-6047.2001.00211.x
   Prentice AM, 2009, NESTLE NUTR WORKS SE, V63, P47, DOI 10.1159/000209972
   Sichieri R, 2010, BRIT J NUTR, V103, P1534, DOI 10.1017/S0007114509993448
   Sidhu Sharda, 2005, Anthropologischer Anzeiger, V63, P341
   Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4
   WHO, 2000, WHO TECHN REP SER, V894
   Yadav K, 2008, OBES REV, V9, P400, DOI 10.1111/j.1467-789X.2008.00505.x
NR 21
TC 8
Z9 12
U1 0
U2 4
PU I C D D R B-CENTRE HEALTH POPULATION RESEARCH
PI DHAKA
PA MOHAKHALI, 1212 DHAKA, BANGLADESH
SN 1606-0997
J9 J HEALTH POPUL NUTR
JI J. Heatlh Popul. Nutr.
PD JUN
PY 2011
VL 29
IS 3
BP 286
EP 289
DI 10.3329/jhpn.v29i3.7876
PG 4
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA 791LR
UT WOS:000292667200012
PM 21766564
OA Bronze, Green Published
DA 2020-12-01
ER

PT J
AU Fuchs, FD
   Fuchs, SC
   Moreira, LB
   Gus, M
   Nobrega, AC
   Poli-de-Figueiredo, CE
   Mion, D
   Bortoloto, L
   Consolim-Colombo, F
   Nobre, F
   Coelho, EB
   Vilela-Martin, JF
   Moreno, H
   Cesarino, EJ
   Franco, R
   Brandao, AA
   de Sousa, MR
   Ribeiro, ALP
   Jardim, PC
   Neto, AA
   Scala, LCN
   Mota, M
   Chaves, H
   Alves, JG
   Sobral, DC
   Silva, RPE
   Neto, JAF
   Irigoyen, MC
   Castro, I
   Steffens, AA
   Schlatter, R
   de Mello, RB
   Mosele, F
   Ghizzoni, F
   Berwanger, O
AF Fuchs, Flavio D.
   Fuchs, Sandra C.
   Moreira, Leila B.
   Gus, Miguel
   Nobrega, Antonio C.
   Poli-de-Figueiredo, Carlos E.
   Mion, Decio
   Bortoloto, Luiz
   Consolim-Colombo, Fernanda
   Nobre, Fernando
   Coelho, Eduardo Barbosa
   Vilela-Martin, Jose F.
   Moreno, Heitor, Jr.
   Cesarino, Evandro Jose
   Franco, Roberto
   Brandao, Andrea Araujo
   de Sousa, Marcos R.
   Pinho Ribeiro, Antonio Luiz
   Jardim, Paulo Cesar
   Afiune Neto, Abrahao
   Scala, Luiz Cesar N.
   Mota, Marco
   Chaves, Hilton
   Alves, Joao Guilherme
   Sobral Filho, Dario C.
   Pereira e Silva, Ricardo
   Figueiredo Neto, Jose A.
   Irigoyen, Maria Claudia
   Castro, Iran
   Steffens, Andre Avelino
   Schlatter, Rosane
   de Mello, Renato Bandeira
   Mosele, Francisca
   Ghizzoni, Flavia
   Berwanger, Otavio
TI Prevention of hypertension in patients with pre-hypertension: protocol
   for the PREVER-prevention trial
SO TRIALS
LA English
DT Article
ID NORMAL BLOOD-PRESSURE; DRUGS; SALT
AB Background: Blood pressure (BP) within pre-hypertensive levels confers higher cardiovascular risk and is an intermediate stage for full hypertension, which develops in an annual rate of 7 out of 100 individuals with 40 to 50 years of age. Non-drug interventions to prevent hypertension have had low effectiveness. In individuals with previous cardiovascular disease or diabetes, the use of BP-lowering agents reduces the incidence of major cardiovascular events. In the absence of higher baseline risk, the use of BP agents reduces the incidence of hypertension. The PREVER-prevention trial aims to investigate the efficacy, safety and feasibility of a population-based intervention to prevent the incidence of hypertension and the development of target-organ damage.
   Methods: This is a randomized, double-blind, placebo-controlled clinical trial, with participants aged 30 to 70 years, with pre-hypertension. The trial arms will be chlorthalidone 12.5 mg plus amiloride 2.5 mg or identical placebo. The primary outcomes will be the incidence of hypertension, adverse events and development or worsening of microalbuminuria and of left ventricular hypertrophy in the EKG. The secondary outcomes will be fatal or non-fatal cardiovascular events: myocardial infarction, stroke, heart failure, evidence of new sub-clinical atherosclerosis, and sudden death. The study will last 18 months. The sample size was calculated on the basis of an incidence of hypertension of 14% in the control group, a size effect of 40%, power of 85% and P alpha of 5%, resulting in 625 participants per group. The project was approved by the Ethics committee of each participating institution.
   Discussion: The early use of blood pressure-lowering drugs, particularly diuretics, which act on the main mechanism of blood pressure rising with age, may prevent cardiovascular events and the incidence of hypertension in individuals with hypertension. If this intervention shows to be effective and safe in a population-based perspective, it could be the basis for an innovative public health program to prevent hypertension in Brazil.
C1 [Fuchs, Flavio D.; Fuchs, Sandra C.; Moreira, Leila B.; Gus, Miguel; Schlatter, Rosane; de Mello, Renato Bandeira; Mosele, Francisca; Ghizzoni, Flavia] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.
   [Nobrega, Antonio C.] Univ Fed Fluminense, Hosp Univ Antonio Pedro, Niteroi, RJ, Brazil.
   [Poli-de-Figueiredo, Carlos E.] Pontificia Univ Catolica Rio Grande do Sul, Hosp Sao Lucas, Porto Alegre, RS, Brazil.
   [Mion, Decio] Univ Sao Paulo, Hosp Clin, Sao Paulo, Brazil.
   [Bortoloto, Luiz; Consolim-Colombo, Fernanda] Univ Sao Paulo, Inst Coracao, Sao Paulo, Brazil.
   [Nobre, Fernando; Coelho, Eduardo Barbosa] Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto, Brazil.
   [Vilela-Martin, Jose F.] Fac Med Sao Jose do Rio Preto, Sao Jose Do Rio Preto, Brazil.
   [Moreno, Heitor, Jr.] Univ Estadual Campinas, Fac Ciencias Med, Campinas, SP, Brazil.
   [Cesarino, Evandro Jose] Univ Sao Paulo, Fac Ciencias Farmaceut, BR-14049 Ribeirao Preto, Brazil.
   [Franco, Roberto] Univ Estadual Sao Paulo, Fac Med Botucatu, Botucatu, SP, Brazil.
   [Brandao, Andrea Araujo] Univ Estado Rio de Janeiro, BR-20550011 Rio De Janeiro, Brazil.
   [de Sousa, Marcos R.; Pinho Ribeiro, Antonio Luiz] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil.
   [Jardim, Paulo Cesar] Univ Fed Goias, Hosp Clin Goiania, Goiania, Brazil.
   [Afiune Neto, Abrahao] Anis Rassi Hosp, Goiania, Brazil.
   [Scala, Luiz Cesar N.] Univ Fed Mato Grosso, Hosp Univ Julio Muller, Cuiaba, Brazil.
   [Mota, Marco] Univ Ciencias Saude Alagoas, Fac Med, Maceio, Brazil.
   [Chaves, Hilton] Univ Fed Pernambuco, Fac Med, Recife, PE, Brazil.
   [Alves, Joao Guilherme] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Sobral Filho, Dario C.] Univ Pernambuco, Hosp Univ Oswaldo Cruz PROCAPE, Recife, PE, Brazil.
   [Pereira e Silva, Ricardo] Univ Fed Ceara, Hosp Univ Valter Cantidio, Fortaleza, Ceara, Brazil.
   [Figueiredo Neto, Jose A.] Univ Fed Maranhao, Hosp Univ, Sao Luis, Brazil.
   [Irigoyen, Maria Claudia; Castro, Iran] Fundacao Univ Cardiol, Inst Cardiol, Porto Alegre, RS, Brazil.
   [Steffens, Andre Avelino] Univ Fed Pelotas, Fac Med, Pelotas, Brazil.
   [Berwanger, Otavio] Hosp Coracao, Sao Paulo, Brazil.
RP Fuchs, FD (corresponding author), Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.
EM ffuchs@hcpa.ufrgs.br
RI JARDIM, PAULO CESAR V/C-4574-2015; Nobrega, Antonio Claudio/F-4825-2012;
   Coelho, Eduardo B/G-3463-2012; Fuchs, Sandra C/T-2670-2019; de
   Figueiredo, Carlos E Poli/A-2027-2013; Ribeiro, Antonio L/C-2707-2009;
   Schlatter, Rosane/U-2709-2019; Iats, Inct/K-2300-2013; Moreira,
   Leila/G-1251-2013; Fuchs, Flavio D/L-5078-2016; IRIGOYEN, MARIA CLAUDIA
   C/N-6880-2014; Colombo, Fernanda MC/C-6911-2018; da Nobrega, Antonio
   Claudio Lucas/O-5107-2019; Schlatter, Rosane/L-5507-2017; Coelho,
   Eduardo Barbosa/M-8532-2019; Alves, Joao G/J-6483-2013; Filho, Dario
   Sobral/H-8624-2019; MOREIRA, LEILA LEILA B/AAC-2240-2019; VILELA-MARTIN,
   JOSE/I-8305-2014; Cesarino, Evandro JosA© EJC/H-7018-2016
OI JARDIM, PAULO CESAR V/0000-0002-5333-013X; Nobrega, Antonio
   Claudio/0000-0002-3830-2886; Coelho, Eduardo B/0000-0003-3491-3396; de
   Figueiredo, Carlos E Poli/0000-0002-7333-8884; Ribeiro, Antonio
   L/0000-0002-2740-0042; Moreira, Leila/0000-0002-4730-7988; IRIGOYEN,
   MARIA CLAUDIA C/0000-0003-2097-3662; Colombo, Fernanda
   MC/0000-0003-3220-019X; da Nobrega, Antonio Claudio
   Lucas/0000-0002-3830-2886; Coelho, Eduardo Barbosa/0000-0003-3491-3396;
   Alves, Joao G/0000-0002-9170-0808; Filho, Dario
   Sobral/0000-0002-5301-7741; VILELA-MARTIN, JOSE/0000-0001-6960-2825;
   Cesarino, Evandro JosA© EJC/0000-0003-1672-4612; da Silva Franco,
   Roberto Jorge/0000-0001-9787-4393; Bandeira de Mello,
   Renato/0000-0003-4944-0085; fuchs, flavio/0000-0002-1191-0523
FU Ministry of Health, Division of Science and Technology (DECIT); Ministry
   of Science and Technology; FINEPCiencia Tecnologia e Inovacao (FINEP);
   CNPq, BrazilNational Council for Scientific and Technological
   Development (CNPq)
FX the Ministry of Health, Division of Science and Technology (DECIT), and
   Ministry of Science and Technology, FINEP and CNPq, Brazil, funded the
   study.
CR [Anonymous], 2002, WORLD HLTH REP 2002
   Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083
   Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601
   DAHL LK, 1977, GENEST, P548
   FOLKOW B, 1973, CIRC RES, V32, P2
   Franse LV, 2000, HYPERTENSION, V35, P1025, DOI 10.1161/01.HYP.35.5.1025
   Fuchs FD, 2009, BRAZ J MED BIOL RES, V42, P224, DOI 10.1590/S0100-879X2009000300002
   Fuchs FD, 1997, J HYPERTENS, V15, P783, DOI 10.1097/00004872-199715070-00011
   Fuchs Flavio D, 2004, Expert Rev Cardiovasc Ther, V2, P771, DOI 10.1586/14779072.2.5.771
   Fuchs FD, 2010, CARDIOVASC THER, V28, P339, DOI 10.1111/j.1755-5922.2010.00167.x
   Fuchs Flavio Danni, 2009, Expert Rev Cardiovasc Ther, V7, P591, DOI 10.1586/erc.09.32
   Guerrero P, 2008, CLIN EXP HYPERTENS, V30, P553, DOI 10.1080/10641960802441906
   GUYTON AC, 1972, AM J MED, V52, P584, DOI 10.1016/0002-9343(72)90050-2
   Hooper L, 2002, BMJ-BRIT MED J, V325, P628, DOI 10.1136/bmj.325.7365.628
   Hsia J, 2007, CIRCULATION, V115, P855, DOI 10.1161/CIRCULATIONAHA.106.656850
   Julius S, 2006, NEW ENGL J MED, V354, P1685, DOI 10.1056/NEJMoa060838
   Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3
   Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665
   LEITSCHUH M, 1991, HYPERTENSION, V17, P22, DOI 10.1161/01.HYP.17.1.22
   Lewington S, 2002, LANCET, V360, P1903
   Luders S, 2008, J HYPERTENS, V26, P1487, DOI 10.1097/HJH.0b013e3282ff8864
   Moreira LB, 2008, J HUM HYPERTENS, V22, P48, DOI 10.1038/sj.jhh.1002252
   Russell LB, 2004, ARCH INTERN MED, V164, P2119, DOI 10.1001/archinte.164.19.2119
   [Anonymous], 2010, Arq. Bras. Cardiol., V95, pI, DOI 10.1590/S0066-782X2010001700001
   TOBIAN L, 1991, HYPERTENSION, V17, pI52, DOI 10.1161/01.HYP.17.1_Suppl.I52
   Whelton PK, 1997, ARCH INTERN MED, V157, P657
NR 26
TC 22
Z9 28
U1 0
U2 14
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1745-6215
J9 TRIALS
JI Trials
PD MAR 5
PY 2011
VL 12
AR 65
DI 10.1186/1745-6215-12-65
PG 7
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 735NT
UT WOS:000288424900001
PM 21375762
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Fuchs, FD
   Fuchs, SC
   Moreira, LB
   Gus, M
   Nobrega, AC
   Poli-de-Figueiredo, CE
   Mion, D
   Bortolotto, L
   Consolim-Colombo, F
   Nobre, F
   Coelho, EB
   Vilela-Martin, JF
   Moreno, H
   Cesarino, EJ
   Franco, R
   Brandao, AA
   de Sousa, MR
   Ribeiro, ALP
   Jardim, PC
   Neto, AA
   Scala, LCN
   Mota, M
   Chaves, H
   Alves, JG
   Sobral, DC
   Silva, RPE
   Neto, JAF
   Irigoyen, MC
   Castro, I
   Steffens, AA
   Schlatter, R
   de Mello, RB
   Mosele, F
   Ghizzoni, F
   Berwanger, O
AF Fuchs, Flavio D.
   Fuchs, Sandra C.
   Moreira, Leila B.
   Gus, Miguel
   Nobrega, Antonio C.
   Poli-de-Figueiredo, Carlos E.
   Mion, Decio
   Bortolotto, Luiz
   Consolim-Colombo, Fernanda
   Nobre, Fernando
   Coelho, Eduardo Barbosa
   Vilela-Martin, Jose F.
   Moreno, Heitor, Jr.
   Cesarino, Evandro Jose
   Franco, Roberto
   Brandao, Andrea Araujo
   de Sousa, Marcos R.
   Pinho Ribeiro, Antonio Luiz
   Jardim, Paulo Cesar
   Afiune Neto, Abrahao
   Scala, Luiz Cesar N.
   Mota, Marco
   Chaves, Hilton
   Alves, Joao Guilherme
   Sobral Filho, Dario C.
   Pereira e Silva, Ricardo
   Figueiredo Neto, Jose A.
   Irigoyen, Maria Claudia
   Castro, Iran
   Steffens, Andre Avelino
   Schlatter, Rosane
   de Mello, Renato Bandeira
   Mosele, Francisca
   Ghizzoni, Flavia
   Berwanger, Otavio
TI A comparison between diuretics and angiotensin-receptor blocker agents
   in patients with stage I hypertension (PREVER-treatment trial): study
   protocol for a randomized double-blind controlled trial
SO TRIALS
LA English
DT Article
ID HIGH-RISK; ENALAPRIL; OUTCOMES
AB Background: Cardiovascular disease is the leading cause of death in Brazil, and hypertension is its major risk factor. The benefit of its drug treatment to prevent major cardiovascular events was consistently demonstrated. Angiotensin-receptor blockers (ARB) have been the preferential drugs in the management of hypertension worldwide, despite the absence of any consistent evidence of advantage over older agents, and the concern that they may be associated with lower renal protection and risk for cancer. Diuretics are as efficacious as other agents, are well tolerated, have longer duration of action and low cost, but have been scarcely compared with ARBs. A study comparing diuretic and ARB is therefore warranted.
   Methods/design: This is a randomized, double-blind, clinical trial, comparing the association of chlorthalidone and amiloride with losartan as first drug option in patients aged 30 to 70 years, with stage I hypertension. The primary outcomes will be variation of blood pressure by time, adverse events and development or worsening of microalbuminuria and of left ventricular hypertrophy in the EKG. The secondary outcomes will be fatal or non-fatal cardiovascular events: myocardial infarction, stroke, heart failure, evidence of new subclinical atherosclerosis and sudden death. The study will last 18 months. The sample size will be of 1200 participants for group in order to confer enough power to test for all primary outcomes. The project was approved by the Ethics committee of each participating institution.
   Discussion: The putative pleiotropic effects of ARB agents, particularly renal protection, have been disputed, and they have been scarcely compared with diuretics in large clinical trials, despite that they have been at least as efficacious as newer agents in managing hypertension. Even if the null hypothesis is not rejected, the information will be useful for health care policy to treat hypertension in Brazil.
C1 [Fuchs, Flavio D.; Fuchs, Sandra C.; Moreira, Leila B.; Gus, Miguel; Schlatter, Rosane; de Mello, Renato Bandeira; Mosele, Francisca; Ghizzoni, Flavia] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.
   [Nobrega, Antonio C.] Univ Fed Fluminense, Hosp Univ Antonio Pedro, Niteroi, RJ, Brazil.
   [Poli-de-Figueiredo, Carlos E.] Pontificia Univ Catolica Rio Grande do Sul, Hosp Sao Lucas, Porto Alegre, RS, Brazil.
   [Mion, Decio] Univ Sao Paulo, Hosp Clin, Sao Paulo, Brazil.
   [Bortolotto, Luiz; Consolim-Colombo, Fernanda] Univ Sao Paulo, Inst Coracao, Sao Paulo, Brazil.
   [Nobre, Fernando; Coelho, Eduardo Barbosa] Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto, Brazil.
   [Vilela-Martin, Jose F.] Fac Med Sao Jose Rio Preto, Sao Jose Do Rio Preto, Brazil.
   [Moreno, Heitor, Jr.] Univ Estadual Campinas, Fac Ciencias Med, Campinas, SP, Brazil.
   [Cesarino, Evandro Jose] Univ Sao Paulo, Fac Ciencias Farmaceut, BR-14049 Ribeirao Preto, Brazil.
   [Franco, Roberto] Univ Estadual Sao Paulo, Fac Med Botucatu, Botucatu, SP, Brazil.
   [Brandao, Andrea Araujo] Univ Estado Rio de Janeiro, BR-20550011 Rio De Janeiro, Brazil.
   [de Sousa, Marcos R.; Pinho Ribeiro, Antonio Luiz] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil.
   [Jardim, Paulo Cesar] Univ Fed Goias, Hosp Clin Goiania, Goiania, Go, Brazil.
   [Afiune Neto, Abrahao] Anis Rassi Hosp, Goiania, Go, Brazil.
   [Scala, Luiz Cesar N.] Univ Fed Mato Grosso, Hosp Univ Julio Muller, Cuiaba, Brazil.
   [Mota, Marco] Univ Ciencias Saude Alagoas, Fac Med, Maceio, Brazil.
   [Chaves, Hilton] Univ Fed Pernambuco, Fac Med, Recife, PE, Brazil.
   [Alves, Joao Guilherme] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Sobral Filho, Dario C.] Univ Pernambuco, Hosp Univ Oswaldo Cruz PROCAPE, Recife, PE, Brazil.
   [Pereira e Silva, Ricardo] Univ Fed Ceara, Hosp Univ Valter Cantidio, Fortaleza, Ceara, Brazil.
   [Figueiredo Neto, Jose A.] Univ Fed Maranhao, Univ Hosp, Sao Luis, Brazil.
   [Irigoyen, Maria Claudia; Castro, Iran] Fundacao Univ Cardiol, Inst Cardiol, Porto Alegre, RS, Brazil.
   [Steffens, Andre Avelino] Univ Fed Pelotas, Fac Med, Pelotas, Brazil.
   [Berwanger, Otavio] Hosp Coracao, Sao Paulo, Brazil.
RP Fuchs, FD (corresponding author), Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.
EM ffuchs@hcpa.ufrgs.br
RI Cesarino, Evandro JosA© EJC/H-7018-2016; Alves, Joao G/J-6483-2013;
   Schlatter, Rosane/U-2709-2019; Moreira, Leila/G-1251-2013; Colombo,
   Fernanda MC/C-6911-2018; Fuchs, Flavio D/L-5078-2016; VILELA-MARTIN,
   JOSE/I-8305-2014; Filho, Dario Sobral/H-8624-2019; Nobrega, Antonio
   Claudio/F-4825-2012; da Nobrega, Antonio Claudio Lucas/O-5107-2019; de
   Figueiredo, Carlos E Poli/A-2027-2013; IRIGOYEN, MARIA CLAUDIA
   C/N-6880-2014; Schlatter, Rosane/L-5507-2017; Fuchs, Sandra
   C/T-2670-2019; MOREIRA, LEILA LEILA B/AAC-2240-2019; Iats,
   Inct/K-2300-2013; Ribeiro, Antonio L/C-2707-2009; JARDIM, PAULO CESAR
   V/C-4574-2015; Coelho, Eduardo Barbosa/M-8532-2019; Coelho, Eduardo
   B/G-3463-2012; Bortolotto, Luiz/S-1940-2017
OI Cesarino, Evandro JosA© EJC/0000-0003-1672-4612; Alves, Joao
   G/0000-0002-9170-0808; Moreira, Leila/0000-0002-4730-7988; Colombo,
   Fernanda MC/0000-0003-3220-019X; VILELA-MARTIN,
   JOSE/0000-0001-6960-2825; Filho, Dario Sobral/0000-0002-5301-7741;
   Nobrega, Antonio Claudio/0000-0002-3830-2886; da Nobrega, Antonio
   Claudio Lucas/0000-0002-3830-2886; de Figueiredo, Carlos E
   Poli/0000-0002-7333-8884; IRIGOYEN, MARIA CLAUDIA C/0000-0003-2097-3662;
   Ribeiro, Antonio L/0000-0002-2740-0042; JARDIM, PAULO CESAR
   V/0000-0002-5333-013X; Coelho, Eduardo Barbosa/0000-0003-3491-3396;
   Coelho, Eduardo B/0000-0003-3491-3396; de Figueiredo Neto, Jose
   Albuquerque/0000-0003-3739-7702; Bortolotto, Luiz/0000-0002-4865-6442;
   Bandeira de Mello, Renato/0000-0003-4944-0085; da Silva Franco, Roberto
   Jorge/0000-0001-9787-4393; fuchs, flavio/0000-0002-1191-0523
FU Department of Science and Technology (DECIT)Department of Science &
   Technology (India); Health Ministry; CNPqNational Council for Scientific
   and Technological Development (CNPq); FINEPCiencia Tecnologia e Inovacao
   (FINEP); Science and Technology Ministry; FIPE; Hospital de Clinicas de
   Porto Alegre, Brazil
FX Grants: Department of Science and Technology (DECIT), Health Ministry,
   CNPq and FINEP, Science and Technology Ministry, and FIPE, Hospital de
   Clinicas de Porto Alegre, Brazil
CR *ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI [DOI 10.1001/JAMA.288.23.2981, 10.1001/jama.288.23.2981]
   Correa V, 2010, EXPERT REV CARDIOVAS, V8, P775, DOI [10.1586/erc.10.59, 10.1586/ERC.10.59]
   Fuchs FD, 2009, BRAZ J MED BIOL RES, V42, P224, DOI 10.1590/S0100-879X2009000300002
   Fuchs Flavio Danni, 2009, Expert Rev Cardiovasc Ther, V7, P591, DOI 10.1586/erc.09.32
   Guerrero P, 2008, CLIN EXP HYPERTENS, V30, P553, DOI 10.1080/10641960802441906
   Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9
   Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665
   Marre M, 2004, J HYPERTENS, V22, P1613, DOI 10.1097/01.hjh.0000133733.32125.09
   Mauer M, 2009, NEW ENGL J MED, V361, P40, DOI 10.1056/NEJMoa0808400
   Rahman M, 2005, ARCH INTERN MED, V165, P936, DOI 10.1001/archinte.165.8.936
   Sipahi I, 2010, LANCET ONCOL, V11, P627, DOI 10.1016/S1470-2045(10)70106-6
   Smith RET, 2007, NAT REV DRUG DISCOV, V6, P597, DOI 10.1038/nrd2354
   [Anonymous], 2010, Arq. Bras. Cardiol., V95, pI, DOI 10.1590/S0066-782X2010001700001
   Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317
NR 14
TC 6
Z9 6
U1 0
U2 15
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1745-6215
J9 TRIALS
JI Trials
PD FEB 24
PY 2011
VL 12
AR 53
DI 10.1186/1745-6215-12-53
PG 5
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 735NJ
UT WOS:000288423900001
PM 21349192
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Alves, JG
   Figueiroa, JN
   Alves, LV
AF Bezerra Alves, Joao Guilherme
   Figueiroa, Jose Natal
   Alves, Lucas Victor
TI Prevalence and Predictors of Physical Inactivity in a Slum in Brazil
SO JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE
LA English
DT Article
DE Physical activity; Poverty areas; Slum
ID SOCIOECONOMIC-STATUS; OBESITY; OVERWEIGHT; NUTRITION; POPULATIONS;
   TRANSITION; EPIDEMIC; PATTERNS
AB The aim of this study was to ascertain the prevalence of physical inactivity and examine the role of potential predictors in a very low-income adult population in a slum located in Recife city, northeast of Brazil. A cross-sectional study was conducted with 1,176 subjects aged 20-60 years residing in a slum. Using the short version of the International Physical Activity Questionnaire, 307 (26.1%) study participants-97 (23.8%) men and 210 (27.3%) women-have a low physical activity score (MET-minutes per week). Increased age was associated with physical inactivity only in people without overweight/obesity. Low physical activity was less common (i.e., respondents were more active) than in other Brazilian population-based studies. These results suggest that the relationship between physical activity and socioeconomic level is more complex and depends on the internal characteristics of the community.
C1 [Bezerra Alves, Joao Guilherme; Figueiroa, Jose Natal] Inst Med Integral Prof Fernando Figueira IMIP, Recife, PE, Brazil.
   [Alves, Lucas Victor] Univ Estadual Pernambuco, Recife, PE, Brazil.
RP Alves, JGB (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Rua Coelhos,300 Boa Vista, Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq)
FX Data collection was funded by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq).
CR Alves JG, 2009, AM J PUBLIC HEALTH, V99, P76, DOI 10.2105/AJPH.2007.124495
   Batista Filho Malaquias, 2003, Cad. Saúde Pública, V19, pS181, DOI 10.1590/S0102-311X2003000700019
   Bell AC, 2002, OBES RES, V10, P277, DOI 10.1038/oby.2002.38
   Cerin E, 2008, SOC SCI MED, V66, P2596, DOI 10.1016/j.socscimed.2008.02.012
   Coutinho JG, 2008, CAD SAUDE PUBLICA, V24, pS332, DOI 10.1590/S0102-311X2008001400018
   Ferreira Vanessa Alves, 2005, Cad. Saúde Pública, V21, P1792, DOI 10.1590/S0102-311X2005000600027
   Filozof C, 2001, Obes Rev, V2, P99, DOI 10.1046/j.1467-789x.2001.00029.x
   Florencio TMDT, 2001, BRIT J NUTR, V86, P277, DOI 10.1079/BJN2001396
   Gordon-Larsen P, 2002, OBES RES, V10, P141, DOI 10.1038/oby.2002.23
   Hallal PC, 2003, MED SCI SPORT EXER, V35, P1894, DOI 10.1249/01.MSS.0000093615.33774.0E
   Kelishadi R, 2007, EPIDEMIOL REV, V29, P62, DOI 10.1093/epirev/mxm003
   LIMA TL, 2009, HABITACAO INFRAESTRU
   Matsudo SM, 2000, REV BRAS CIEN MOV, V10, P41
   Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940
   Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]
   Popkin BM, 2001, ASIA PAC J CLIN NUTR, V10, pS13, DOI 10.1046/j.1440-6047.2001.00211.x
   *PREF REC, CID REC
   Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272
   Prentice AM, 2009, NESTLE NUTR WORKS SE, V63, P47, DOI 10.1159/000209972
   Stubbs CO, 2004, MED J AUSTRALIA, V181, P489, DOI 10.5694/j.1326-5377.2004.tb06406.x
   Telford RD, 2007, MED SCI SPORT EXER, V39, P1233, DOI 10.1249/mss.0b013e31806215b7
   *US DEP JUST NAT I, 1996, RES PREV EXT COST CR, P1
   Valladares L. P., 2005, INVENCAO FAVELA MITO
   Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35
   Woods SC, 2002, INT J OBESITY, V26, pS8, DOI 10.1038/sj.ijo.0802211
   Yadav K, 2008, OBES REV, V9, P400, DOI 10.1111/j.1467-789X.2008.00505.x
   YUNES J, 1972, REV SAUDE PUBL, V6, P48
NR 27
TC 2
Z9 2
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1099-3460
EI 1468-2869
J9 J URBAN HEALTH
JI J. Urban Health
PD FEB
PY 2011
VL 88
IS 1
BP 168
EP 175
DI 10.1007/s11524-010-9531-8
PG 8
WC Public, Environmental & Occupational Health; Medicine, General &
   Internal
SC Public, Environmental & Occupational Health; General & Internal Medicine
GA 724PU
UT WOS:000287589500014
PM 21274645
OA Green Published
DA 2020-12-01
ER

PT J
AU Meneses, J
   Bhandari, V
   Alves, JG
   Herrmann, D
AF Meneses, Jucille
   Bhandari, Vineet
   Alves, Joao Guilherme
   Herrmann, Delia
TI Noninvasive Ventilation for Respiratory Distress Syndrome: A Randomized
   Controlled Trial
SO PEDIATRICS
LA English
DT Article
DE respiratory distress syndrome; preterm infant; noninvasive ventilation
ID POSITIVE AIRWAY PRESSURE; INTERMITTENT MANDATORY VENTILATION;
   BIRTH-WEIGHT INFANTS; NASAL CPAP; PREMATURE-INFANTS; SURFACTANT
   TREATMENT; EXTUBATION; NEWBORNS; MECHANISMS; INTUBATION
AB CONTEXT: Strategies for reducing exposure to endotracheal ventilation through the use of early noninvasive ventilation has proven to be safe and effective, but the option with the greatest benefits needs to be determined.
   OBJECTIVE: To determine, in infants with respiratory distress syndrome, if early nasal intermittent positive-pressure ventilation (NIPPV) compared with nasal continuous positive airway pressure (NCPAP) decreases the need for mechanical ventilation.
   PATIENTS AND METHODS: In this single-center, randomized controlled trial, infants (gestational ages 26 to 33 6/7 weeks) with respiratory distress syndrome were randomly assigned to receive early NIPPV or NCPAP. Surfactant was administered as rescue therapy. The primary outcome was the need for mechanical ventilation within the first 72 hours of life.
   RESULTS: A total of 200 infants, 100 in each arm, were randomly assigned. Rates of the primary outcome did not differ significantly between the NIPPV (25%) and NCPAP (34%) groups (relative risk [RR]: 0.71 [95% confidence interval (CI): 0.48-1.14]). In posthoc analysis, from 24 to 72 hours of life, significantly more infants in the NIPPV group remained extubated compared with those in the NCPAP groups (10 vs 22%; RR: 0.45 [95% CI: 0.22-0.91]). This difference was also noted in the group of infants who received surfactant therapy, NIPPV (10.9%), and NCPAP (27.1%) (RR: 0.40 [95% CI: 0.18-0.86]).
   CONCLUSIONS: Early NIPPV did not decrease the need for mechanical ventilation compared with NCPAP, overall, in the first 72 hours of life. However, further studies to assess the potential benefits of noninvasive ventilation are warranted, especially for the most vulnerable or preterm infants. Pediatrics 2011; 127: 300-307
C1 [Meneses, Jucille; Alves, Joao Guilherme] Inst Med Integral Prof Fernando Figueira IMIP, Dept Pediat, Recife, PE, Brazil.
   [Bhandari, Vineet] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA.
   [Herrmann, Delia] Univ Alagoas, Dept Pediat, Maceio, Brazil.
RP Meneses, J (corresponding author), Rua Dom Jose Lopes 955,Apt 1801, BR-51021370 Recife, PE, Brazil.
EM jmeneses@elogica.com.br
RI Alves, Joao G/J-6483-2013; Bhandari, Vineet/AAS-3365-2020
OI Alves, Joao G/0000-0002-9170-0808; 
CR Aghai ZH, 2006, PEDIATR PULM, V41, P875, DOI 10.1002/ppul.20461
   Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X
   Aly H, 2005, PEDIATRICS, V115, P1660, DOI 10.1542/peds.2004-2493
   Ammari A, 2005, J PEDIATR-US, V147, P341, DOI 10.1016/j.jpeds.2005.04.062
   Andersen Tina, 2006, Ugeskr Laeger, V168, P3723
   [Anonymous], 2008, PEDIATRICS, V121, P419, DOI [10.1542/peds.2007-3281, 10.1542/peds.2007-3283]
   AVERY ME, 1987, PEDIATRICS, V79, P26
   Bancalari E, 2008, EARLY HUM DEV, V84, P815, DOI 10.1016/j.earlhumdev.2008.09.010
   Barrington KJ, 2001, PEDIATRICS, V107, P638, DOI 10.1542/peds.107.4.638
   Bhandari V, 2007, J PERINATOL, V27, P697, DOI 10.1038/sj.jp.7211805
   Bhandari V, 2010, J PERINATOL, V30, P505, DOI 10.1038/jp.2009.165
   Bhandari V, 2009, PEDIATRICS, V124, P517, DOI 10.1542/peds.2008-1302
   Bohlin K, 2007, J PERINATOL, V27, P422, DOI 10.1038/sj.jp.7211754
   Dani C, 2004, PEDIATRICS, V113, pE560, DOI 10.1542/peds.113.6.e560
   Davis PG, 2009, SEMIN FETAL NEONAT M, V14, P14, DOI 10.1016/j.siny.2008.08.003
   Finer NN, 2010, NEW ENGL J MED, V362, P2235
   Finer NN, 2010, NEW ENGL J MED, V362, P1970, DOI 10.1056/NEJMoa0911783
   Friedlich P, 1999, J Perinatol, V19, P413, DOI 10.1038/sj.jp.7200205
   GARNER A, 1984, ARCH OPHTHALMOL-CHIC, V102, P1130
   Gittermann MK, 1997, EUR J PEDIATR, V156, P384, DOI 10.1007/s004310050620
   Jobe AH, 2006, BIOL NEONATE, V89, P298, DOI 10.1159/000092866
   Jobe AH, 1998, EARLY HUM DEV, V53, P81, DOI 10.1016/S0378-3782(98)00045-0
   Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723
   KATTWINKEL J, 2000, TXB NEONATAL RESUSCI
   KERO PO, 1979, EUR J PEDIATR, V130, P271, DOI 10.1007/BF00441363
   Khalaf MN, 2001, PEDIATRICS, V108, P13, DOI 10.1542/peds.108.1.13
   Kiciman NM, 1998, PEDIATR PULM, V25, P175, DOI 10.1002/(SICI)1099-0496(199803)25:3<175::AID-PPUL7>3.0.CO;2-L
   Kishore MSS, 2009, ACTA PAEDIATR, V98, P1412, DOI 10.1111/j.1651-2227.2009.01348.x
   Kliegman R M, 1987, Curr Probl Pediatr, V17, P213
   Kugelman A, 2007, J PEDIATR-US, V150, P521, DOI 10.1016/j.jpeds.2007.01.032
   Meneses Jucille, 2007, J Pediatr, V151, pe19, DOI 10.1016/j.jpeds.2007.07.027
   Moretti C, 1999, EARLY HUM DEV, V56, P167, DOI 10.1016/S0378-3782(99)00046-8
   Moretti C, 2008, PEDIATR INT, V50, P85, DOI 10.1111/j.1442-200X.2007.02525.x
   Morley CJ, 2008, NEW ENGL J MED, V358, P700, DOI 10.1056/NEJMoa072788
   Owen L S, 2008, Arch Dis Child Fetal Neonatal Ed, V93, pF148
   PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0
   RAMANATHAN R, 2009, EPAS, V3213, P3216
   Reininger Ann, 2005, J Perinatol, V25, P703, DOI 10.1038/sj.jp.7211381
   Rojas MA, 2009, PEDIATRICS, V123, P137, DOI 10.1542/peds.2007-3501
   Van Marter LJ, 2000, PEDIATRICS, V105, P1194, DOI 10.1542/peds.105.6.1194
   Verder H, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.2.e24
   Verder H, 2007, ACTA PAEDIATR, V96, P482, DOI 10.1111/j.1651-2227.2007.00263.x
   Verder H, 2009, ACTA PAEDIATR, V98, P1400, DOI 10.1111/j.1651-2227.2009.01413.x
   Watterberg KL, 1996, PEDIATRICS, V97, P210
NR 44
TC 63
Z9 83
U1 0
U2 9
PU AMER ACAD PEDIATRICS
PI ELK GROVE VILLAGE
PA 141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA
SN 0031-4005
EI 1098-4275
J9 PEDIATRICS
JI Pediatrics
PD FEB
PY 2011
VL 127
IS 2
BP 300
EP 307
DI 10.1542/peds.2010-0922
PG 8
WC Pediatrics
SC Pediatrics
GA 714JF
UT WOS:000286805200047
PM 21262883
DA 2020-12-01
ER

PT J
AU Alves, JG
   Farias, MP
   Gazineu, RM
   Bandeira, F
   Menezes, J
   Silva, EJDE
AF Alves, Joao Guilherme
   Farias, Maria Paula
   Gazineu, Renata Maria
   Bandeira, Francisco
   Menezes, Jucille
   da Costa e Silva, Eduardo Just
TI Waist Circumference and Mesenteric Fat in Neonates: Negative Correlation
SO INDIAN JOURNAL OF PEDIATRICS
LA English
DT Article
DE Visceral adiposity; Newborn; Sonography
ID INTIMA-MEDIA THICKNESS; BODY-FAT; CHILDHOOD OBESITY; ADIPOSE-TISSUE;
   RISK-FACTORS; PREPERITONEAL; ASSOCIATION; PHENOTYPE; ORIGINS
AB To measure mesenteric fat thickness with ultrasound scan in neonates and to assess the correlation with waist circumference.
   Ninety five healthy newborns had the maximum thickness of mesenteric leaves measured by ultrasound examinations of abdomen with an Envisor scanner (Philips Ultrasound, Bothell, Wash) and a L12-5 transducer (Philips Ultrasound). The correlation between the thickness of mesenteric leaves with abdominal waist was calculated.
   Maximum thickness of mesenteric leaves ranged from 0.24 to 1.00 mm (x = 0.57 +/- 0.17). There was a significant negative correlation between abdominal waist (AW) and mesenteric fat thickness (r = -0.384; p < 0.001).
   Mesenteric fat thickness in newborns is inversely associated with waist circumference. Higher visceral adiposity in neonates may be a protective mechanism from intrauterine growth restriction however this could persist into adulthood life.
C1 [Alves, Joao Guilherme; Menezes, Jucille; da Costa e Silva, Eduardo Just] Inst Med Integral Prof Fernando Figueira IMIP, BR-52050080 Recife, PE, Brazil.
   [Farias, Maria Paula; Gazineu, Renata Maria] EPS, Recife, PE, Brazil.
   [Bandeira, Francisco] Univ Pernambuco, Recife, PE, Brazil.
RP Alves, JG (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Rua Antenor Navarro,301 Apt 1301 Gracas, BR-52050080 Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Alves, Joao G/J-6483-2013; Bandeira, Francisco/AAO-1702-2020
OI Alves, Joao G/0000-0002-9170-0808; 
CR Bienstock JL, 2008, ULTRASOUND OBST GYN, V31, P517, DOI 10.1002/uog.5316
   Bulcao C, 2006, CURR DIABETES REV, V2, P19, DOI 10.2174/157339906775473617
   Canoy D, 2008, CURR OPIN CARDIOL, V23, P591, DOI 10.1097/HCO.0b013e328313133a
   Ford ES, 2008, J CLIN ENDOCR METAB, V93, pS1, DOI 10.1210/jc.2008-1356
   Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387
   Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5
   Karagiannides I, 2008, ANN NY ACAD SCI, V1144, P127, DOI 10.1196/annals.1418.009
   Krishnaveni GV, 2005, INDIAN PEDIATR, V42, P527
   Kulkarni ML, 2009, INDIAN J PEDIATR, V76, P369, DOI 10.1007/s12098-009-0010-8
   Liu KH, 2006, DIABETES CARE, V29, P379, DOI 10.2337/diacare.29.02.06.dc05-1578
   Liu KH, 2005, ATHEROSCLEROSIS, V179, P299, DOI 10.1016/j.atherosclerosis.2004.10.038
   Liu KH, 2003, INT J OBESITY, V27, P1267, DOI 10.1038/sj.ijo.0802398
   McMillen IC, 2009, ADV EXP MED BIOL, V646, P71, DOI 10.1007/978-1-4020-9173-5_8
   Ohman MK, 2009, CURR VASC PHARMACOL, V7, P169, DOI 10.2174/157016109787455680
   Semiz S, 2007, INT J OBESITY, V31, P53, DOI 10.1038/sj.ijo.0803414
   Semiz S, 2008, INDIAN PEDIATR, V45, P457
   Yajnik CS, 2004, J NUTR, V134, P205
NR 17
TC 2
Z9 2
U1 0
U2 0
PU ALL INDIA INST MEDICAL SCIENCES
PI NEW DELHI
PA ANSARI NAGAR, NEW DELHI 110 029, INDIA
SN 0019-5456
J9 INDIAN J PEDIATR
JI Indian J. Pediatr.
PD NOV
PY 2010
VL 77
IS 11
BP 1266
EP 1269
DI 10.1007/s12098-010-0179-x
PG 4
WC Pediatrics
SC Pediatrics
GA 684IA
UT WOS:000284542400006
PM 20821279
DA 2020-12-01
ER

PT J
AU Sampaio, MJAD
   Cavalcanti, NV
   Alves, JGB
   Fernandes, MJC
   Correia, JB
AF Alves de Queiroz Sampaio, Marcia Jaqueline
   Cavalcanti, Nara Vasconcelos
   Bezerra Alves, Joao Guilherme
   Costa Fernandes Filho, Mario Jorge
   Correia, Jailson B.
TI Risk Factors for Death in Children with Visceral Leishmaniasis
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID PROGNOSTIC-FACTORS
AB Background: Despite the major public health importance of visceral leishmaniasis (VL) in Latin America, well-designed studies to inform diagnosis, treatment and control interventions are scarce. Few observational studies address prognostic assessment in patients with VL. This study aimed to identify risk factors for death in children aged less than 15 years admitted for VL treatment in a referral center in northeast Brazil.
   Methodology/Principal Findings: In a retrospective cohort, we reviewed 546 records of patients younger than 15 years admitted with the diagnosis of VL at the Instituto de Medicina Integral Professor Fernando Figueira between May 1996 and June 2006. Age ranged from 4 months to 13.7 years, and 275 (50%) were male. There were 57 deaths, with a case-fatality rate of 10%. In multivariate logistic regression, the independent predictors of risk of dying from VL were (adjusted OR, 95% CI): mucosal bleeding (4.1, 1.3-13.4), jaundice (4.4, 1.7-11.2), dyspnea (2.8, 1.2-6.1), suspected or confirmed bacterial infections (2.7, 1.2-6.1), neutrophil count <500/mm(3) (3.1, 1.4-6.9) and platelet count <50,000/mm(3) (11.7, 5.4-25.1). A prognostic score was proposed and had satisfactory sensitivity (88.7%) and specificity (78.5%).
   Conclusions/Significance: Prognostic and severity markers can be useful to inform clinical decisions such as whether a child with VL can be safely treated in the local healthcare facility or would potentially benefit from transfer to referral centers where advanced life support facilities are available. High risk patients may benefit from interventions such as early use of extended-spectrum antibiotics or transfusion of blood products. These baseline risk-based supportive interventions should be assessed in clinical trials.
C1 [Alves de Queiroz Sampaio, Marcia Jaqueline; Cavalcanti, Nara Vasconcelos; Bezerra Alves, Joao Guilherme; Costa Fernandes Filho, Mario Jorge; Correia, Jailson B.] Inst Med Integral Prof Fernando Figueira IMIP, Recife, PE, Brazil.
   [Alves de Queiroz Sampaio, Marcia Jaqueline; Cavalcanti, Nara Vasconcelos; Bezerra Alves, Joao Guilherme] Fac Pernambucana Saude, Recife, PE, Brazil.
   [Bezerra Alves, Joao Guilherme; Correia, Jailson B.] Univ Pernambuco, Fac Ciencias Med, Recife, PE, Brazil.
   [Costa Fernandes Filho, Mario Jorge] Univ Fed Pernambuco, Recife, PE, Brazil.
RP Sampaio, MJAD (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Recife, PE, Brazil.
EM jcorreia@imip.org.br
RI Correia, Jailson B./J-4331-2015; Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
FU Insituto de Medicina Integral Professor Fernando Figueira
FX MJAdQS received financial support from Insituto de Medicina Integral
   Professor Fernando Figueira. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR ABDELMOULA MS, 2003, TUNIS MED, V81, P545
   ALVES JGB, 2004, FERNANDO FIGUEIRA PE
   Barquet N, 1997, JAMA-J AM MED ASSOC, V278, P491, DOI 10.1001/jama.278.6.491
   Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313
   Collin S, 2004, CLIN INFECT DIS, V38, P612, DOI 10.1086/381203
   JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X
   *MIN HLTH BRAZ, 2006, LEISHM VISC GRAV NOR
   *MIN HLTH BRAZ, 2010, LET LEISHM VISC BRAS
   *MIN HLTH BRAZ, 2010, COEF INC LEISHM VISC
   *MIN HLTH BRAZ, 2010, SIST INF AGR NOT
   Mueller Y, 2009, TROP MED INT HEALTH, V14, P910, DOI 10.1111/j.1365-3156.2009.02305.x
   Queiroz Márcia J. A., 2004, J. Pediatr. (Rio J.), V80, P141, DOI 10.1590/S0021-75572004000200012
   Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584
   Seaman J, 1996, ANN INTERN MED, V124, P664, DOI 10.7326/0003-4819-124-7-199604010-00007
   Werneck GL, 2003, INFECTION, V31, P174, DOI 10.1007/s15010-003-3139-9
   World Health Organization (WHO) = Organisation mondiale de la Sante (OMS), 2002, WKLY EPIDEMIOL REC, V77, P365
NR 16
TC 42
Z9 43
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD NOV
PY 2010
VL 4
IS 11
AR e877
DI 10.1371/journal.pntd.0000877
PG 5
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 687GB
UT WOS:000284765900019
PM 21072238
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Alves, JG
   Silva, E
   Didier, R
   Bandeira, M
   Bandeira, F
AF Alves, J. G.
   Silva, E.
   Didier, R.
   Bandeira, M.
   Bandeira, F.
TI Abdominal wall fat index in neonates: correlation with birth size
SO JOURNAL OF DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE
LA English
DT Article
DE intra-abdominal fat; infant; newborn; ultrasonography
ID CORONARY-HEART-DISEASE; VISCERAL FAT; WAIST CIRCUMFERENCE; SUBCUTANEOUS
   FAT; OBESITY; ULTRASONOGRAPHY; GROWTH; RISK; ATHEROSCLEROSIS;
   ASSOCIATION
AB Low birth weight is associated with obesity in later life and a more central fat distribution has a positive correlation with cardiovascular disease. However, the correlation between visceral adiposity in newborns and birth size is unknown. We measured the visceral adiposity in 118 newborns using the abdominal wall fat index (AFI), ratio between the maximum thickness of preperitoneal and the minimum thickness of subcutaneous fat evaluated by ultrasound. There was a weak negative correlation between AFI and birth weight (r=-0.197; P=0.033) but not with birth length (r=-0.118; P=0.201), body mass index (r=-0.138; P=0.176) and abdominal circumference (r=0.063; P=0.497). In conclusion, we suggest that AFI is a useful parameter for evaluating the fat distribution in newborns and that visceral adiposity has a weak negative correlation with birth weight.
RP Alves, JG (corresponding author), Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Alves, Joao G/J-6483-2013; Bandeira, Francisco/AAO-1702-2020
OI Alves, Joao G/0000-0002-9170-0808; 
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq)
FX Renata Maria Gazineu was sponsored by Programa Institucional de Bolsas
   de Iniciacao Cientifica (PIBIC), Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq).
CR Canoy D, 2008, CURR OPIN CARDIOL, V23, P591, DOI 10.1097/HCO.0b013e328313133a
   CLARKE WR, 1993, CRIT REV FOOD SCI, V33, P423, DOI 10.1080/10408399309527641
   Drapeau V, 2003, PANMINERVA MED, V45, P189
   Funahashi T, 1999, INTERNAL MED, V38, P202, DOI 10.2169/internalmedicine.38.202
   Gonzalez DA, 2010, INT J OBESITY, V34, P195, DOI 10.1038/ijo.2009.201
   Gower BA, 1999, DIABETES, V48, P1515, DOI 10.2337/diabetes.48.8.1515
   Greenwood PL, 1998, J ANIM SCI, V76, P2354
   Hutley L, 2005, AM J MED SCI, V330, P280, DOI 10.1097/00000441-200512000-00005
   Kawamoto R, 2005, J ATHEROSCLER THROMB, V12, P85, DOI 10.5551/jat.12.85
   Klein S, 2007, AM J CLIN NUTR, V85, P1197
   Laclaustra M, 2007, NUTR METAB CARDIOVAS, V17, P125, DOI 10.1038/ki.2008.517
   Ljung T, 2002, J ENDOCRINOL INVEST, V25, P229, DOI 10.1007/BF03343995
   Lofgren I, 2004, J NUTR, V134, P1071
   Mathieu P, 2008, INT J BIOCHEM CELL B, V40, P821, DOI 10.1016/j.biocel.2007.12.001
   MILES JB, 2007, ENDOCRINOLOGY, V148, P1350
   Ohman MK, 2009, CURR VASC PHARMACOL, V7, P169, DOI 10.2174/157016109787455680
   Oken E, 2003, OBES RES, V11, P496, DOI 10.1038/oby.2003.69
   Sayer AA, 2005, EARLY HUM DEV, V81, P735, DOI 10.1016/j.earlhumdev.2005.07.003
   Soyama A, 2005, ENDOCR J, V52, P229, DOI 10.1507/endocrj.52.229
   SPARKS JW, 1984, SEMIN PERINATOL, V8, P74
   SUZUKI R, 1993, AM J MED, V95, P309, DOI 10.1016/0002-9343(93)90284-V
   VANDERKOOY K, 1993, INT J OBESITY, V17, P187
   Yajnik CS, 2002, J CLIN ENDOCR METAB, V87, P5575, DOI 10.1210/jc.2002-020434
NR 23
TC 4
Z9 4
U1 0
U2 0
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 2040-1744
EI 2040-1752
J9 J DEV ORIG HLTH DIS
JI J. Dev. Orig. Health Dis.
PD JUN
PY 2010
VL 1
IS 3
BP 203
EP 205
DI 10.1017/S2040174410000206
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 755DH
UT WOS:000289906400007
PM 25141787
DA 2020-12-01
ER

PT J
AU Gomes, BDR
   Alves, JGB
   Nascimento, LC
AF Ribeiro Gomes, Betania da Mata
   Bezerra Alves, Joao Guilherme
   Nascimento, Lucila Castanheira
TI Alcohol consumption by public school students in Greater Metropolitan
   Recife, Pernambuco State, Brazil
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Alcohol Drinking; Students; Adolescent Behavior
ID SAO-PAULO; DRUG-USE; ADOLESCENTS; DRINKING; TOBACCO; BEHAVIOR; HEALTH;
   CITY
AB This study analyzes alcohol consumption and health risk behaviors in adolescents, using a cross-sectional, population-based, epidemiological design from April to September 2006, within a sample stratified according to school size and shift. Using the Portuguese version of the Global School-Based Student Health Survey questionnaire, 1,878 students from 29 public schools in Greater Metropolitan Recife, Pernambuco State, Brazil, were analyzed by age, gender, alcohol consumption, lifetime history of intoxication, and negative consequences. Alcohol consumption in the previous 30 days was 29.8%. Adolescents reported easy acquisition of alcoholic beverages from commercial establishments and in social settings. Lifetime history of intoxication was reported by 30.5% of the students. Negative consequences were reported by 14.5%. Knowledge of risk behaviors for alcohol consumption by adolescents can provide backing for appropriate public polices in health education.
C1 [Ribeiro Gomes, Betania da Mata] Univ Pernambuco, Fac Enfermagem, BR-50100130 Recife, PE, Brazil.
   [Ribeiro Gomes, Betania da Mata; Nascimento, Lucila Castanheira] Univ Sao Paulo, Escola Enfermagem Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil.
   [Bezerra Alves, Joao Guilherme] Inst Materno Infantil Prof Fernando Figueira, Recife, PE, Brazil.
   [Nascimento, Lucila Castanheira] Ctr Colaborador OMS Desenvolvimento Pesquisa Enfe, Ribeirao Preto, Brazil.
RP Gomes, BDR (corresponding author), Univ Pernambuco, Fac Enfermagem, Rua Arnobio Marques 310, BR-50100130 Recife, PE, Brazil.
EM betaniadamata@hotmail.com
RI Alves, Joao G/J-6483-2013; Nascimento, Lucila C/J-1999-2012; Nascimento,
   Lucila/X-5859-2019
OI Alves, Joao G/0000-0002-9170-0808; Nascimento, Lucila
   C/0000-0002-7900-7111; Nascimento, Lucila/0000-0002-7900-7111
CR Barroso T, 2009, REV LAT-AM ENFERM, V17, P347, DOI 10.1590/S0104-11692009000300011
   Bonomo Y, 2005, BMJ-BRIT MED J, V330, P777, DOI 10.1136/bmj.330.7494.777
   BROOK JS, 1996, INTERVENING DRUG INV, P23
   Carlini-Cotrim B, 2000, REV SAUDE PUBL, V34, P636, DOI 10.1590/S0034-89102000000600012
   *COORD NAC DST AID, 2003, POL MIN SAUD AT INT
   de Souza DPO, 2005, REV SAUDE PUBL, V39, P585, DOI 10.1590/S0034-89102005000400011
   GALDUROZ JCF, 2005, 5 LEV NAC CONS DROG
   Hingson R, 2003, ALCOHOL RES HEALTH, V27, P63
   Horta RL, 2007, CAD SAUDE PUBLICA, V23, P775, DOI 10.1590/S0102-311X2007000400005
   Laranjeira Ronaldo, 2004, Revista Brasileira de Psiquiatria, V26, pS68, DOI 10.1590/S1516-44462004000500017
   Garcia KSL, 2008, REV LAT-AM ENFERM, V16, P299, DOI 10.1590/S0104-11692008000200020
   Lucas Ana Cyra dos Santos, 2006, Cad. Saúde Pública, V22, P663, DOI 10.1590/S0102-311X2006000300021
   Mathews Ines Silva, 2004, Rev. Latino-Am. Enfermagem, V12, P359, DOI 10.1590/S0104-11692004000700010
   Newman K, 2008, REV LAT-AM ENFERM, V16, P142, DOI 10.1590/S0104-11692008000100022
   *ORG MUND SAUD, GLOB SCH BAS STUD HL
   Pitkanen T, 2005, ADDICTION, V100, P652, DOI 10.1111/j.1360-0443.2005.01053.x
   Reboussin BA, 2006, DRUG ALCOHOL DEPEN, V83, P199, DOI 10.1016/j.drugalcdep.2005.11.013
   REGO RA, 1990, REV SAUDE PUBL, V24, P277, DOI 10.1590/S0034-89101990000400005
   Romano M, 2007, REV SAUDE PUBL, V41, P495, DOI 10.1590/S0034-89102007000400001
   Silva LVER, 2006, REV SAUDE PUBL, V40, P280, DOI [10.1590/S0034-89102006000200014, 10.1590/s0034-89102006000200014]
   Schenker M., 2005, Ciencia & Saude Coletiva, V10, P707, DOI 10.1590/S1413-81232005000300027
   Schenker Miriam, 2004, Cad. Saúde Pública, V20, P649, DOI 10.1590/S0102-311X2004000300002
   *SECR NAC ANT, 2007, 1 LEV NAC PADR CONS
   SOUZA FGM, 1999, REV PSIQ CLIN-BRAZIL, V26, P188
   Strauch ES, 2009, REV SAUDE PUBL, V43, P647, DOI 10.1590/s0034-89102009005000044
   Vieira DL, 2007, REV SAUDE PUBL, V41, P396, DOI 10.1590/s0034-89102006005000022
   Vieira PC, 2008, CAD SAUDE PUBLICA, V24, P2487, DOI 10.1590/S0102-311X2008001100004
   *WHO, 2002, ISS COMM RISK WORLD
   World Health Organization World Health Organization: Substance Abuse Department World Health Organization. Department of Mental Health & Substance Abuse, 2004, GLOB STAT REP ALC 20
NR 29
TC 8
Z9 13
U1 0
U2 3
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD APR
PY 2010
VL 26
IS 4
BP 706
EP 712
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 602OM
UT WOS:000278148700007
PM 20512211
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Alves, JGB
   Siqueira, FV
   Figueiroa, JN
   Facchini, LA
   da Silveira, DS
   Piccini, RX
   Tomasi, E
   Thume, E
   Hallal, PC
AF Bezerra Alves, Joao Guilherme
   Siqueira, Fernando Vinholes
   Figueiroa, Jose Natal
   Facchini, Luiz Augusto
   da Silveira, Denise Silva
   Piccini, Roberto Xavier
   Tomasi, Elaine
   Thume, Elaine
   Hallal, Pedro C.
TI Physical inactivity among adults and elderly living in areas covered by
   primary healthcare units with and without the Family Health Program in
   Pernambuco State, Brazil
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Motor Activity; Health Centers; Adult; Aged
ID NORTHEAST; OBESITY; SOUTH
AB The epidemiological transition in Brazil has been explained partially by the low levels of physical activity. However, few studies have explored physical inactivity in low-income population groups. Within this context, primary healthcare units gain strategic importance. This article describes the prevalence of sedentary lifestyle and associated factors in a cross-sectional study, including 1,018 adults and 1,010 elderly adults in 10 cities in Pernambuco State. Prevalence of sedentary lifestyle was 37.8% (95% CI: 34.0-40.2) in adults and 68.3% (95% CI: 65.3-71.3) in the elderly. Identification of physical activity as the most important factor for good health was associated with sedentary lifestyle in elderly adults. A lower proportion of sedentary lifestyle among non-elderly adults was associated with good self-reported health status. We concluded that sedentary lifestyle prevalence is high in elderly and non-elderly people covered by primary healthcare units in Pernambuco State as compared to the South of Brazil.
C1 [Bezerra Alves, Joao Guilherme; Figueiroa, Jose Natal] Inst Med Integral Prof Fernando Figueira, BR-50070550 Recife, PE, Brazil.
   [Siqueira, Fernando Vinholes] Univ Catolica Pelotas, Ctr Ciencias Vida & Saude, Pelotas, Brazil.
   [Facchini, Luiz Augusto; da Silveira, Denise Silva; Piccini, Roberto Xavier] Univ Fed Pelotas, Dept Social Med, Pelotas, Brazil.
   [Tomasi, Elaine] Univ Catolica Pelotas, Programa Posgrad Saude & Comportamento, Pelotas, Brazil.
   [Thume, Elaine] Univ Fed Pelotas, Fac Enfermagem & Obstet, Pelotas, Brazil.
   [Hallal, Pedro C.] Univ Fed Pelotas, Programa Posgrad Epidemiol, Pelotas, Brazil.
   [Hallal, Pedro C.] Univ Fed Pelotas, Programa Posgrad Educ Fis, Pelotas, Brazil.
RP Alves, JGB (corresponding author), Inst Med Integral Prof Fernando Figueira, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
EM joaoguilhermealves@hotmail.com
RI Alves, Joao G/J-6483-2013; Facchini, Luiz A/A-2268-2009; Thume,
   Elaine/A-8252-2011; Hallal, Pedro C/A-3249-2011
OI Alves, Joao G/0000-0002-9170-0808; Facchini, Luiz A/0000-0002-5746-5170;
   Hallal, Pedro C/0000-0003-1470-6461
CR Allender S, 2007, J EPIDEMIOL COMMUN H, V61, P344, DOI 10.1136/jech.2006.050807
   Alves JG, 2009, AM J PUBLIC HEALTH, V99, P76, DOI 10.2105/AJPH.2007.124495
   Baretta E, 2007, CAD SAUDE PUBLICA, V23, P1595, DOI 10.1590/S0102-311X2007000700010
   Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21
   Benedetti Tânia R Bertoldo, 2008, Rev. Saúde Pública, V42, P302, DOI 10.1590/s0034-89102008000200016
   Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
   de Barros MVG, 2001, REV SAUDE PUBL, V35, P554, DOI 10.1590/S0034-89102001000600009
   FACCHINI LA, 2006, CIENC SAUDE COLETIVA, V11, P669, DOI DOI 10.1590/S1413-81232006000300015
   Facchini LA, 2008, CAD SAUDE PUBLICA, V24, pS159, DOI 10.1590/S0102-311X2008001300020
   Filozof C, 2001, Obes Rev, V2, P99, DOI 10.1046/j.1467-789x.2001.00029.x
   Fuscaldo Joseph M, 2002, W V Med J, V98, P250
   Garrett NA, 2004, AM J PREV MED, V27, P304, DOI 10.1016/j.amepre.2004.07.014
   Hallal PC, 2003, MED SCI SPORT EXER, V35, P1894, DOI 10.1249/01.MSS.0000093615.33774.0E
   Hallal PC, 2007, REV SAUDE PUBL, V41, P453, DOI 10.1590/S0034-89102007000300018
   Hollmann W, 2007, EUR J CARDIOV PREV R, V14, P730, DOI 10.1097/HJR.0b013e32828622f9
   Matsudo S., 2002, REV BRAS CIENC MOV, V10, P41
   *MIN SAUD, 2004, TERM REF EST LINH BA
   Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940
   *ORG MUND SAUD, ESTR GLOB AL SAUD AT
   Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]
   Secretaria de Gestao Estrategica e Participativa Secretaria de Vigilancia em Saude Ministerio da Saude, 2009, VIGITEL BRAS 2008 VI
   Siqueira FV, 2008, CAD SAUDE PUBLICA, V24, P39, DOI 10.1590/S0102-311X2008000100005
   *USDHHS, PHYS ACT PATT MOD CU
   Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35
   Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224
   Warburton DER, 2007, APPL PHYSIOL NUTR ME, V32, pS16, DOI 10.1139/H07-123
   World Health Organization, PHYS IN GLOB PUBL HL
NR 27
TC 17
Z9 20
U1 0
U2 7
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD MAR
PY 2010
VL 26
IS 3
BP 543
EP 556
DI 10.1590/S0102-311X2010000300012
PG 14
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 594TK
UT WOS:000277561100012
PM 20464073
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Guimaraes, TMR
   Alves, JGB
   Tavares, MMF
AF Rocha Guimaraes, Tania Maria
   Bezerra Alves, Joao Guilherme
   Ferreira Tavares, Marcia Maia
TI Impact of immunization measures by the Family Health Program on infant
   mortality from preventable diseases in Olinda, Pernambuco State, Brazil
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Immunization Programs; Infant Mortality; Family Health Program
AB This article analyzes the impact of the Family Health Program (FHP) on infant health in Olinda, Pernambuco State, Brazil, evaluating immunization and infant mortality from vaccine-preventable diseases. A time-series study was conducted with data from the principal health information systems, analyzing indicators before and after implementation of the FHP in 1995. The independent variable was year of birth, related to degree of population coverage by the FHP. Three periods were analyzed: 1990-1994 (prior), 1995-1996 ( implementation phase: 0 to 30% coverage), and 1997-2002 (intervention: coverage of 38.6% to 54%). Trends in the indicators were analyzed by simple linear regression, testing significance with the t test. During the implementation period there was an increase in all the vaccination coverage rates (176% BCG, 223% polio, 52% DPT, 61% measures) and a decrease in infant mortality from preventable diseases (12.7 deaths/year), even without a decrease in absolute poverty in the municipality or an increase in either coverage by the public health care system or the sewage system. Improvement in the indicators demonstrates the effectiveness of FHP actions in the municipality.
C1 [Rocha Guimaraes, Tania Maria; Ferreira Tavares, Marcia Maia] Univ Fed Pernambuco, BR-50100130 Recife, PE, Brazil.
   [Bezerra Alves, Joao Guilherme] Inst Med, Recife, PE, Brazil.
RP Guimaraes, TMR (corresponding author), Univ Fed Pernambuco, Rua Arnobio Marques 314, BR-50100130 Recife, PE, Brazil.
EM tmrguimaraes@ig.com.br
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808; GUIMARAES, TANIA MARIA
   ROCHA/0000-0001-6950-2015
CR AGUILAR M. J., 1994, AVALIACAO SERVICOS P
   Brasil. Ministerio da Saude, 1997, SAUD FAM ESTR REOR M
   CAVALCANTEESILV.A, 2004, 6 C BRAS EP LIVR RES
   CONILL EM, 2002, CAD SAUDE PUBLICA S, P191
   *COORD DISTR PSF S, 2003, REL UN PROGR SAUD CO
   *DEP AC PROGR ESTR, 2005, AG COMPR SAUD INT CR
   *DEP AN SIT SAUD S, 2004, SAUD BRAS 2004 AN SI
   DRAIBE SM, 2001, TENDENCIAS PERSPECTI, P15
   FACCHINI LA, 2006, CIENC SAUDE COLETIVA, V11, P669, DOI DOI 10.1590/S1413-81232006000300015
   GUIMARAES TMR, 2004, THESIS I MATERNO INF
   LIRA KP, 2004, 6 C BRAS EP LIVR RES
   Macinko J, 2006, J EPIDEMIOL COMMUN H, V60, P13, DOI 10.1136/jech.2005.038323
   Macinko J, 2007, SOC SCI MED, V65, P2070, DOI 10.1016/j.socscimed.2007.06.028
   MENDES EV, 1996, NOVO PARADIGMA SANIT, P258
   *MIN SAUD, 2000, AV IMPL FUNC PROGR S
   *MIN SAUD, 2001, PORT GM MS N 723 10
   Ribeiro José Mendes, 2004, Cad. Saúde Pública, V20, P534, DOI 10.1590/S0102-311X2004000200022
   Roncalli Angelo Giuseppe, 2006, Ciênc. saúde coletiva, V11, P713, DOI 10.1590/S1413-81232006000300018
   SANTOS DM, 2004, 6 C BARS EP LIVR RES
   SENNA MCM, 2002, CAD SAUDE PUBLICA S, V18, P203, DOI DOI 10.1590/S0102-311X2002000700020
   SILVA JB, 1995, THESIS U ESTADUAL CA
   Starfield B, 2002, ATENCAO PRIMARIA EQU
   Tomasi E, 2003, REV SAUDE PUBL, V37, P800, DOI 10.1590/S0034-89102003000600017
   VERAS CLS, 2004, 6 C BRAS EP LIVR RES
   Vianna ALD, 1998, PHYSIS-REV SAUDE COL, V8, P11, DOI DOI 10.1590/S0103-73311998000200002
NR 25
TC 18
Z9 20
U1 0
U2 0
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD APR
PY 2009
VL 25
IS 4
BP 868
EP 876
DI 10.1590/S0102-311X2009000400018
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 429DH
UT WOS:000264900500018
PM 19347213
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Falbo, AR
   Alves, JGB
   Batista, M
   Caminha, MDC
   Cabral-Filho, JE
AF Falbo, Ana Rodrigues
   Bezerra Alves, Joao Guilherme
   Batista Filho, Malaquias
   Costa Caminha, Maria de Fatima
   Cabral-Filho, Jose Eulalio
TI Decline in hospital mortality rate after the use of the World Health
   Organization protocol for management of severe malnutrition
SO TROPICAL DOCTOR
LA English
DT Article
ID GUIDELINES
AB We studied the implementation of the World Health Organization protocol for the treatment of malnourished children at the largest maternal and infant hospital in the northeast of Brazil. The implementation of the protocol resulted in a reduction in the mortality rate from 38.0% to 16.2%.
C1 [Falbo, Ana Rodrigues; Bezerra Alves, Joao Guilherme; Batista Filho, Malaquias; Costa Caminha, Maria de Fatima; Cabral-Filho, Jose Eulalio] Inst Materno Infantil Prof Fernando Figueira IMIP, Recife, PE, Brazil.
RP Falbo, AR (corresponding author), Rua Coelhos,300 Boa Vista, BR-50070550 Recife, PE, Brazil.
EM anafalbo@imip.org.br
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
CR Ahmed T, 1999, LANCET, V353, P1919, DOI 10.1016/S0140-6736(98)07499-6
   Ashworth A, 2004, LANCET, V363, P1110, DOI 10.1016/S0140-6736(04)15894-7
   ASHWORTH A, 2003, GUIDELINES INPATIENT, P5
   Deen JL, 2003, B WORLD HEALTH ORGAN, V81, P237
   Falbo Ana Rodrigues, 2006, Cad. Saúde Pública, V22, P561, DOI 10.1590/S0102-311X2006000300011
   Falbo Ana Rodrigues, 2002, Cad. Saúde Pública, V18, P1473, DOI 10.1590/S0102-311X2002000500041
   Karaolis N, 2007, ARCH DIS CHILD, V92, P198, DOI 10.1136/adc.2005.087346
   Maitland K, 2006, PLOS MED, V3, P2431, DOI 10.1371/journal.pmed.0030500
   Schofield C., 1997, Revista Panamericana de Salud Publica, V1, P295, DOI 10.1590/S1020-49891997000400006
   World Health Organization, 2000, MAN CHILD SER INF SE
NR 10
TC 5
Z9 6
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0049-4755
EI 1758-1133
J9 TROP DOCT
JI Trop. Dr.
PD APR
PY 2009
VL 39
IS 2
BP 71
EP 72
DI 10.1258/td.2008.080035
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 446VD
UT WOS:000266148600004
PM 19299283
DA 2020-12-01
ER

PT J
AU Gomes, BDR
   Alves, JGB
AF Ribeiro Gomes, Betania da Mata
   Bezerra Alves, Joao Guilherme
TI Prevalence of high blood pressure and associated factors in students
   from public schools in Greater Metropolitan Recife, Pernambuco State,
   Brazil, 2006
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Hypertension; Students; Adolescent Health
ID RISK-FACTORS; ADOLESCENTS; CHILDREN
AB The aim of this study was to identify the prevalence of systemic arterial hypertension (high blood pressure) and associated health factors in adolescents, using a cross-sectional, population-based, epidemiological design from April to September 2006, within a stratified sample according to school size and shift. Using the Portuguese version of the Global School-Based Student Health Survey questionnaire, 1,878 students from 29 public schools in Greater Metropolitan Recife, Pernambuco State, Brazil, were analyzed for: age, gender, body mass index, fruit, vegetable, alcohol, and tobacco consumption, as well as blood pressure, adopting the 1996 Task Force Report on High Blood Pressure in Children and Adolescents and Centers for Disease Control and Prevention parameters for nutritional status. Prevalence rates for high blood pressure, overweight, and obesity were 17.3%, 6.9%, and 3.7%, respectively. Factors associated with high blood pressure were: male gender, obesity, overweight, and lack of physical activity. Knowledge of factors associated with arterial hypertension in adolescents can help support health education campaigns.
C1 [Ribeiro Gomes, Betania da Mata] Univ Fed Pernambuco, Fac Enfermagem, BR-50100130 Recife, PE, Brazil.
   [Bezerra Alves, Joao Guilherme] Inst Materno Infantil Prof Fernando Figueira, Recife, PE, Brazil.
RP Gomes, BDR (corresponding author), Univ Fed Pernambuco, Fac Enfermagem, Rua Arnobio Marques 310, BR-50100130 Recife, PE, Brazil.
EM betaniadamata@hotmail.com
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
CR ALVES JGB, 2004, PEDIAT IMIP, P33
   [Anonymous], 1996, PEDIATRICS 1, V98, P649
   Caputo JL, 1998, J BEHAV MED, V21, P115, DOI 10.1023/A:1018771706685
   *CDCP, 1997, COORD SCH HLTH PROGR
   Garcia Frederico D, 2004, J. Pediatr. (Rio J.), V80, P29, DOI 10.1590/S0021-75572004000100007
   He Q, 2000, HYPERTENSION, V36, P165, DOI 10.1161/01.HYP.36.2.165
   Koch VH, 2000, REV BRAS HIPERTENS, V7, P71
   LAUER RM, 1993, PEDIATR CLIN N AM, V40, P23
   Lima Eleonora M., 2004, J. Pediatr. (Rio J.), V80, P3, DOI 10.1590/S0021-75572004000100002
   LONDE S, 1996, CLIN PEDIATR, V5, P71
   MION D, 2006, 5 DIRETRIZES BRASILE
   Moura Adriana A, 2004, J. Pediatr. (Rio J.), V80, P35, DOI 10.1590/S0021-75572004000100008
   Oliveira R G, 1999, J Pediatr (Rio J), V75, P256
   *ORG MUND SAUD, GLOB SCH BAS STUD HL
   ROSNER B, 1993, J PEDIATR-US, V123, P871, DOI 10.1016/S0022-3476(05)80382-8
   Salgado CM, 2003, J PEDIAT, V79, P115
   Singh Akhil Kant, 2006, Indian Journal of Pediatrics, V73, P901, DOI 10.1007/BF02859283
   *SOC BRAS CARD, 3 CONS BRAS HIP ART
   *WHO, 2002, ISS COMM RISK WORLD
   Yamamoto-Kimura L, 2006, J ADOLESCENT HEALTH, V38, P591, DOI 10.1016/j.jadohealth.2005.04.004
NR 20
TC 24
Z9 35
U1 0
U2 3
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD FEB
PY 2009
VL 25
IS 2
BP 375
EP 381
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 407NV
UT WOS:000263372500016
PM 19219245
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Alves, JG
   Ambrosi, PA
   Bartlett, DT
   Currivan, L
   van Dijk, JWE
   Fantuzzi, E
   Kamenopoulou, V
AF Alves, J. G.
   Ambrosi, P. A.
   Bartlett, D. T.
   Currivan, L.
   van Dijk, J. W. E.
   Fantuzzi, E.
   Kamenopoulou, V.
TI Revision of European Commission technical recommendations on individual
   monitoring of external radiation exposure
SO RADIATION PROTECTION DOSIMETRY
LA English
DT Editorial Material
RI Alves, Joao H G/K-1127-2013; Alves, Joao G/J-6483-2013
OI Alves, Joao H G/0000-0001-7221-871X; Alves, Joao G/0000-0002-9170-0808
CR *BIPM IEC IFCC ISO, 2008, 200 JCGM BIPM IEC IF
   BIPM IEC IFCC ISO IUPAC IUPAP OIML, 2008, GUID EXPR UNC MEAS
   *COMM EUR COMM, 1975, 5287 CEC EUR
   *EUR COMM, 1994, 14852 EUR EUR COMM
   *INT COMM RAD UN M, 2007, ICRP PUBL, V103
   *INT ORG STAND, 2007, 99 ISOIEC
   *INT ORG STAND, 1995, 98 ISOIEC 3
   International Organization for Standarization, 2005, 17025 ISOIEC
NR 8
TC 0
Z9 0
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0144-8420
J9 RADIAT PROT DOSIM
JI Radiat. Prot. Dosim.
PD FEB
PY 2009
VL 133
IS 3
BP 127
EP 129
DI 10.1093/rpd/ncp036
PG 3
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical
   Imaging
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA 431XQ
UT WOS:000265098500001
PM 19346363
DA 2020-12-01
ER

PT J
AU Alves, JG
   Gale, CR
   Mutrie, N
   Correia, JB
   Batty, GD
AF Alves, Joao G.
   Gale, Catharine R.
   Mutrie, Nanette
   Correia, Jailson B.
   Batty, G. David
TI A 6-Month Exercise Intervention Among Inactive and Overweight
   Favela-Residing Women in Brazil: The Caranguejo Exercise Trial
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article
ID LONG-TERM; BODY-WEIGHT; CHILDHOOD OBESITY; PHYSICAL-ACTIVITY; AEROBIC
   CAPACITY; BLOOD-LIPIDS; METAANALYSIS; MORTALITY; DISEASE; ADULTS
AB Objectives. We examined the viability and efficacy of a known quantity of exercise in facilitating weight loss among previously sedentary or irregularly active overweight and obese adult women residing in a slum (favela) in Brazil.
   Methods. In this randomized controlled trial, 156 women were randomized to a control or intervention group (78 in each group). Exercise was supervised, consisting of three 50-minute aerobic sessions each week for 6 months.
   Results. Ninety-one percent (71) of the participants in the intervention group completed 6 months of the exercise program. At 6 months, women in the treatment group showed significant reduction in weight (mean=-1.69 kg; 95% confidence interval [CI]=-2.36,-1.03) and body mass index (mean=-0.63 kg/m(2); 95% CI=-0.97, -0.30) compared with controls (P for both <.001).
   Conclusions. A moderately intense, structured exercise program resulted in modest weight loss in women when sustained for 6 months. (Am J Public Health. 2008;99:76-80. doi:10.2105/AJPH.2007.124495)
C1 [Alves, Joao G.; Correia, Jailson B.] Inst Materno Infantil Prof Fernando Figueira, BR-50070080 Boa Vista Recife, PE, Brazil.
   [Gale, Catharine R.] Univ Southampton, UK MRC Epidemiol Resource Ctr, Southampton, Hants, England.
   [Mutrie, Nanette] Univ Strathclyde, Dept Sport Culture & Arts, Glasgow, Lanark, Scotland.
   [Batty, G. David] Univ Glasgow, UK MRC Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland.
RP Alves, JG (corresponding author), Inst Materno Infantil Prof Fernando Figueira, Rua Coelhos 300, BR-50070080 Boa Vista Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Correia, Jailson B./J-4331-2015; Gale, Catharine R/B-1653-2012; Batty,
   GD/Y-4401-2018; Alves, Joao G/J-6483-2013
OI Batty, GD/0000-0003-1822-5753; Alves, Joao G/0000-0002-9170-0808; Gale,
   Catharine/0000-0002-3361-8638
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Governo
   do BrasilNational Council for Scientific and Technological Development
   (CNPq) [505782200405]; Wellcome Trust FellowWellcome Trust [WRS
   U.1300.00.006.00012.01]; Medical Research CouncilMedical Research
   Council UK (MRC) [U1475000002, MC_U130059821] Funding Source:
   researchfish
FX This study was supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico, Governo do Brasil (505782200405). G. D. Batty
   is a Wellcome Trust Fellow (WRS U.1300.00.006.00012.01). This article
   was written while G. D. Batty was a visiting fellow at Institute,
   Materno Infantil Prof Fernando Figueira, Recife, Pernambuco - Brazil.
CR *ACT SOC AM ASS LI, 1913, MED ACT MORT INV
   *AM COLL SPORTS ME, 2000, GUID EX TEST PRESCR
   BALLOR DL, 1991, INT J OBESITY, V15, P717
   BALLOR DL, 1988, AM J CLIN NUTR, V47, P19
   BATTY G, SALUD CIENC IN PRESS
   Batty GD, 2006, HEART, V92, P886, DOI 10.1136/hrt.2005.072637
   Batty GD, 2007, DIABETES CARE, V30, P2388, DOI 10.2337/dc07-0294
   Batty GD, 2005, INT J OBESITY, V29, P1267, DOI 10.1038/sj.ijo.0803020
   Catenacci VA, 2007, NAT CLIN PRACT ENDOC, V3, P518, DOI 10.1038/ncpendmet0554
   DATTILO AM, 1992, AM J CLIN NUTR, V56, P320
   DAVIS BR, 1993, ARCH INTERN MED, V153, P1773, DOI 10.1001/archinte.153.15.1773
   Donnelly JE, 2003, ARCH INTERN MED, V163, P1343, DOI 10.1001/archinte.163.11.1343
   Donnelly JE, 2000, INT J OBESITY, V24, P566, DOI 10.1038/sj.ijo.0801198
   Douketis JD, 2005, INT J OBESITY, V29, P1153, DOI 10.1038/sj.ijo.0802982
   Francischetti EA, 2007, INT J CLIN PRACT, V61, P269, DOI 10.1111/j.1742-1241.2006.01262.x
   GARROW JS, 1995, EUR J CLIN NUTR, V49, P1
   GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406
   Hallal PC, 2003, MED SCI SPORT EXER, V35, P1894, DOI 10.1249/01.MSS.0000093615.33774.0E
   Jorm AF, 2003, AUST NZ J PUBL HEAL, V27, P434, DOI 10.1111/j.1467-842X.2003.tb00423.x
   KNOWLER WC, 1981, AM J EPIDEMIOL, V113, P144, DOI 10.1093/oxfordjournals.aje.a113079
   Lau DCW, 2007, CAN MED ASSOC J, V176, pS1, DOI 10.1503/cmaj.061409
   Machin D, 1997, SAMPLE SIZE TABLES C
   MANCINI M, 1981, INT J OBESITY, V5, P341
   Martorell R, 2000, EUR J CLIN NUTR, V54, P247, DOI 10.1038/sj.ejcn.1600931
   McTigue KM, 2003, ANN INTERN MED, V139, P933, DOI 10.7326/0003-4819-139-11-200312020-00013
   Miller WC, 1997, INT J OBESITY, V21, P941, DOI 10.1038/sj.ijo.0800499
   Monteiro CA, 2000, EUR J CLIN NUTR, V54, P342, DOI 10.1038/sj.ejcn.1600960
   PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402
   Pinhas-Hamiel O, 2000, PREV MED, V31, P702, DOI 10.1006/pmed.2000.0752
   Raymond SU, 2006, CURR OPIN CLIN NUTR, V9, P111, DOI 10.1097/01.mco.0000214568.52192.91
   *SECR SAUD REC I M, 2005, PROGR SAUD FAM FAV C
   Shaw K, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003817.pub3
   Snyder KA, 1997, INT J OBESITY, V21, P1180, DOI 10.1038/sj.ijo.0800533
   Song YM, 2004, STROKE, V35, P831, DOI 10.1161/01.STR.0000119386.22691.1C
   Viner RM, 2005, BRIT MED J, V330, P1354, DOI 10.1136/bmj.38453.422049.E0
   *WHO, 2000, TECHN REP SER, V894
   *WHO, 1995, TECHN REP SER, V854
NR 37
TC 14
Z9 14
U1 1
U2 2
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD JAN
PY 2009
VL 99
IS 1
BP 76
EP 80
DI 10.2105/AJPH.2007.124495
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 391OA
UT WOS:000262241400014
PM 18556608
OA Green Published
DA 2020-12-01
ER

PT J
AU Alves, JGB
   Siqueira, PP
   Figueiroa, JN
AF Bezerra Alves, Joao Guilherme
   Siqueira, Pollyanna P.
   Figueiroa, Jose Natal
TI Overweight and physical inactivity in children living in favelas in the
   metropolitan region of Recife, Brazil
SO JORNAL DE PEDIATRIA
LA English
DT Article
ID SAO-PAULO; DEVELOPMENTAL ORIGINS; NUTRITION TRANSITION; METABOLIC-RATE;
   ADULT DISEASE; OBESITY; COUNTRIES; MALNUTRITION; SHANTYTOWNS; POPULATION
AB Objective: To assess the prevalence of overweight and obesity and its association with physical activity levels in children living in favelas in the city of Recife, state of Pernambuco, Brazil.
   Methods: A cross-sectional study was performed with 973 children ranging from 7 to 10 years old, all from two favelas in Recife, Fragoso and Caranguejo (total population of 9,315); of the 973 children assessed, 733 were included in the study. Overweight was defined as body mass index (BMI) equal to or above the 85th percentile, and obesity as BMI equal to or above the 95th percentile, using Centers for Disease Control and Prevention growth charts. Physical activity level was assessed by the Physical Activity Questionnaire for Older Children (PAQ-C). Children with scores >= 3 were considered active, while those with scores < 3 were considered inactive.
   Results: Of the 733 children studied, overweight and obesity were observed in 92 (12.6%). There was no statistical association between physical inactivity and sex, income, maternal schooling, number of siblings and hours of television. However, more children with physical inactivity were observed among overweight or obese children, 66/92 (71.6%) vs. 363/641 (56.7%) (p = 0.008).
   Conclusions: The prevalence of overweight and obesity is high, and is associated with physical inactivity in children living in favelas in the city of Recife, Brazil.
C1 [Bezerra Alves, Joao Guilherme; Figueiroa, Jose Natal] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Siqueira, Pollyanna P.] Inst Med Integral Prof Fernando Figueira IMIP, Recife, PE, Brazil.
RP Alves, JGB (corresponding author), Rua dos Coelhos 300, BR-50070550 Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Alves, Joao G/J-6483-2013; Patriota, Pollyanna/O-9289-2014
OI Alves, Joao G/0000-0002-9170-0808; Patriota,
   Pollyanna/0000-0003-0853-1458
CR Abrantes Marcelo M., 2002, J. Pediatr. (Rio J.), V78, P335, DOI 10.1590/S0021-75572002000400014
   ALVES JG, 1998, DOENCAS ADULTO CORN
   Alves João Guilherme B., 2004, J. Pediatr. (Rio J.), V80, P339, DOI 10.1590/S0021-75572004000500018
   Alves João Guilherme Bezerra, 2005, Rev Bras Med Esporte, V11, P291, DOI 10.1590/S1517-86922005000500009
   Alves João Guilherme Bezerra, 2004, Cad. Saúde Pública, V20, P1525, DOI 10.1590/S0102-311X2004000600009
   Barker DJP, 2003, EUR J EPIDEMIOL, V18, P733, DOI 10.1023/A:1025388901248
   Batista Filho Malaquias, 2003, Cad. Saúde Pública, V19, pS181, DOI 10.1590/S0102-311X2003000700019
   Campbell T, 2007, J URBAN HEALTH, V84, pI54, DOI 10.1007/s11524-007-9181-7
   Caroli M, 2004, INT J OBESITY, V28, pS104, DOI 10.1038/sj.ijo.0802802
   Costa Roberto Fernandes da, 2006, Arq Bras Endocrinol Metab, V50, P60, DOI 10.1590/S0004-27302006000100009
   Crocker PRE, 1997, MED SCI SPORT EXER, V29, P1344, DOI 10.1097/00005768-199710000-00011
   da Silva R C, 2000, Cad Saude Publica, V16, P1091, DOI 10.1590/S0102-311X2000000400027
   Florencio TT, 2007, EUR J CARDIOV PREV R, V14, P346, DOI 10.1097/HJR.0b013e328010f24d
   Florencio TT, 2003, EUR J CLIN NUTR, V57, P1437, DOI 10.1038/sj.ejcn.1601708
   Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004
   Gluckman PD, 2005, MATERN CHILD NUTR, V1, P130, DOI 10.1111/j.1740-8709.2005.00020.x
   Grillo LP, 2005, EUR J CLIN NUTR, V59, P835, DOI 10.1038/sj.ejcn.1602150
   Guo SS, 1999, AM J CLIN NUTR, V70, p145S
   Hoffman DJ, 2000, AM J CLIN NUTR, V72, P1025
   Hoffman DJ, 2000, AM J CLIN NUTR, V72, P702
   Kokkinos Peter, 2004, J Cardiopulm Rehabil, V24, P197, DOI 10.1097/00008483-200405000-00011
   Krishnaswamy K, 2002, NUTR REV, V60, pS35, DOI 10.1301/00296640260130713
   Monteiro CA, 2004, AM J PUBLIC HEALTH, V94, P433, DOI 10.2105/AJPH.94.3.433
   Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289
   Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272
   Reilly JJ, 2003, P NUTR SOC, V62, P611, DOI 10.1079/PNS2003276
   Rivera JA, 2004, NUTR REV, V62, pS149, DOI 10.1111/j.1753-4887.2004.tb00086.x
   SAWAYA AL, 1995, OBES RES, V3, pS107, DOI 10.1002/j.1550-8528.1995.tb00453.x
   Sichieri R, 2007, CAD SAUDE PUBLICA, V23, P1721, DOI 10.1590/S0102-311X2007000700025
   Sune FR, 2007, CAD SAUDE PUBLICA, V23, P1361, DOI 10.1590/S0102-311X2007000600011
   2000, HHS NEWS        0530
NR 31
TC 15
Z9 23
U1 0
U2 6
PU SOC BRASIL PEDIATRIA
PI RIO DE JANEIRO, RJ
PA RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL
SN 0021-7557
EI 1678-4782
J9 J PEDIAT-BRAZIL
JI J. Pediatr.
PD JAN-FEB
PY 2009
VL 85
IS 1
BP 67
EP 71
DI 10.2223/JPED.1862
PG 5
WC Pediatrics
SC Pediatrics
GA 416ZN
UT WOS:000264044200012
PM 19198735
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU Alves, JGB
   Figueiroa, JN
   Barros, I
AF Alves, Joao Guilherme Bezerra
   Figueiroa, Jose Natal
   Barros, Isabela
TI Does breast feeding provide protection against acute appendicitis? A
   case-control study
SO TROPICAL DOCTOR
LA English
DT Article
ID ETIOLOGY
AB Breast feeding stimulates a more tolerant lymphoid tissue at the base of the appendix and this could provide protection against acute appendicitis. Two studies reported that children and adolescents with appendicitis were less likely to have been breast fed. In a case-control study of 200 children with histologically confirmed acute appendicitis matched by 200 siblings with the same sex and difference age - up to three-year-old - we found breast feeding in at least the first two months of life and for more than four months provides protection against acute appendicitis. These findings suggesting that breast feeding may possibly give protection against the development of appendicitis.
C1 [Alves, Joao Guilherme Bezerra; Figueiroa, Jose Natal; Barros, Isabela] Inst Materno Infantil Prof Fernando Figueira, Escola Pernambucana Med, FBV, BR-50070550 Pernambuco, Brazil.
RP Alves, JGB (corresponding author), Inst Materno Infantil Prof Fernando Figueira, Escola Pernambucana Med, FBV, Rua Coelhos,300 Boa Vista, BR-50070550 Pernambuco, Brazil.
EM joaoguilherme@imip.org.br
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
FU CNPq - Programa Institucional de Bolsa de Iniciacao Cientifica
   (PIBIC)National Council for Scientific and Technological Development
   (CNPq)
FX Isabela Barros was sponsored by CNPq - Programa Institucional de Bolsa
   de Iniciacao Cientifica (PIBIC).
CR ADDISS DG, 1990, AM J EPIDEMIOL, V132, P910, DOI 10.1093/oxfordjournals.aje.a115734
   BARKER DJP, 1985, BRIT MED J, V290, P1125, DOI 10.1136/bmj.290.6475.1125
   BURKITT DP, 1971, BRIT J SURG, V58, P695, DOI 10.1002/bjs.1800580916
   COGGON D, 1991, J EPIDEMIOL COMMUN H, V45, P244, DOI 10.1136/jech.45.3.244
   Gauderer MWL, 2001, J PEDIATR SURG, V36, P1214, DOI 10.1053/jpsu.2001.25765
   Gomez-Alcala Alejandro V, 2005, Gac Med Mex, V141, P501
   Hanson LA, 2003, ANN ALLERG ASTHMA IM, V90, P59, DOI 10.1016/S1081-1206(10)61662-6
   HEATON KW, 1987, BRIT MED J, V294, P1632, DOI 10.1136/bmj.294.6588.1632
   PISACANE A, 1995, BRIT MED J, V310, P836, DOI 10.1136/bmj.310.6983.836
   Prystowsky JB, 2005, CURR PROB SURG, V42, P683, DOI 10.1067/j.cpsurg.2005.07.003
NR 10
TC 2
Z9 3
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0049-4755
EI 1758-1133
J9 TROP DOCT
JI Trop. Dr.
PD OCT
PY 2008
VL 38
IS 4
BP 235
EP 236
DI 10.1258/td.2008.070404
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 365MK
UT WOS:000260410500017
PM 18820196
DA 2020-12-01
ER

PT J
AU Batty, GD
   Alves, JG
   Marmot, MG
   Shipley, MJ
   Smith, GD
AF Batty, G. David
   Alves, Joao G.
   Marmot, Michael G.
   Shipley, Martin J.
   Smith, George Davey
TI Obesity and mortality in men according to coronary heart disease status
SO SALUD I CIENCIA
LA Spanish
DT Article
DE obesity; overweight; coronary heart disease; mortality
ID BODY-MASS INDEX; PHYSICAL-ACTIVITY; CANCER-MORTALITY; WEIGHT CHANGE;
   OVERWEIGHT; RISK; MORBIDITY; ISCHEMIA; HEIGHT; LONDON
AB The few reports on the association of obesity or overweight with mortality in persons with existing coronary heart disease (CND) reveal inconsistent findings. In the Whitehall study of London-based male government employees, 18 403 middle-age men were followed up for up for a maximum of 38 years having participated in a medical examination between 1967 and 1970. In men with baseline CHD, there was evidence of a modest elevated risk for mortality from all-causes and coronary heart disease but not stroke in overweight and obese groups relative to normal weight men. While these slopes were markedly steeper in men who were CHD-free at study induction, the difference in the gradients according to baseline CHD status did not attain statistical significance at conventional levels. Avoidance of obesity and overweight in adult life in both men with and without CHD may reduce their later risk of total and coronary heart disease mortality.
C1 [Alves, Joao G.] Inst Materno Infantil Pernambuco, Recife, PE, Brazil.
   [Marmot, Michael G.] UCL, Dept Epidemiol & Publ Hlth, London, Reino Unido, England.
   [Smith, George Davey] Univ Bristol, Dept Social Med, Bristol, Avon, England.
RP Batty, GD (corresponding author), UK Med Res Council, Social & Public Hlth Sci Res Unit, Glasgow G12 8RZ, Lanark, Scotland.
EM david-b@msoc.mrc.gla.ac.uk
RI Alves, Joao G/J-6483-2013; Batty, GD/Y-4401-2018; Smith, George
   Davey/Y-7521-2019; Smith, George Davey/A-7407-2013; Marmot, M
   G/Y-3920-2019
OI Alves, Joao G/0000-0002-9170-0808; Batty, GD/0000-0003-1822-5753; Smith,
   George Davey/0000-0002-1407-8314; Smith, George
   Davey/0000-0002-1407-8314; Marmot, M G/0000-0002-2431-6419
FU British Heart FoundationBritish Heart Foundation [RG/07/008/23674]
   Funding Source: researchfish; Economic and Social Research
   CouncilEconomic & Social Research Council (ESRC) [ES/F02679X/1] Funding
   Source: researchfish; Medical Research CouncilMedical Research Council
   UK (MRC) [G0100222, MC_U130059821, G8802774, G19/35] Funding Source:
   researchfish
CR [Anonymous], 1977, MANUAL INT STAT CLAS
   [Anonymous], 1992, INT STAT CLASSIFICAT
   Batty GD, 2006, HEART, V92, P886, DOI 10.1136/hrt.2005.072637
   Batty GD, 2004, CANCER CAUSE CONTROL, V15, P873, DOI 10.1007/s10552-004-1050-z
   Batty GD, 2001, EUR J EPIDEMIOL, V17, P863, DOI 10.1023/A:1015609909969
   Batty GD, 2005, INT J OBESITY, V29, P1267, DOI 10.1038/sj.ijo.0803020
   Batty GD, 2004, BRIT J CANCER, V90, P1875, DOI 10.1038/sj.bjc.6601799
   Batty GD, 2003, J PUBLIC HEALTH MED, V25, P190, DOI 10.1093/pubmed/fdg043
   Batty GD, 2002, DIABETIC MED, V19, P580, DOI 10.1046/j.1464-5491.2002.00748.x
   Berrington de Gonzalez A, 2003, BRIT J CANCER, V89, P519, DOI 10.1038/sj.bjc.6601140
   Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423
   Cooper R S, 1992, Ann Epidemiol, V2, P637
   COX DR, 1972, J R STAT SOC B, V34, P187
   ERENS B, 1999, HLTH SURVEY ENGLAND, V1
   HOIT BD, 1987, AM HEART J, V114, P1334, DOI 10.1016/0002-8703(87)90534-5
   Kaplan RC, 2002, J CLIN EPIDEMIOL, V55, P654, DOI 10.1016/S0895-4356(02)00405-5
   Luepker RV, 2004, CARDIOVASCULAR SURVE
   McGovern PG, 1996, NEW ENGL J MED, V334, P884, DOI 10.1056/NEJM199604043341403
   Ness AR, 2002, J EPIDEMIOL COMMUN H, V56, P218, DOI 10.1136/jech.56.3.218
   NEWTON KM, 1996, J WOMENS HEALTH, V5, P433
   REID DD, 1974, LANCET, V1, P469
   ROSE G, 1977, LANCET, V1, P105
   ROSE G, 1965, BRIT HEART J, V27, P595
   ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645
   ROSE GA, 1968, WHO MONOGRAPH SERIES, V56
   Smith GD, 2000, PUBLIC HEALTH, V114, P308, DOI 10.1016/S0033-3506(00)00353-X
   Solomon CG, 1997, AM J CLIN NUTR, V66, P1044
   SONG YM, 2004, STROKE
   Wannamethee SG, 2005, J EPIDEMIOL COMMUN H, V59, P134, DOI 10.1136/jech.2003.015651
   Whitlock Gary, 2002, Semin Vasc Med, V2, P369, DOI 10.1055/s-2002-36766
   Widlansky ME, 2004, ARCH INTERN MED, V164, P2326, DOI 10.1001/archinte.164.21.2326
   WILLETT WC, 1995, JAMA-J AM MED ASSOC, V273, P461, DOI 10.1001/jama.273.6.461
   World Health Organization, 1995, WHO TECH REP SER
   1967, MANUAL INT STAT CLAS
NR 34
TC 0
Z9 0
U1 0
U2 1
PU SOC IBEROAMERICANA INFORMACION CIENTIFICA-S I I C
PI BUENOS AIRES
PA AVE BELGRANO 430-C1092AAR, BUENOS AIRES, 00000, ARGENTINA
SN 1667-8982
J9 SALUD CIENC
JI Salud Cienc.
PD JUN
PY 2008
VL 16
IS 2
BP 183
EP 188
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA 330FP
UT WOS:000257925700013
DA 2020-12-01
ER

PT J
AU Alves, JGB
   de Almeida, NDCM
   de Almeida, CDCM
AF Bezerra Alves, Joao Guilherme
   Camara Marques de Almeida, Natalia Dornelas
   Camara Marques de Almeida, Camila Dornelas
TI Tepid sponging plus dipyrone versus dipyrone alone for reducing body
   temperature in febrile children
SO SAO PAULO MEDICAL JOURNAL
LA English
DT Article
DE fever; dipyrone; child; baths; antipyretics
ID FEVER; PARACETAMOL; EFFICACY
AB CONTEXT AND OBJECTIVE: The role of tepid sponging to promote fever control in children is controversial. We did not find any studies reporting on the effectiveness of tepid sponging in addition to dipyrone. The aim of this study was to compare the effects of tepid sponging plus dipyrone with dipyrone alone for reducing fever.
   DESIGN AND SETTING: A randomized clinical trial was undertaken at Instituto Materno-Infantil Professor Fernando Figueira, Recife, Pernambuco.
   METHODS: Children from six months to five years old with axillary temperature greater than 38 degrees C in the emergency word between January and July 2006 were eligible. One hundred and twenty children were randomly assigned to receive oral dipyrone (20 mg/kq) or oral dipyrone and tepid sponging for 15 minutes. The primary outcome was mean temperature reduction after 15, 30, 60, 90 and 120 minutes. Secondary outcomes were crying and irritability.
   RESULTS: 106 children finished the study, After the first 15 minutes, the fall in axillary temperature was significantly greater in the sponged group than in the control group (p < 0.001). From 30 to 120 minutes, better fever control was observed in the control group. Crying and irritability were observed respectively in 52% and 36% of the sponged children and in none and only two of the controls.
   CONCLUSIONS: Tepid sponging plus dipyrone cooled faster during the first 15 minutes, but dipyrone alone presented better fever control over the two-hour period. Tepid sponging caused mild discomfort, crying and irritability for most of the children.
C1 [Bezerra Alves, Joao Guilherme] Inst Materno Infantil Prof Fernando Figueira, Dept Pediat, Recife, PE, Brazil.
   [Camara Marques de Almeida, Natalia Dornelas; Camara Marques de Almeida, Camila Dornelas] Univ Fed Pernambuco, Recife, PE, Brazil.
RP Alves, JGB (corresponding author), Rua Coelhos,300 Boa Vista, BR-50070550 Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
FU Programa Institucinal de Bolsas de Iniciacao Cientifica (PIBIC);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Pesquisa
   (CNPq)National Council for Scientific and Technological Development
   (CNPq)
FX Coauthor Camila Dornelas Camara Marques de Almeida was sponsored by
   Programa Institucinal de Bolsas de Iniciacao Cientifica (PIBIC),
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Pesquisa
   (CNPq).
CR Agbolosu NB, 1997, ANN TROP PAEDIATR, V17, P283, DOI 10.1080/02724936.1997.11747899
   Aksoylar S, 1997, ACTA PAEDIATR JAPON, V39, P215
   [Anonymous], 1986, JAMA, V256, P1749
   *ANV, 2001, PAIN INT AV SEG DIP
   Arcila-Herrera Heriberto, 2004, Gac Med Mex, V140, P99
   Axelrod P, 2000, CLIN INFECT DIS, V31, pS224, DOI 10.1086/317516
   BAUCHER R, 2001, PRIMARY CARE PEDIAT, P343
   Bernath VF, 2002, MED J AUSTRALIA, V176, P130, DOI 10.5694/j.1326-5377.2002.tb04321.x
   Betz MG, 2006, EUR J EMERG MED, V13, P129, DOI 10.1097/01.mej.0000194401.15335.c7
   FISHER RG, 2005, MOFFETS PEDIAT INFEC, P319
   FRIEDMAN A D, 1990, Pediatric Emergency Care, V6, P6, DOI 10.1097/00006565-199003000-00003
   Greisman LA, 2002, CURR OPIN INFECT DIS, V15, P241, DOI 10.1097/00001432-200206000-00005
   Mackowiak PA, 1997, CLIN INFECT DIS, V24, P1214, DOI 10.1086/513659
   Mackowiak PA, 1998, ANN NY ACAD SCI, V856, P214, DOI 10.1111/j.1749-6632.1998.tb08328.x
   MAHAR AF, 1994, CLIN PEDIATR, V33, P227, DOI 10.1177/000992289403300407
   Meremikwu M. M., 2003, COCHRANE DB SYST REV, V2, DOI 10. 1002/14651858. CD004264
   PREWITT EM, 2005, CRIT CARE NURSE S, V8, P18
   Purssell E, 2000, ARCH DIS CHILD, V82, P238, DOI 10.1136/adc.82.3.238
   Sharber J, 1997, AM J EMERG MED, V15, P188, DOI 10.1016/S0735-6757(97)90099-1
   STYRT B, 1990, ARCH INTERN MED, V150, P1589, DOI 10.1001/archinte.150.8.1589
NR 20
TC 4
Z9 4
U1 0
U2 4
PU ASSOCIACAO PAULISTA MEDICINA
PI SAO PAULO
PA AV BRIG LUIS ANTONIO, 278-7 ANDAR, SAO PAULO, CEP01318-901, BRAZIL
SN 1516-3180
J9 SAO PAULO MED J
JI Sao Paulo Med. J.
PD MAR 6
PY 2008
VL 126
IS 2
BP 107
EP 111
DI 10.1590/S1516-31802008000200008
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA 340SF
UT WOS:000258664600008
PM 18553033
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Alves, JGB
   Gale, CR
   Souza, E
   Batty, GD
AF Alves, Joao Guilherme B.
   Gale, Catharine R.
   Souza, Edvaldo
   Batty, G. David
TI Effect of physical exercise on bodyweight in overweight children: a
   randomized controlled trial in a Brazilian slum
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE nutritional epidemiology; obesity; overweight; physical education and
   training; child
ID OBESE CHILDREN; RESEARCH ISSUES; ADOLESCENTS; CHILDHOOD; HEALTH;
   EPIDEMIC
AB Given the increase in obesity in developed and developing countries and its concomitant morbidity, successful treatment approaches are needed. We examined the effect of a structured exercise intervention in overweight children in a slum in Recife, Pernambuco State, Brazil. This was a randomized, controlled efficacy trial. Seventy-eight children were randomized. Exercise was supervised, consisting of three 50' group aerobics sessions per week for six months. All participants maintained ad libitum diets. Based on intention-to-treat analyses, children in both groups had a significant increase in weight at follow-up (p-value for within-group increase = 0.01). The increase in weight was significantly lower in the exercise group (mean difference between groups; -1.37; 95% CI: -2.00; -0.74). A significant difference (p = 0.049) between the exercise and control groups at six-month followup was also found for BMI (mean difference between groups; -0.53; 95% CI: -1.06; -0.002). When we restricted the analyses to children who completed the trial (intervention = 30 and control = 38), the results were the same. An exercise program for children, sustained for six months, was effective for reducing weight gain in overweight children living in a very poor neighborhood.
C1 [Alves, Joao Guilherme B.; Souza, Edvaldo] Inst Materno Infantil Prof Fernando Figueira, BR-50070550 Recife, PE, Brazil.
   [Gale, Catharine R.] Univ Southampton, MRC, Southampton, Hants, England.
   [Gale, Catharine R.] Univ Southampton, Epidemiol Resource Ctr, Southampton, Hants, England.
   [Batty, G. David] Univ Glasgow, MRC, Glasgow, Lanark, Scotland.
   [Batty, G. David] Univ Glasgow, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland.
RP Alves, JGB (corresponding author), Inst Materno Infantil Prof Fernando Figueira, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Gale, Catharine R/B-1653-2012; Batty, GD/Y-4401-2018; Alves, Joao
   G/J-6483-2013
OI Batty, GD/0000-0003-1822-5753; Alves, Joao G/0000-0002-9170-0808; Gale,
   Catharine/0000-0002-3361-8638
FU Medical Research CouncilMedical Research Council UK (MRC) [U1475000002]
   Funding Source: researchfish; Medical Research CouncilMedical Research
   Council UK (MRC) [MC_U130059821] Funding Source: Medline
CR Atlantis E, 2006, INT J OBESITY, V30, P1027, DOI 10.1038/sj.ijo.0803286
   Batista Filho Malaquias, 2003, Cad. Saúde Pública, V19, pS181, DOI 10.1590/S0102-311X2003000700019
   Boran P, 2007, J PEDIAT-BRAZIL, V83, P171, DOI [10.2223/JPED.1609, 10.2223/JPED., 10.1590/S0021-75572007000200012]
   Botton J, 2007, METABOLISM, V56, P614, DOI 10.1016/j.metabol.2006.12.006
   Cheung YB, 2004, J CLIN EPIDEMIOL, V57, P1316, DOI 10.1016/j.jclinepi.2004.04.010
   Dias-da-Costa Juvenal Soares, 2005, Cad. Saúde Pública, V21, P275, DOI 10.1590/S0102-311X2005000100030
   Epstein LH, 1999, MED SCI SPORT EXER, V31, pS553, DOI 10.1097/00005768-199911001-00011
   Flodmark CE, 2004, INT J OBESITY, V28, P1189, DOI 10.1038/sj.ijo.0802787
   Hallal PC, 2007, REV SAUDE PUBL, V41, P453, DOI 10.1590/S0034-89102007000300018
   Harsha DW, 1995, AM J MED SCI, V310, pS109, DOI 10.1097/00000441-199512000-00019
   Kaur S, 2005, CURR SCI INDIA, V88, P1052
   KENNEDY E, 1995, NUTR REV, V53, P111, DOI 10.1111/j.1753-4887.1995.tb01534.x
   Kosti Rena I., 2006, Central European Journal of Public Health, V14, P151
   Li LB, 2007, PEDIATR INT, V49, P280, DOI 10.1111/j.1442-200X.2007.02350.x
   Meyer AA, 2006, J AM COLL CARDIOL, V48, P1865, DOI 10.1016/j.jacc.2006.07.035
   Monteiro Carlos A., 2003, Rev Panam Salud Publica, V14, P246, DOI 10.1590/S1020-49892003000900005
   Must A, 1999, INT J OBESITY, V23, pS2, DOI 10.1038/sj.ijo.0800852
   NEEDLMAN RD, 2000, NELSON TXB PEDIAT, P23
   Olsen LW, 2006, EPIDEMIOLOGY, V17, P292, DOI 10.1097/01.ede.0000208349.16893.e0
   Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748
   Reilly JJ, 2003, P NUTR SOC, V62, P611, DOI 10.1079/PNS2003276
   Sichieri R, 2007, CAD SAUDE PUBLICA, V23, P1721, DOI 10.1590/S0102-311X2007000700025
   Snethen Julia A, 2006, J Pediatr Nurs, V21, P45, DOI 10.1016/j.pedn.2005.06.006
   Speiser PW, 2005, J CLIN ENDOCR METAB, V90, P1871, DOI 10.1210/jc.2004-1389
   Taylor ED, 2006, PEDIATRICS, V117, P2167, DOI 10.1542/peds.2005-1832
   Williams J, 2005, JAMA-J AM MED ASSOC, V293, P70, DOI 10.1001/jama.293.1.70
   Wing RR, 1999, MED SCI SPORT EXER, V31, pS547, DOI 10.1097/00005768-199911001-00010
NR 27
TC 19
Z9 21
U1 0
U2 8
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2008
VL 24
SU 2
BP S353
EP S359
DI 10.1590/S0102-311X2008001400020
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 335ZR
UT WOS:000258334600020
PM 18670715
OA DOAJ Gold, Green Accepted
DA 2020-12-01
ER

PT J
AU Pinto, EAE
   Alves, JG
AF Ataide e Pinto, Elisabeth
   Alves, Joao Guilherme
TI The causes of death of hospitalized children in Angola
SO TROPICAL DOCTOR
LA English
DT Letter
AB Angola currently has the second mortality rate for children in the world. A cross-sectional study was performed containing 1322 random selected children of the 10288 hospitalized from December 2004 to May 2005 at the Hospital Pediatrico David Bernardino, the largest hospital in Angola and health reference centre located in the capital city of Luanda. Hospital mortality was 18% and the main causes of death were: malaria (22.4%), undernutrition (21.5%), pneumonia (11.8%), neonatal affections (9.3%) and meningitis (8.0%). Programmes must be rapidly implemented to eradicate undernutrition, improve perinatal care and control infections, especially malaria, pneumonia and meningitis.
C1 [Alves, Joao Guilherme] Inst Materno Infantil Prof Fernando Figueira, Dept Pediat, BR-50070550 Recife, PE, Brazil.
RP Alves, JG (corresponding author), Rua Coelhos 300 Boa Vista, BR-50070550 Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
CR [Anonymous], 2005, STAT WORLDS CHILDR 2
   Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8
   Falbo Ana Rodrigues, 2006, Cad. Saúde Pública, V22, P561, DOI 10.1590/S0102-311X2006000300011
   *HOSP PED LUAND, 2004, REL ACT CONT 2003
   PELLETIER DL, 1995, B WORLD HEALTH ORGAN, V73, P443
   *UNICEF, 2001, PROGR WORLD SUMM CHI
   WHO, 1999, MAN SEV MALN MAN PHY
NR 7
TC 4
Z9 6
U1 0
U2 3
PU ROYAL SOC MEDICINE PRESS LTD
PI LONDON
PA 1 WIMPOLE STREET, LONDON W1G 0AE, ENGLAND
SN 0049-4755
J9 TROP DOCT
JI Trop. Dr.
PD JAN
PY 2008
VL 38
IS 1
BP 66
EP 67
DI 10.1258/td.2006.006352
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 269HF
UT WOS:000253639400033
PM 18302879
DA 2020-12-01
ER

PT J
AU Batty, GD
   Alves, JG
   Correia, J
   Lawlor, DA
AF Batty, G. D.
   Alves, J. G.
   Correia, J.
   Lawlor, D. A.
TI Examining life-course influences on chronic disease: the importance of
   birth cohort studies from low-and middle-income countries. An overview
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE birth cohort; chronic disease; developing country; epidemiology;
   life-course
ID CORONARY-HEART-DISEASE; CAUSE-SPECIFIC MORTALITY; BLOOD-PRESSURE;
   RISK-FACTORS; FOLLOW-UP; SOCIOECONOMIC POSITION; INSULIN-RESISTANCE;
   ABERDEEN CHILDREN; PHYSICAL-ACTIVITY; EARLY ADULTHOOD
AB The objectives of this overview are to describe the past and potential contributions of birth cohorts to understanding chronic disease aetiology; advance a justification for the maintenance of birth cohorts from low- and middle-income countries ( LMIC); provide an audit of birth cohorts from LMIC; and, finally, offer possible future directions for this sphere of research. While the contribution of birth cohorts from affluent societies to understanding disease aetiology has been considerable, we describe several reasons to anticipate why the results from such studies might not be directly applied to LMIC. More than any other developing country, Brazil has a tradition of establishing, maintaining and exploiting birth cohort studies. The clear need for a broader geographical representation may be precipitated by a greater collaboration worldwide in the sharing of ideas, fieldwork experience, and cross-country cohort data comparisons in order to carry out the best science in the most efficient manner. This requires the involvement of a central overseeing body - such as the World Health Organization - that has the respect of all countries and the capacity to develop strategic plans for `global' life-course epidemiology while addressing such issues as data-sharing. For rapid progress to be made, however, there must be minimal bureaucratic entanglements.
C1 MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland.
   Inst Materno Infantil Prof Fernando Figueira, Recife, PE, Brazil.
   Univ Bristol, Dept Social Med, Bristol, Avon, England.
RP Batty, GD (corresponding author), MRC, Social & Publ Hlth Sci Unit, 4 Lilybank Gardens, Glasgow G12 8RZ, Lanark, Scotland.
EM david-b@msoc.mrc.gla.ac.uk
RI Batty, GD/Y-4401-2018; Correia, Jailson B./J-4331-2015; Alves, Joao
   G/J-6483-2013
OI Batty, GD/0000-0003-1822-5753; Alves, Joao G/0000-0002-9170-0808;
   Lawlor, Debbie A/0000-0002-6793-2262
FU Medical Research CouncilMedical Research Council UK (MRC)
   [MC_U130059821, G0600705] Funding Source: Medline
CR Adair LS, 2003, HYPERTENSION, V41, P451, DOI 10.1161/01.HYP.0000054212.23528.B2
   Andersen LB, 1996, DAN MED BULL, V43, P407
   Araujo CL, 2006, INT J OBESITY, V30, P500, DOI 10.1038/sj.ijo.0803160
   Barbieri MA, 2006, BRAZ J MED BIOL RES, V39, P1041, DOI 10.1590/S0100-879X2006000800007
   Barker D. J. P., 1998, MOTHERS BABIES HLTH
   Barros FC, 2005, LANCET, V365, P847, DOI 10.1016/S0140-6736(05)71042-4
   Batty GD, 2007, ANN ONCOL, V18, P21, DOI 10.1093/annonc/mdl473
   Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010
   Batty GD, 2006, PEDIATRICS, V118, P943, DOI 10.1542/peds.2006-0168
   Batty GD, 2006, BMJ-BRIT MED J, V332, P580, DOI 10.1136/bmj.38723.660637.AE
   Batty GD, 2005, PAEDIATR PERINAT EP, V19, P452, DOI 10.1111/j.1365-3016.2005.00671.x
   Batty GD, 2005, BRIT J PSYCHIAT, V187, P180, DOI 10.1192/bjp.187.2.180
   Batty GD, 2004, PAEDIATR PERINAT EP, V18, P221, DOI 10.1111/j.1365-3016.2004.00552.x
   Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698
   Bobak M, 1999, ANN EPIDEMIOL, V9, P335
   Cardoso VC, 2007, BRAZ J MED BIOL RES, V40, P1165, DOI 10.1590/S0100-879X2006005000148
   DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279
   Doll R, 2005, BRIT J CANCER, V92, P426, DOI 10.1038/sj.bjc.6602359
   DOLL R, 1950, BRIT MED J, V2, P739, DOI 10.1136/bmj.2.4682.739
   Ebrahim S, 2005, INT J EPIDEMIOL, V34, P961, DOI 10.1093/ije/dyi188
   Ebrahim S, 1997, BMJ-BRIT MED J, V314, P1666, DOI 10.1136/bmj.314.7095.1666
   Elliott J, 2006, INT J EPIDEMIOL, V35, P836, DOI 10.1093/ije/dyl174
   ENOS WF, 1953, JAMA-J AM MED ASSOC, V152, P1090, DOI 10.1001/jama.1953.03690120006002
   Eriksson JG, 2007, J INTERN MED, V261, P418, DOI 10.1111/j.1365-2796.2007.01798.x
   Galobardes B, 2004, EPIDEMIOL REV, V26, P7, DOI 10.1093/epirev/mxh008
   Golding J, 2001, PAEDIATR PERINAT EP, V15, P74
   Golding J, 2004, EUR J ENDOCRINOL, V151, pU119, DOI 10.1530/eje.0.151U119
   Gupta PC, 2003, RESPIROLOGY, V8, P419, DOI 10.1046/j.1440-1843.2003.00507.x
   Hallal PC, 2006, BMJ-BRIT MED J, V332, P1002, DOI 10.1136/bmj.38776.434560.7C
   Hardy R, 2007, BJOG-INT J OBSTET GY, V114, P721, DOI 10.1111/j.1471-0528.2007.01324.x
   Hayes RB, 1996, ENVIRON HEALTH PERSP, V104, P1349, DOI 10.2307/3433189
   Huxley R, 2002, LANCET, V360, P659, DOI 10.1016/S0140-6736(02)09834-3
   KUH D, 2004, LIFECOURSE APPROACH
   Kuzawa CW, 2003, AM J CLIN NUTR, V77, P960
   Last JM, 1995, DICT EPIDEMIOLOGY
   LAWLOR D, IN PRESS STROKE
   Lawlor DA, 2006, DIABETOLOGIA, V49, P2614, DOI 10.1007/s00125-006-0408-z
   Lawlor DA, 2005, BRIT MED J, V331, P183, DOI 10.1136/bmj.331.7510.183
   Lawlor DA, 2007, AM J EPIDEMIOL, V165, P1405, DOI 10.1093/aje/kwm028
   Lawlor DA, 2006, AM J EPIDEMIOL, V164, P907, DOI 10.1093/aje/kwj319
   Leon DA, 2006, INT J EPIDEMIOL, V35, P549, DOI 10.1093/ije/dyi319
   LIPWORTH L, 1995, EUR J CANCER PREV, V4, P7, DOI 10.1097/00008469-199502000-00002
   Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411
   MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9
   Magnus P, 2001, ARCH INTERN MED, V161, P2657, DOI 10.1001/archinte.161.22.2657
   MARMOT MG, 1978, BMJ-BRIT MED J, V2, P1109, DOI 10.1136/bmj.2.6145.1109
   MARMOT MG, 1984, LANCET, V1, P1003
   Martin LT, 2004, J EPIDEMIOL COMMUN H, V58, P674, DOI 10.1136/jech.2003.016444
   MARTORELL R, 1995, J NUTR, V125, pS1027, DOI 10.1093/jn/125.suppl_4.1027S
   MCCARRON P, 2003, LIFECOURSE APPROACH, P49
   McKee M, 1999, ALCOHOL ALCOHOLISM, V34, P824, DOI 10.1093/alcalc/34.6.824
   McKee M, 2001, ANN EPIDEMIOL, V11, P1, DOI 10.1016/S1047-2797(00)00080-6
   MCKEE M, 1995, BRIT MED J, V310, P1668
   MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P
   Murray CJ, 1996, GLOBAL BURDEN DIS
   Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4
   Najman JM, 2005, INT J EPIDEMIOL, V34, P992, DOI 10.1093/ije/dyi119
   Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201
   Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183
   RAMACHANDRAN A, 1992, DIABETES CARE, V15, P1348, DOI 10.2337/diacare.15.10.1348
   Rantakallio P, 1988, Paediatr Perinat Epidemiol, V2, P59, DOI 10.1111/j.1365-3016.1988.tb00180.x
   Richter L, 2007, INT J EPIDEMIOL, V36, P504, DOI 10.1093/ije/dym016
   Richter LM, 2004, PAEDIATR PERINAT EP, V18, P290, DOI 10.1111/j.1365-3016.2004.00572.x
   Silva P A, 1990, Paediatr Perinat Epidemiol, V4, P76, DOI 10.1111/j.1365-3016.1990.tb00621.x
   Smith L, 2002, ASTM STAND NEWS, V30, P34
   STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823
   Stewart BW, 2005, J CLIN ONCOL, V23, P392, DOI 10.1200/JCO.2005.05.132
   Syddall HE, 2005, INT J EPIDEMIOL, V34, P1234, DOI 10.1093/ije/dyi127
   Victora CG, 2006, INT J EPIDEMIOL, V35, P237, DOI 10.1093/ije/dyi290
   Vineis P, 2004, JNCI-J NATL CANCER I, V96, P99, DOI 10.1093/jnci/djh014
   Wadsworth MEJ, 2003, SOC SCI MED, V57, P2193, DOI 10.1016/S0277-9536(03)00083-2
   WADSWORTH MEJ, 1992, J EPIDEMIOL COMMUN H, V46, P300, DOI 10.1136/jech.46.3.300
   Yach D, 1991, Paediatr Perinat Epidemiol, V5, P211, DOI 10.1111/j.1365-3016.1991.tb00702.x
   Yajnik CS, 2004, LANCET, V363, P163, DOI 10.1016/S0140-6736(03)15269-5
   Yajnik CS, 2002, J CLIN ENDOCR METAB, V87, P5575, DOI 10.1210/jc.2002-020434
   1997, MORTALITY STAT CAUSE
   2002, TOBACCO ATLAS
NR 77
TC 31
Z9 33
U1 0
U2 11
PU ASSOC BRAS DIVULG CIENTIFICA
PI RIBEIRAO PRETO
PA FACULDADE MEDICINA, CASA 10, 14049 RIBEIRAO PRETO, RIBEIRAO PRETO, SP
   14049, BRAZIL
SN 0100-879X
EI 1414-431X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD SEP
PY 2007
VL 40
IS 9
BP 1277
EP 1286
DI 10.1590/S0100-879X2007000900015
PG 10
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA 211HQ
UT WOS:000249515300015
PM 17876486
OA DOAJ Gold, Green Accepted
DA 2020-12-01
ER

PT J
AU Nunes, MMDA
   Figueroa, JN
   Alves, JGB
AF De Araujo Nunes, Marilia Medeiros
   Figueroa, Jose Natal
   Bezerra Alves, Joao Gumherme
TI Overweight, physical activity and foods habits in adolescents from
   different economic levels, campina grande (PB)
SO REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
LA Portuguese
DT Article
DE obesity; overweight; physical activity; food habits socioeconomic level
ID ASSOCIATION; TELEVISION; CHILDHOOD; OBESITY; RISK
AB OBJECTIVE. To compare overweight and obesity, eating habits and life style among adolescents from different economic levels.
   METHODS. A cross-sectional study was undertaken with 588 adolescents from a public and a private school in Compina Grande, PB. They belonged to economic levels A(1), A(2) and B-1(292) and C, D and E (296), according to the Brazilian Criteria of Economic Classification of the Brazilian Association of Research listitutes, Height and body weight were measured and Body Moss Index (BMI) was calculated; >= p85 = overweight and >= p95 = obesity. A questionnaire for assessment of leisure time, physical activity, time spent watching TV and eating habits was administered.
   RESULTS. Overweight and obesity were more common in the higher economic level than in the lower economic one; 31.4% versus 18.1%; p < 0.001. Leisure time for physical activity was more present in adolescents with A(1), A(2) e B-1 economic status. Watching TVdisclosed no difference between the two economic levels surveyed. Doily consumption of softs drinks, sweets and salty snacks were more common in the higher economic level but this was not associated with obesity. A low consumption of fruits was observed in all economic levels.
   CONCLUSION. Overweight and obesity ore frequent among adolescents of Compina Grande, PB, as well as time spent watching TV and unhealthy eating habits, especially among those of the higher economic level., The amount of time spent on leisure for physical activities was low, especially in the lower economic level.
C1 [De Araujo Nunes, Marilia Medeiros; Figueroa, Jose Natal; Bezerra Alves, Joao Gumherme] Trabalho Realizado Inst Materno Infantil Prof Fer, Recife, PE, Brazil.
RP Alves, JGB (corresponding author), Rua Coelhos 300, Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
CR Altieri A, 2004, ANN EPIDEMIOL, V14, P461, DOI 10.1016/j.annepidem.2003.11.005
   Ball K, 2005, SOC SCI MED, V60, P1987, DOI 10.1016/j.socscimed.2004.08.056
   Caroli M, 2004, INT J OBESITY, V28, pS104, DOI 10.1038/sj.ijo.0802802
   Coleman KJ, 2005, ARCH PEDIAT ADOL MED, V159, P217, DOI 10.1001/archpedi.159.3.217
   Delpeuch F, 1997, Med Trop (Mars), V57, P380
   Dietz WH, 2004, NEW ENGL J MED, V350, P855, DOI 10.1056/NEJMp048008
   Gómez Luis Fernando, 2004, Cad. Saúde Pública, V20, P1103, DOI 10.1590/S0102-311X2004000400026
   Hancox RJ, 2004, LANCET, V364, P257, DOI 10.1016/S0140-6736(04)16675-0
   Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1
   Mendonça Cristina Pinheiro, 2004, Cad. Saúde Pública, V20, P698, DOI 10.1590/S0102-311X2004000300006
   Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940
   Pollock ML, 1998, MED SCI SPORT EXER, V30, P975, DOI 10.1097/00005768-199806000-00032
   Sarlio-Lahteenkorva S, 1999, INT J EPIDEMIOL, V28, P445, DOI 10.1093/ije/28.3.445
   Silva Giselia Alves Pontes da, 2005, Rev. Bras. Saude Mater. Infant., V5, P53, DOI 10.1590/S1519-38292005000100007
   Silva Maria Alayde Mendonça da, 2005, Arq. Bras. Cardiol., V84, P387, DOI 10.1590/S0066-782X2005000500007
   St-Onge MP, 2003, AM J CLIN NUTR, V78, P1068
   US Department of Health and Human Services, 2000, HLTH PEOPL 2010 UND
   WHO (World Health Organization), 2000, 894 WHO
NR 18
TC 44
Z9 68
U1 0
U2 3
PU ASSOC MEDICA BRASILEIRA
PI SAO PAULO
PA RUA SAO CARLOS DO PINHAL 324, CAIXA POSTAL 8904, SAO PAULO, SP, BRAZIL
EI 1806-9282
J9 REV ASSOC MED BRAS
JI Rev. Assoc. Med. Bras.
PD MAR-APR
PY 2007
VL 53
IS 2
BP 130
EP 134
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA 281ZW
UT WOS:000254538400017
PM 17568916
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Alves, JGB
   Neto, FJC
   Almeida, CDC
   Almeida, NDC
AF Bezerra Alves, Joao Guilherme
   Cardoso Neto, Fortunato Jose
   Camara Almeida, Camila Dornelas
   Camara Almeida, Natalia Dornelas
TI Dipyrone and acetaminophen: correct dosing by parents?
SO SAO PAULO MEDICAL JOURNAL
LA English
DT Article
DE fever; antipyretics; dipyrone; acetaminophen; dose; cross-sectional
   studies
ID FEVER; CHILDREN; MOTHERS
AB CONTEXT AND OBJECTIVE: Several studies in developed countries have documented that a significant percentage of children are given inappropriate doses of acetaminophen and ibuprofen. The objective of this paper was to investigate parents' accuracy in giving dipyrone and acetaminophen to their children, in a poor region.
   DESIGN AND SETTING: Cross-sectional study at the pediatric emergency department of Instituto Materno-Infantil Prof. Fernando Figueira, a teaching hospital in Pernambuco.
   METHODS: The inclusion criteria were age between 3 and 36 months, main complaint of fever and at least one dose of dipyrone or acetaminophen given to the child during the 24 hours preceding their arrival at the emergency department. The mothers were asked for demographic information and about the antipyretic doses given, which were compared with the recommended dosage.
   RESULTS: Among the 200 patients studied, 1 17 received dipyrone and 83 received acetaminophen. Overall, 75% received an incorrect dose of antipyretic. Of the patients who received dipyrone, 105 (89.7%) were given an incorrect dose, 16 (15.2%) received too little dipyrone, and 89 (84.8%) received too much. Of the patients who received acetaminophen, 45 (54.2%) were given an incorrect dose, 38 (84.4%) received too little acetaminophen, and 7 (15.6%) received too much. There were no differences in maternal and child characteristics between the groups receiving correct and incorrect doses of medication, except for the type of medication (dipyrone versus acetaminophen).
   CONCLUSIONS: Most of the children treated were given inappropriate doses, mainly dipyrone overdosing and acetaminophen underdosing.
C1 [Bezerra Alves, Joao Guilherme; Cardoso Neto, Fortunato Jose] Inst Materno Infantil Pernambuco, Recife, PE, Brazil.
   [Camara Almeida, Camila Dornelas; Camara Almeida, Natalia Dornelas] Univ Fed Pernambuco, Recife, PE, Brazil.
RP Alves, JGB (corresponding author), Rua Coelhos 300 Boa Vista, BR-50070550 Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
CR Al-Nouri L, 2006, J TROP PEDIATRICS, V52, P113, DOI 10.1093/tropej/fmi076
   Alves JGB, 2002, TROP DOCT, V32, P145, DOI 10.1177/004947550203200308
   ALVES JGB, 2002, J PEDIATR, V78, P534
   AMES JT, 1982, CLIN PEDIATR, V21, P298, DOI 10.1177/000992288202100506
   Arcila-Herrera Heriberto, 2004, Gac Med Mex, V140, P99
   Bonkowsky JL, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e98
   Crocetti M, 2001, PEDIATRICS, V107, P1241, DOI 10.1542/peds.107.6.1241
   Goldman RD, 2004, PEDIATR EMERG CARE, V20, P89, DOI 10.1097/01.pec.0000113877.10140.d2
   GRIBETZ B, 1987, PEDIATRICS, V80, P630
   HAWKINS N, 1995, BRIT J CLIN PHARMACO, V40, P79, DOI 10.1111/j.1365-2125.1995.tb04539.x
   Li SF, 2000, PEDIATR EMERG CARE, V16, P394, DOI 10.1097/00006565-200012000-00003
   Losek JD, 2004, PEDIATR EMERG CARE, V20, P285
   Mcerlean MA, 2001, PEDIATR EMERG CARE, V17, P249, DOI 10.1097/00006565-200108000-00005
NR 13
TC 3
Z9 3
U1 0
U2 2
PU ASSOCIACAO PAULISTA MEDICINA
PI SAO PAULO
PA AV BRIG LUIS ANTONIO, 278-7 ANDAR, SAO PAULO, CEP01318-901, BRAZIL
SN 1516-3180
J9 SAO PAULO MED J
JI Sao Paulo Med. J.
PD JAN 4
PY 2007
VL 125
IS 1
BP 57
EP 59
DI 10.1590/S1516-31802007000100011
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA 337IL
UT WOS:000258429600011
PM 17505687
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Hazin, AN
   Alves, JGB
   Falbo, AR
AF Hazin, Adriano Nassri
   Alves, Joao Guilherme Bezerra
   Falbo, Ana Rodrigues
TI The myelination process in severely malnourished children: MRI findings
SO INTERNATIONAL JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE brain; magnetic resonance imaging; myelination; protein energy
   malnutrition
ID BRAIN; MALNUTRITION; KWASHIORKOR
AB This study reports cranial magnetic resonance imaging (MRI) findings in children with severe protein energy malnutrition (PEM) performed to determine malnutrition related myelination delay. A total of 20 children aged 2 months to 24 months were included in this study. Eleven (55%) of the children had severe wasting, five (25%) children had edematous malnutrition, and four (20%) children had severe stunting. The MRI findings of two (10%) children, both with severe stunting, indicated myelination delay according to Barkovich et al. (2000) and van der Knaap and Valk criteria 2005. Seventeen (85%) children also had MRI findings of cerebral atrophy. Conclusions indicate that the brain myelination process in the first two years of life of severely malnourished infants, as assessed by MRI, does not show significant delay caused by the nutritional impact on the myelination process.
C1 Inst Materno Infantil Prof Fernando Figueira IMIP, BR-50070 Recife, PE, Brazil.
RP Alves, JGB (corresponding author), Inst Materno Infantil Prof Fernando Figueira IMIP, Rua Dos Coelhos,300 Boa Vista, BR-50070 Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
CR Barkovich A. J, 2000, PEDIAT NEUROIMAGING, P13
   EGWIM PO, 1986, COMP BIOCHEM PHYS A, V83, P67, DOI 10.1016/0300-9629(86)90089-7
   GUNSTON GD, 1992, ARCH DIS CHILD, V67, P1030, DOI 10.1136/adc.67.8.1030
   HOUSEHAM KC, 1991, ARCH DIS CHILD, V66, P623, DOI 10.1136/adc.66.5.623
   LEVITSKY DA, 1995, J NUTR, V125, pS2212, DOI 10.1093/jn/125.suppl_8.2212S
   Odabas D, 2005, INT J NEUROSCI, V115, P829, DOI 10.1080/00207450590882082
   Stephenson LS, 2000, PARASITOLOGY, V121, pS5, DOI 10.1017/S0031182000006478
   STRAIN GW, 1981, PSYCHIAT CLIN N AM, V4, P253
   UDANI P M, 1992, Indian Journal of Pediatrics, V59, P165, DOI 10.1007/BF02759978
   van der Knaap MS, 2005, MAGNETIC RESONANCE M, P37
   WHO, 1999, MAN SEV MALN MAN PHY
NR 11
TC 7
Z9 7
U1 0
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0020-7454
J9 INT J NEUROSCI
JI Int. J. Neurosci.
PY 2007
VL 117
IS 8
BP 1209
EP 1214
DI 10.1080/00207450600934945
PG 6
WC Neurosciences
SC Neurosciences & Neurology
GA 193II
UT WOS:000248267300008
PM 17613122
DA 2020-12-01
ER

PT J
AU De Franca, E
   Alves, JGB
   Hutz, MH
AF De Franca, E
   Alves, JGB
   Hutz, MH
TI APOA1/C3/A4 gene cluster variability and lipid levels in Brazilian
   children
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE apolipoproteins; gene variants; lipid levels; children
ID APOLIPOPROTEIN POLYMORPHISMS; PLASMA-LIPOPROTEINS; IV GENE; ASSOCIATION;
   CIII; HYPERTRIGLYCERIDEMIA; CHILDHOOD; DISEASE; APOC3
AB Genetic studies have suggested that polymorphisms of genes coding for apolipoproteins are significant determinants of serum lipoprotein and lipid levels in adults. However, only a few studies have investigated the association of these polymorphisms in children. Therefore, in the present investigation we studied the distribution of APOA1 -75 G > A, +83 C > T, APOC3 -482 C > T, -455 T > C and 3238 C > G, and APOA4 Q360H and T347S polymorphisms and their influence on plasma lipoprotein levels in children from a Brazilian northeastern admixed population. The seven polymorphic sites were genotyped in 414 children aged 5 to 15 years (mean 8.9 +/- 2.9). The genotypes of the seven polymorphic sites were assessed by PCR-RFLP methods. The frequencies of the less common alleles were, in general, intermediate among parental populations, as expected. Strong linkage disequilibrium was detected. between polymorphisms at the APOA1, APOC3 and APOA4 loci in this admixed population sample. Overall the genotype effects seen in adults were weaker or absent in children. The APOC31-455 and APOA4 T347S variants showed significant effects on HDL cholesterol in girls (P = 0.033 and P = 0.016, respectively). Significantly higher plasma total (P = 0.003) and LDL cholesterol (P = 0.004) levels were observed in boys who were carriers of the 3238G allele at the APOC3/3238 C > G site. These results disclosed an overall absence of associations between these polymorphisms and lipids in children. This finding is not unexpected because expression of the effect of these polymorphisms might depend on the interaction with environmental variables both internal and external to the individual.
C1 UFRGS, Dept Genet, BR-91501970 Porto Alegre, RS, Brazil.
   Inst Materno Infantil Pernambuco, Escola Posgrad Saude Materno Infantil, Recife, PE, Brazil.
RP Hutz, MH (corresponding author), UFRGS, Dept Genet, Caixa Postal 15053, BR-91501970 Porto Alegre, RS, Brazil.
EM mara.hutz@ufrgs.br
RI Alves, Joao G/J-6483-2013; Hutz, Mara H/I-4070-2012
OI Alves, Joao G/0000-0002-9170-0808; Hutz, Mara/0000-0002-9146-1229
CR AALTOSETALA K, 1991, J LIPID RES, V32, P1477
   Brotons C, 1998, ATHEROSCLEROSIS, V139, P1, DOI 10.1016/S0021-9150(98)00056-2
   Fiegenbaum M, 2003, INT J OBESITY, V27, P484, DOI 10.1038/sj.ijo.0802256
   FIELDING CJ, 1995, J LIPID RES, V36, P211
   Hegele RA, 1997, ARTERIOSCL THROM VAS, V17, P2753, DOI 10.1161/01.ATV.17.11.2753
   Hegele RA, 1997, ARTERIOSCL THROM VAS, V17, P1060, DOI 10.1161/01.ATV.17.6.1060
   Jong MC, 1999, ARTERIOSCL THROM VAS, V19, P472, DOI 10.1161/01.ATV.19.3.472
   Kamboh MI, 1999, GENET EPIDEMIOL, V16, P205, DOI 10.1002/(SICI)1098-2272(1999)16:2<205::AID-GEPI7>3.3.CO;2-G
   KAMBOH MI, 1990, HUM HERED, V40, P193, DOI 10.1159/000153931
   KARATHANASIS SK, 1985, P NATL ACAD SCI USA, V82, P6374, DOI 10.1073/pnas.82.19.6374
   Long J. C., 1999, MULTIPLE LOCUS HAPLO
   OPPERT JM, 1992, INT J OBESITY, V16, P891
   Salzano FM, 2002, EVOLUTION GENETICS L
   Schneider S, 2000, ARLEQUIN VERSION 200
   Shoulders CC, 1996, HUM GENET, V98, P557, DOI 10.1007/s004390050259
   Sing CF, 2003, ARTERIOSCL THROM VAS, V23, P1190, DOI 10.1161/01.ATV.0000075081.51227.86
   TALMUD PJ, 2001, AGE RELATED GENETIC
   Wang GQ, 2003, ANN HUM GENET, V67, P107, DOI 10.1046/j.1469-1809.2003.00023.x
   Wang XL, 1996, GENET EPIDEMIOL, V13, P1, DOI 10.1002/(SICI)1098-2272(1996)13:1<1::AID-GEPI1>3.0.CO;2-D
   Weinberg RB, 2002, CURR OPIN LIPIDOL, V13, P125, DOI 10.1097/00041433-200204000-00003
   XU CF, 1993, GENET EPIDEMIOL, V10, P113, DOI 10.1002/gepi.1370100204
NR 21
TC 25
Z9 25
U1 0
U2 2
PU ASSOC BRAS DIVULG CIENTIFICA
PI RIBEIRAO PRETO
PA FACULDADE MEDICINA, CASA 10, 14049 RIBEIRAO PRETO, RIBEIRAO PRETO, SP
   14049, BRAZIL
SN 0100-879X
EI 1414-431X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD APR
PY 2005
VL 38
IS 4
BP 535
EP 541
DI 10.1590/S0100-879X2005000400006
PG 7
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA 924EW
UT WOS:000228962700006
PM 15962178
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU De Franca, E
   Alves, JGB
   Hutz, MH
AF De Franca, E
   Alves, JGB
   Hutz, MH
TI Apolipoprotein E polymorphism and its association with serum lipid
   levels in Brazilian children
SO HUMAN BIOLOGY
LA English
DT Article
DE APOE; Brazilian populations; lipids; atherosclerosis
ID CARDIOVASCULAR RISK; E PHENOTYPE; POPULATION; CHOLESTEROL; ALLELE;
   FREQUENCIES; PLASMA; SAMPLE; SEX
AB The influence of apolipoprotein E (APOE) genotypes on plasma lipid levels was determined in 414 Brazilian healthy children of mixed ethnicity, age 5 to 15 years (mean 8.9 +/- 2.9). The APOE*3 allele was the most frequent (77%), followed by APOE*4 (17%) and APOE*2 (6%). The pattern of lipid differences among genotypes was similar in both boys and girls. We did not detect an increase in cholesterol levels with the presence of the APOE*4 allele. Because a growing body of evidence suggests that the effect of *4 depends on its interaction with diet, the frequency of *4 might be more variable in children than in adults as well as among populations. Children carrying a *2 allele had lower total cholesterol (TC) and LDL-cholesterol levels (138.47 +/- 24.32 and 77.72 +/- 19.42, respectively) compared with *3/*3 children (158.33 +/- 25.28 and 97.05 +/- 21.82, respectively). Mean TC/HDLC ratio was also lower in children with the APOE*2 allele (3.27 +/- 0.66 versus 3.64 +/- 0.76). In this highly admixed population sample, the *2 anti-atherogenic lipid pattern is already detected in children.
C1 Univ Fed Rio Grande do Sul, Dept Genet, Inst Biociencias, BR-91501970 Porto Alegre, RS, Brazil.
   Inst Materno Infantil Pernanbuco, Programa Posgrad Saude Materno Infantil, BR-50070550 Recife, PE, Brazil.
RP De Franca, E (corresponding author), Univ Fed Rio Grande do Sul, Dept Genet, Inst Biociencias, Caixa Postal 15053, BR-91501970 Porto Alegre, RS, Brazil.
RI Alves, Joao G/J-6483-2013; Hutz, Mara H/I-4070-2012
OI Alves, Joao G/0000-0002-9170-0808; Hutz, Mara/0000-0002-9146-1229
CR [Anonymous], 1993, Arterioscler Thromb, V13, P1291
   Bertrais S, 2000, ANN EPIDEMIOL, V10, P316, DOI 10.1016/S1047-2797(00)00056-9
   Bohnet K, 1996, ANN HUM GENET, V60, P509, DOI 10.1111/j.1469-1809.1996.tb01617.x
   de Andrade FM, 2000, ANN HUM BIOL, V27, P29, DOI 10.1080/030144600282352
   de-Andrade FM, 2000, BRAZ J MED BIOL RES, V33, P529, DOI 10.1590/S0100-879X2000000500007
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Gerdes LU, 1996, HUM GENET, V98, P546, DOI 10.1007/s004390050257
   GERDES LU, 1992, GENET EPIDEMIOL, V9, P155, DOI 10.1002/gepi.1370090302
   HALLMAN DM, 1991, AM J HUM GENET, V49, P338
   Hegele RA, 1997, ARTERIOSCL THROM VAS, V17, P1060, DOI 10.1161/01.ATV.17.6.1060
   HIXSON JE, 1991, ARTERIOSCLER THROMB, V11, P1237, DOI 10.1161/01.ATV.11.5.1237
   Isasi CR, 2000, PEDIATRICS, V106, P568, DOI 10.1542/peds.106.3.568
   KAMBOH MI, 1995, HUM BIOL, V67, P195
   KAMBOH MI, 1995, ATHEROSCLEROSIS, V112, P145, DOI 10.1016/0021-9150(94)05409-C
   LEHTIMAKI T, 1995, J LIPID RES, V36, P653
   Lucotte G, 1997, HUM BIOL, V69, P253
   Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507
   MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935
   Morrison JA, 2002, METABOLISM, V51, P432, DOI 10.1053/meta.2002.31321
   Nelson MR, 1999, ANN HUM GENET, V63, P311, DOI 10.1046/j.1469-1809.1999.6340311.x
   ORCHARD TJ, 1981, INT J EPIDEMIOL, V10, P161, DOI 10.1093/ije/10.2.161
   Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148
   PORKKA KVK, 1994, CLIN GENET, V45, P113
   Rask-Nissila L, 2002, ARTERIOSCL THROM VAS, V22, P492, DOI 10.1161/hq0302.104516
   Salzano FM, 2002, EVOLUTION GENETICS L
   Sanghera DK, 1996, ATHEROSCLEROSIS, V126, P35
   Scacchi R, 1997, HUM BIOL, V69, P375
   SEPEHRNIA B, 1989, AM J HUM GENET, V45, P586
   SRINIVASAN SR, 1993, METABOLISM, V42, P381, DOI 10.1016/0026-0495(93)90091-2
   Valveny N, 1997, CLIN GENET, V51, P354
   Wilson PWF, 1996, ARTERIOSCL THROM VAS, V16, P1250, DOI 10.1161/01.ATV.16.10.1250
   Wissler RW, 1998, AM J PATHOL, V153, P1023, DOI 10.1016/S0002-9440(10)65647-7
   Zekraoui L, 1997, HUM BIOL, V69, P575
   Ziv E, 2003, PHARMACOGENOMICS, V4, P431, DOI 10.1517/phgs.4.4.431.22758
NR 34
TC 21
Z9 23
U1 0
U2 2
PU WAYNE STATE UNIV PRESS
PI DETROIT
PA 4809 WOODWARD AVE, DETROIT, MI 48201-1309 USA
SN 0018-7143
EI 1534-6617
J9 HUM BIOL
JI Hum. Biol.
PD APR
PY 2004
VL 76
IS 2
BP 267
EP 275
DI 10.1353/hub.2004.0030
PG 9
WC Anthropology; Biology; Genetics & Heredity
SC Anthropology; Life Sciences & Biomedicine - Other Topics; Genetics &
   Heredity
GA 842WU
UT WOS:000223036000006
PM 15359535
DA 2020-12-01
ER

PT J
AU Pinto, KDBPC
   Maggi, RRS
   Alves, JGB
AF Pinto, KDBPC
   Maggi, RRS
   Alves, JGB
TI Analysis of social and environmental risk for pleural involvement in
   severe pneumonia in children younger than 5 years of age
SO REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC
   HEALTH
LA Portuguese
DT Article
ID ACUTE RESPIRATORY-INFECTIONS; PARAPNEUMONIC EFFUSIONS; HOSPITALIZED
   CHILDREN; EXPERIENCE; EMPYEMA
AB Objective. To determine social and environmental risk factors associated with pleural involvement among children from 3 to 59 months old who were hospitalized with severe pneumonia in northeastern Brazil.
   Methods. This was an observational and descriptive cross-sectional study with an analytical component. We evaluated 154 patients hospitalized due to severe pneumonia, with or without pleural involvement. Pleural involvement was determined based on radiological findings. The following variables were analyzed: age, sex, place of residence, housing conditions, day care attendance, passive smoking, family income, presence of consumer goods in the home (e.g., television, radio, refrigerator, automobile), and schooling and occupation of the mother or other caregiver. The information was obtained by interviewing the mother or other caregiver or by consulting-the inpatient medical chart.
   Results. The frequency of pleural involvement among the 154 patients evaluated was 25.3%. The following factors were associated with pleural involvement: living in a rural area, being in a household with two or fewer rooms, family income below 170 U.S. dollars per month, and birthweight < 2 500 g.
   Conclusions. These findings indicate the need to improve the socioeconomic and living conditions of the less-privileged population, especially in rural areas. The health sector should emphasize primary care, focusing on a preventive approach beginning in the prenatal period.
C1 IMIP, Recife, PE, Brazil.
   Univ Fed Pernambuco, Recife, PE, Brazil.
RP Pinto, KDBPC (corresponding author), Rua Ricardo Salazar,336 Apto 903, BR-50720120 Recife, PE, Brazil.
EM kardani13@hotmail.com
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
CR AMARAL JJF, 1997, INVESTIGACOES OPERAC, P85
   Banajeh SM, 1998, J TROP PEDIATRICS, V44, P343, DOI 10.1093/tropej/44.6.343
   BENGUIGUI Y, 1987, Boletin de la Oficina Sanitaria Panamericana, V102, P36
   BENGUIGUI Y, 1997, INVESTIGACOES OPERAC, P159
   BENGUIGUI Y, 1997, ACOES SAUDE MATERNO
   BENGUIGUI Y, 2001, INVESTIGACIONES OPER
   BEREZIN EN, 1999, 39 INT C ANT AG CHEM
   *BRAS MIN SAUD, 2000, MAN INF RESP AG CRIA
   *BRAS MIN SAUD, 1998, 2 PESQ EST SAUD NUTR
   Broor S, 2001, Indian Pediatr, V38, P1361
   BULLA A, 1978, B WORLD HEALTH ORGAN, V56, P481
   CARBALLAL G, 1990, REV INFECT DIS, V12, pS1074
   DEAN JG, 1994, EPI INFO 6 0 WORD PR
   Demers AM, 2000, PEDIATR INFECT DIS J, V19, P424, DOI 10.1097/00006454-200005000-00007
   ESCOBAR MM, 1989, REV FACULTAD MED I C, V3, P15
   FREIJ BJ, 1984, PEDIATR INFECT DIS J, V3, P578, DOI 10.1097/00006454-198411000-00021
   FREITAS AEH, 1998, PEDIAT ATUAL, V11, P9
   Hardie WD, 1998, PEDIATRICS, V101, P388, DOI 10.1542/peds.101.3.388
   MUNGLANI R, 1991, RESP MED, V85, P117, DOI 10.1016/S0954-6111(06)80288-X
   RAVITCH MM, 1961, JAMA-J AM MED ASSOC, V175, P1039, DOI 10.1001/jama.1961.03040120001001
   RODRIGUES JR, 1997, INVESTIGACOES OPERAC, P143
   RUVINSKI R, 1998, INFECCOES RESP CRIAN, P217
   SANCHEZ JO, 1995, CIR CIRUJ, V63, P130
   SANTANNA CC, 1999, PEDIAT ATUAL, V12, P50
   SCHUTZE GE, 1992, PEDIATR INFECT DIS J, V11, P160, DOI 10.1097/00006454-199202000-00034
   VICTORA C. G, 1998, INFECCOES RESP CRIAN, P43
   World Health Organization, INT MAN CHILDH ILLN
NR 27
TC 10
Z9 13
U1 0
U2 5
PU PAN AMER HEALTH ORGANIZATION
PI WASHINGTON
PA 525 23RD ST NW, WASHINGTON, DC 20037 USA
SN 1020-4989
J9 REV PANAM SALUD PUBL
JI Rev. Panam. Salud Publica
PD FEB
PY 2004
VL 15
IS 2
BP 104
EP 109
DI 10.1590/S1020-49892004000200005
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 898HT
UT WOS:000227068500005
PM 15030655
OA Bronze
DA 2020-12-01
ER

PT J
AU Franca, E
   Alves, JGB
   Araujo, AS
   Hutz, MH
AF Franca, E
   Alves, JGB
   Araujo, AS
   Hutz, MH
TI Influence of the apolipoprotein polymorphisms on plasma lipid levels in
   Brazilian children
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Meeting Abstract
CT 52nd Annual Meeting of the American-Society-of-Human-Genetics
CY OCT 15-19, 2002
CL BALTIMORE, MARYLAND
SP Amer Soc Human Genet, NICHHD, NCI, NIMH, Affymetrix Inc, Gentra Syst, NIDCD
C1 Univ Fed Rio Grande Sul, Porto Alegre, RS, Brazil.
   Inst Materno Infantil Pernambuco, Recife, PE, Brazil.
   Hemoctr Pernambuco, Recife, PE, Brazil.
RI Hutz, Mara H/I-4070-2012; Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
NR 0
TC 0
Z9 0
U1 0
U2 0
PU UNIV CHICAGO PRESS
PI CHICAGO
PA 1427 E 60TH ST, CHICAGO, IL 60637-2954 USA
SN 0002-9297
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD OCT
PY 2002
VL 71
IS 4
SU S
MA 928
BP 331
EP 331
PG 1
WC Genetics & Heredity
SC Genetics & Heredity
GA 594AC
UT WOS:000178025800932
DA 2020-12-01
ER

PT J
AU Alves, JGB
   Correia, JD
AF Alves, JGB
   Correia, JD
TI Ability of mothers to assess the presence of fever in their children
   without using a thermometer
SO TROPICAL DOCTOR
LA English
DT Article
ID PALPATION
AB Fever is a common complaint in paediatrics and the ability of mothers to identify high temperatures in their children when there is no thermometer available needs to be assessed. A total of 169 mothers from a low social and economic background were studied to assess the accuracy of fever diagnosis in their children by palpation. In 137 children with axillary temperatures greater than or equal to 38degreesC as measured by a mercury glass thermometer, mothers were able to detect fever by palpation in 104 cases (sensitivity of 75.9%). In another 32 children without fever, 29 were correctly identified (specificity of 90.6%). Only 21% of mothers in the study had a thermometer in their home and only 44% of these knew how to use it properly. Results show that mothers use palpation to assess the presence of fever in their children and are able to do it correctly in most cases.
C1 Inst Materno Infantil Pernambuco, Dept Paediat, BR-50070550 Pernambuco, Brazil.
RP Alves, JGB (corresponding author), Inst Materno Infantil Pernambuco, Dept Paediat, Rua Coelhos,300 Ilha Leite, BR-50070550 Pernambuco, Brazil.
RI Correia, Jailson B./J-4331-2015; Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
CR BANCO L, 1984, AM J DIS CHILD, V138, P976, DOI 10.1001/archpedi.1984.02140480078024
   BERGESON PS, 1974, CLIN PEDIATR, V13, P350, DOI 10.1177/000992287401300416
   Cunha BA, 1996, INFECT DIS CLIN N AM, V10, P33, DOI 10.1016/S0891-5520(05)70284-1
   ERNST TN, 1985, AM J DIS CHILD, V139, P546, DOI 10.1001/archpedi.1985.02140080016015
   Graneto JW, 1996, PEDIATR EMERG CARE, V12, P183, DOI 10.1097/00006565-199606000-00009
   Kramer MS, 1997, PEDIATRICS, V100, P128, DOI 10.1542/peds.100.1.128
   Nwanyanwu OC, 1997, ANN TROP MED PARASIT, V91, P359, DOI 10.1080/00034989760978
   SINGHI S, 1990, Indian Pediatrics, V27, P811
   *WHO, 1997, IMCI TRAIN COURS 1 L
NR 9
TC 12
Z9 12
U1 0
U2 4
PU ROYAL SOC MEDICINE PRESS LTD
PI LONDON
PA 1 WIMPOLE STREET, LONDON W1M 8AE, ENGLAND
SN 0049-4755
J9 TROP DOCT
JI Trop. Dr.
PD JUL
PY 2002
VL 32
IS 3
BP 145
EP 146
DI 10.1177/004947550203200308
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 572UH
UT WOS:000176793000007
PM 12139153
DA 2020-12-01
ER

PT J
AU Alves, JGB
AF Alves, JGB
TI Relactation improves nutritional statics in hospitalized infants
SO JOURNAL OF TROPICAL PEDIATRICS
LA English
DT Letter
C1 Inst Materno Infantil Pernambuco, Recife, PE, Brazil.
RP Alves, JGB (corresponding author), Inst Materno Infantil Pernambuco, Recife, PE, Brazil.
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
CR ALVES JGB, 1996, REV IMIP, V10, P115
   AUERBACH KG, 1989, PEDIATRICS, V65, P236
   Dickerson J, 1995, Nurs Times, V91, P44
   *OPS, 1983, POBL SAL AM LAT
   PURMATH CRB, 1993, INDIAN PEDIATR, V30, P1329
NR 5
TC 0
Z9 1
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0142-6338
J9 J TROP PEDIATRICS
JI J. Trop. Pediatr.
PD APR
PY 1999
VL 45
IS 2
BP 120
EP 121
DI 10.1093/tropej/45.2.120-a
PG 2
WC Pediatrics; Tropical Medicine
SC Pediatrics; Tropical Medicine
GA 196KG
UT WOS:000080307100017
PM 10341513
OA Bronze
DA 2020-12-01
ER

PT J
AU Alves, JGB
   Figueira, ACD
   Amaral, F
   Guimaraes, A
AF Alves, JGB
   Figueira, ACD
   Amaral, F
   Guimaraes, A
TI Transfontanelle ultrasonography in infants: Comparative study with
   cranial computed tomography
SO JOURNAL OF TROPICAL PEDIATRICS
LA English
DT Article
ID HEMORRHAGE
AB The findings of transfontanelle ultrasonography, undertaken in 36 infant with clinical evidence of central nervous system (CNS) disorders, were compared with the findings of cranial computed tomography (CT). Considering the CT scan findings as gold standard, cranial ultrasonography had a sensitivity of 82 per cent and a specificity of 75 per cent in identifying cerebral pathology. The positive predictive value was 92 per cent and negative predictive value was 45 per cent.
C1 INST MATERNO INFANTIL PERNAMBUCO,RECIFE,PE,BRAZIL.
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
CR Angtuaco E E, 1994, Curr Probl Diagn Radiol, V23, P69
   BARNES PD, 1992, PEDIATR CLIN N AM, V39, P743
   CARSON SC, 1990, AM J NEURORADIOL, V11, P677
   GRANT EG, 1981, RADIOLOGY, V139, P687, DOI 10.1148/radiology.139.3.7232736
   HILL TA, 1981, VENTRICULITIS NEONAT, P133
   KEENEY SE, 1991, PEDIATRICS, V87, P21
   RAJU VSN, 1995, J TROP PEDIATRICS, V11, P68
   SIEGEL MJ, 1983, RADIOLOGY, V149, P11
   VACHON L, 1987, J ULTRAS MED, V6, P269, DOI 10.7863/jum.1987.6.5.269
NR 9
TC 1
Z9 1
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD, ENGLAND OX2 6DP
SN 0142-6338
J9 J TROP PEDIATRICS
JI J. Trop. Pediatr.
PD JUN
PY 1997
VL 43
IS 3
BP 182
EP 183
DI 10.1093/tropej/43.3.182
PG 2
WC Pediatrics; Tropical Medicine
SC Pediatrics; Tropical Medicine
GA XL463
UT WOS:A1997XL46300014
PM 9231642
OA Bronze
DA 2020-12-01
ER

PT J
AU DASILVA, EO
   ALVES, JG
   ALMEIDA, E
AF DASILVA, EO
   ALVES, JG
   ALMEIDA, E
TI IS THE EEC SYNDROME GENETICALLY HETEROGENEOUS
SO REVISTA BRASILEIRA DE GENETICA
LA English
DT Article
C1 UNIV FED PERNAMBUCO,DEPT BIOL GERAL,GENET LAB,BR-50000 RECIFE,PE,BRAZIL.
   UNIV FED PERNAMBUCO,DEPT OFTALMOL,BR-50000 RECIFE,PE,BRAZIL.
RP DASILVA, EO (corresponding author), INST MATERNO INFANTIL PERNAMBUCO,RUA COELHOS 300,BOA VISTA,BR-50000 RECIFE,PE,BRAZIL.
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
CR ALDENHOFF P, 1978, Z KINDERHEILKD, V126, P375
   BIXLER D, 1971, CLIN GENET, V3, P43
   BRILL CB, 1972, CLIN GENET, V3, P295
   BYSTROM EB, 1975, J ORAL SURG, V33, P192
   CAT I, 1972, HUM HERED, V22, P91, DOI 10.1159/000152474
   FREIREMAIA N, 1970, AM J HUM GENET, V22, P370
   GELLIS SS, 1976, AM J DIS CHILD, V130, P653, DOI 10.1001/archpedi.1976.02120070079015
   GEMME G, 1976, MINERVA PEDIATR, V28, P36
   JAMEHDOR M, 1978, CLEFT PALATE J, V15, P390
   MINER ME, 1980, NEURORADIOLOGY, V20, P163, DOI 10.1007/BF00341782
   PENCHASZADEH VB, 1976, J MED GENET, V13, P281, DOI 10.1136/jmg.13.4.281
   PEREZGONZALEZ J, 1978, AN ESP PEDIATR, V11, P715
   PFEIFFER RA, 1973, Z KINDERHEILKD, V115, P235, DOI 10.1007/BF00440361
   PINHEIRO M, 1980, CLIN GENET, V17, P363
   PRIES C, 1974, AM J DIS CHILD, V127, P840, DOI 10.1001/archpedi.1974.02110250066009
   Romagnoli G, 1974, Pathologica, V66, P95
   ROSENMANN A, 1976, CLIN GENET, V9, P347
   RUDIGER RA, 1970, AM J DIS CHILD, V120, P160
NR 18
TC 6
Z9 6
U1 0
U2 0
PU SOC BRASIL GENETICA
PI RIBEIRAO PRET
PA DEPT GENETICA FAC MEDICINA RIBEIRAO PRETO, 14049-900 RIBEIRAO PRET,
   BRAZIL
SN 0100-8455
J9 REV BRAS GENET
JI Rev. Bras. Genet.
PY 1984
VL 7
IS 4
BP 735
EP 742
PG 8
WC Genetics & Heredity
SC Genetics & Heredity
GA TZ439
UT WOS:A1984TZ43900013
DA 2020-12-01
ER

EF